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Abstract 
This thesis describes cyclometallation at Pd, Mn and Co: functionalisation of C-H 
and C≡C bonds involving cyclisation, rearrangement and isomerisation processes. 
The use of NaNO2/NaNO3 as an oxidant in oxidative Pd-catalyzed processes has 
recently been reported as a complementary co-catalyst to other common oxidants 
(e.g. Cu
II
/Ag
I
 salts). In view of this (Chapter two) the synthesis of a series of 
palladacyclic complexes containing a C^N ligand backbone, and the geometry and 
linkage isomerism at NO2-Pd, has been studied. The geometry about the Pd
(II)
 centre 
shows the crucial role played by bulky ligands in creating hindrance and affecting 
phosphine dissociation. 
Mn-catalysed C-H bond activation is a powerful strategy for the functionalisation of 
organic compounds containing metal-directing groups. Chapter three of this thesis 
reports the characterisation of a highly reactive 7-membered Mn
I
 species which acts 
as anvil point between protonation and reductive elimination to deliver alkenylated 
and/or pyridinium products respectively.  Both processes are exemplified through the 
reactions of a substrate containing a 2-pyridyl directing group and electron-deficient 
2-pyrone motif at Mn
I
, where C-H bond activation occurs regioselectively at C3 
within the 2-pyrone. An unprecedented regioselective Diels-Alder reaction also 
occurs on both the pyridine and 2-pyrone ring systems. These findings provide a 
unique insight into Mn
I
-mediated C-H bond activation processes, especially how 
relatively minor changes in substrate structure influence the product distribution. The 
study shows that Mn
I
-based metallocycles warrant further study more generally in 
organic and organometallic chemistry 
The intermolecular Pauson-Khand (PK) reactions of sterically comparable (2-
pyridylethynyl)-heteroaromatic compounds with norbornene, mediated by Co2(CO)8 
to give cyclopentenone products, were examined in Chapter four of this thesis. The 
π-deficient heteroaromatic substrate, 2-pyrone, favoured the -position while the π-
rich heteroaromatics such as 2-thiophene favour the β-position. The position of the 
nitrogen in pyridyl-containing alkyne substrates also affects the regiochemical 
outcome of the PK reaction. A 2-pyridyl alkyne, possessing a proximal nitrogen 
atom, influences the regioselectivity relative to a 4-pyridyl variant, quite 
dramatically, favouring the β-position in the newly formed cyclopentenone ring. 
Overall, the type of heteroaromatic group greatly influences PK regioselectivity.  
The PK cycloadducts undergo a 6π-electrocyclisation–oxidative aromatisation 
reaction in the presence of light, which is promoted by a LED UV-light controlled 
system, affording benzo[h]indeno[1,2-f]isochromene type products.  
List of Contents 
3 
 
List of Contents 
Abstract ........................................................................................................ 2 
List of Contents ........................................................................................... 3 
List of Figures .............................................................................................. 8 
List of Schemes .......................................................................................... 15 
List of Tables ............................................................................................. 20 
Author’s Declaration ................................................................................ 23 
Chapter 1: General Introduction............................................................. 24 
1.1 Transition metal mediated C–C, C–O and C–N bond formation .................... 24 
1.1.1 Palladium in C-X/C-H cross-coupling bond functionalisation ................... 24 
1.1.2 Recent developments in metal C–C bond formation via C–H bond 
activation – examples from natural product synthesis ............................................ 26 
1.1.3 C-H bond activation methodologies ........................................................... 32 
1.2 Mn-catalysed cross-coupling processes .......................................................... 35 
1.2.1 Mn catalysed cross-coupling with organolithium and Grignard reagents .. 35 
1.2.2 Cross-coupling processes leading to carbon-heteroatom bond formation .. 37 
1.2.3 Mn-catalysed carbonylation reactions......................................................... 38 
1.2.4 Mn-catalysed C–H bond activation processes ............................................ 40 
1.3 Introduction to Pauson-Khand reaction .......................................................... 41 
1.3.1 Mechanism of Pauson-Khand reaction ....................................................... 42 
1.3.2 Regioselectivity in the Pauson-Khand reaction .......................................... 47 
1.3.3 Significance of alkene regioselectivity in intermolecular PKRs................. 48 
List of Contents 
4 
 
1.3.4 Competition between steric and electronic factors ..................................... 49 
1.3.5 Regiochemistry determination with sterically near-equivalent alkynes ..... 52 
1.4 PKR/6π-electrocyclisation/aromatisation reactions ........................................ 54 
1.4.1 Examples of orbital symmetry and torquoselectivity in 6π–
electrocyclisations ................................................................................................... 55 
1.5 Project Aims and Objectives ........................................................................... 56 
1.5.1 Aims ............................................................................................................ 56 
1.5.2 Objectives .................................................................................................... 56 
The following objectives underpin the content of this thesis: ................................ 56 
2 Chapter 2: Synthesis and Characterisation of Cyclopalladated 
C^N Complexes ......................................................................................... 58 
2.1 Introduction ..................................................................................................... 58 
2.1.1 2-Acetate-bridged palladacyclic complexes of 2-phenylpyridine ............. 59 
2.2 Nitrido palladacyclic complexes of 2-phenylpyridine .................................... 63 
2.2.1 Geometry and linkage isomerism in Pd–NO2 and Pd–ONO species .......... 66 
2.2.2 Geometry and linkage isomerism in Pd–NO2 and Pd–ONO species – a 
theoretical perspective ............................................................................................. 67 
2.2.3 Metastable Pd(η1-ONO)(C^N)PR3 and an unusual Pd dimer structure 
(C^N = ligand) ........................................................................................................ 73 
2.3 Palladacyclic complexes of 2-benzlpyridine ................................................... 79 
2.3.1 Geometrical aspects of the Pd complexes ................................................... 80 
2.4 Palladacyclic complexes of 4-(2-pyridyl)-6-methyl-2-pyrone........................ 83 
2.5 Nitrito-palladacyclic complexes of 2-benzylpyridine ..................................... 88 
List of Contents 
5 
 
2.5.1 NMR study of nitrito-palladacyclic complexes of 2-benzylpyridine .......... 91 
2.5.2 Single crystal study of nitrito-palladacyclic complexes of 2-
benzylpyridine ......................................................................................................... 95 
2.5.3 Pd-catalysed C–H bond functionalisation processes................................... 98 
2.5.4 Pd Cat. C-H bond activation the dichotomy between nitration vs 
acetoxylation ........................................................................................................... 98 
2.6 Conclusion .................................................................................................... 101 
3 Chapter 3 Manganese catalysed C-H alkenylation / Diels-Alder 
Reactions .................................................................................................. 102 
3.1 Introduction ................................................................................................... 102 
3.2 Synthesis of 4-(2'-pyridyl)-6-methyl-2-pyrone derivatives 81 and 104 ........ 105 
3.3 Synthesis of five membered manganacycles ................................................ 106 
3.3.1 C-H bond alkenylation .............................................................................. 108 
3.3.2 Density functional theory (DFT) evaluation for 107 ................................ 109 
3.3.3 Alkenylation reaction/Diels-Alder product ............................................... 113 
3.4 Effect of substituted 2-pyridine moiety with 6-methoxy-2-pyridyl moiety 
on 2-pyrone ............................................................................................................... 125 
3.5 Conclusion .................................................................................................... 127 
4 Chapter 4 Pauson-Khand / 6π-electrocyclisation reactions of 
internal alkynes possessing cobalt-directing groups ............................ 129 
4.1 Introduction ................................................................................................... 129 
4.1.1 Synthesis of sterically and electronically near-equivalent alkynes ........... 133 
4.2 Synthesis of sterically and electronically near-equivalent heteroaromatic 
PKR protocol ............................................................................................................. 137 
List of Contents 
6 
 
4.2.1 Evaluation of heteroaromatic containing nitrogen atom or 2-pyrone in 
PKR 138 
4.2.2 Significance of the alkene in determining PKR regioselectivity .............. 147 
4.2.3 Microwave-assisted PKR – a tool for forming other cyclic products ....... 149 
4.3 Photochemical 6-electrocyclisation reaction .............................................. 154 
4.3.1 Orbital symmetry and thermal versus photochemical selective activation 
in 6π electrocyclisations of PKR compound containing 2-pyrone system ........... 155 
4.3.2 Spectroscopic analysis .............................................................................. 159 
4.4 Conclusion .................................................................................................... 165 
5 Chapter 5 Over-arching conclusions .............................................. 166 
5.1 General conclusions ...................................................................................... 166 
6 Chapter 6: Experimental section .................................................... 171 
6.1 General experimental techniques .................................................................. 171 
6.1.1 General procedures.................................................................................... 173 
6.2 Synthetic procedures and compound data ..................................................... 181 
7 Appendices ........................................................................................ 263 
7.1 Appendix 1: X -Ray Diffraction Data ........................................................... 263 
Crystallographic data for complexes 70, 74a and 74b. ............................................. 263 
Crystallographic data for complexes 85, 89, 91 and 93. ........................................... 265 
Crystallographic data for complexes 88, 90 and 92. ................................................. 267 
Crystallographic data for complexes 105a, 105b, 107 and 110. ............................... 269 
Crystallographic data for compound 108 and 109 .................................................... 271 
List of Contents 
7 
 
Crystallographic data for compound 114c, 115c and 130a ....................................... 273 
Crystallographic data for compound 121, 122 and 124...................................... 275 
Crystallographic data for compound 125, 126 and 127 ..................................... 277 
7.2 Appendix 2: UV–Visible spectroscopic data for compound 108 and 109 .... 279 
UV–visible spectroscopic data for compound 108 ................................................... 279 
UV–visible spectroscopic data for compound 109 ................................................... 280 
7.3 Appendix 3: UV–Visible irradiation Spectroscopic Data ............................. 281 
7.3.1 General procedure for the UV light-controlled irradiation for cyclisation 
/ aromatisation ....................................................................................................... 281 
UV–visible irradiation spectroscopic data for compound 113Ato form 113B .... 282 
UV–visible irradiation spectroscopic data for compound 121A to form 121B ........ 283 
UV–visible irradiation spectroscopic data for compound 124A to form 124B .... 284 
UV–visible irradiation spectroscopic data for compound 124Ato form 124B ... 285 
UV–visible irradiation spectroscopic data for compound 125Ato form 125B .... 286 
UV–visible irradiation spectroscopic data for compound 126Ato form 126B ... 287 
7.4 Appendix 4: NMR spectra of prepared compounds ...................................... 288 
Abbreviations ........................................................................................... 366 
References ................................................................................................ 371 
 
List of Figures 
8 
 
List of Figures 
Figure 1 Trend in discovery and number of publications 1999, 2000, 2010 and 2014 
of Pd-catalysed cross-coupling reactions (Based on SciFinder searches, May 2014).
 .................................................................................................................................... 25 
Figure 2 Classical vs modern pathways for metal-catalysed C-H bond 
functionalisation ......................................................................................................... 32 
Figure 3 Synthesis methodology using NOx with Pd ................................................ 33 
Figure 4. Nakamura’s calculated of Energies in PKR using DFT methods. These 
values were for acetylene as an alkyne and ethene as an alkene ............................... 46 
Figure 5 PKR regioselectivity regarding alkene insertion vs. steric effect ............... 47 
Figure 6 Alkene reactivity in the intermolecular PKR .............................................. 48 
Figure 7 HOMO-LUMO orbital interaction of a transition metal d-orbital with 
ethene 
99
 ...................................................................................................................... 49 
Figure 8 Aromatic region of some 
1
H NMR spectra containing a mixture 62A and 
62B ............................................................................................................................. 60 
Figure 9 Phosphorus coupling/de-coupling 
1
H NMR effect on monomeric 
palladacycle containing phosphine ligand ................................................................. 65 
Figure 10 Sine-bell enhancement of 
1
H and 
1
H{
31
P} NMR spectra effect on complex 
illustrating the -N resonance of 67 (red 1H{31P} – green 1H) .................................. 66 
Figure 11 Single crystal X-ray diffraction structure of complex 60 ......................... 67 
Figure 12 Single point energies of complexes of the type [Pd(Ligand)(NO2)PPh3] . 69 
Figure 13 Single crystal X-ray diffraction structure of complex 74a; Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. 
Selected bond lengths (Å); Pd(1)–C(1) 1.972(4), Pd(1)–O(3) 2.173(3), Pd(1)–N(1) 
2.017(3), Pd(1)–N(3) 2.034(3), Pd(1)–Pd(2) 2.9802(5), Pd(2)–C(12) 1.964(4), 
Pd(2)–N(4) 2.027(3), Pd(2)–O(1) 2.172(3), Pd(2)–N(2) 2.024(3) ............................ 75 
List of Figures 
9 
 
Figure 14 Single crystal X-ray diffraction structure of complex 74b; Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. 
Selected bond lengths (Å); Pd(1)–C(1) 1.964(3), Pd(1)-N(1) 2.016(2), Pd(1)–
N(3) 2.033(3), Pd(1)–O(3) 2.172(2), Pd(1)–Pd(2) 2.9707(4), Pd(2)–C(12) 1.962(3), 
Pd(2)–N(2) 2.012(2), Pd(2)–N(4) 2.037(2), Pd(2)–O(1) 2.184(2). ........................... 76 
Figure 15 Single crystal X-ray diffraction structure of complex 70 showing two 
molecules (left – single molecule and right – showing the two independent molecules 
in the unit cell). Hydrogen atoms omitted for clarity. Thermal ellipsoids shown with 
probability of 50%. For selected bond lengths and bond angles see Table 3 page 77.
 .................................................................................................................................... 77 
Figure 16 Geometry of cyclopalladation of 2-benzylpyridine .................................. 80 
Figure 17 Comparison of 
1
H NMR spectra of 76A/B (positive spectra) and 80 
(negative spectra) at (400 MHz, CD2Cl2). I- the negative spectra the protons of the 
pyridiyl group are highlighted .................................................................................... 82 
Figure 18 NMR spectroscopic analysis of complex 82 (400 MHz, CDCl3) – inset 
(top right) is the 
1
H COSY spectra ............................................................................. 86 
Figure 19 Single crystal X-ray diffraction structure of complex 85. Hydrogen atoms 
removed for clarity. Thermal ellipsoids shown with probability of 50%. Selected 
bond lengths (Å); Pd(1)–C(1) 1.9931(18), Pd(1)–Cl(1) 2.3967(5), Pd(1)–N(1) 
2.0353(16), Pd(1)–N(2) 2.0287(15). .......................................................................... 87 
Figure 20 
13
P NMR chemical shift () data from the spectra of complexes 87-96 ... 94 
Figure 21 Single crystal X-ray diffraction structures of complexes 88-93. .............. 97 
Figure 22  Catalytic activity of Pd complexes. (a) and (b) with respect to (c) and (d) 
(5 mol%) with varying equivalents of NaNO3, in the aerobic oxidation of compounds 
1- 2. .......................................................................................................................... 100 
Figure 23 Markovnikov and anti-markovnikov addition vs protonation by terminal 
alkyne and CyNH2
+
 possibilities .............................................................................. 105 
List of Figures 
10 
 
Figure 24 X-ray crystal structures of 105a and 105b (note: arbitrary atom numbering 
used and thermal ellipsoids set to 50%; H-atoms omitted for clarity). .................... 107 
Figure 25 X-ray crystal structure of 2-methyl-4-oxo-6-phenyl-4H-3,75-pyrano[4,3-
a]quinolizin-7-ylium-η4-3,3a,5,6-tricarbonylmanganesuide 107 (note: arbitrary atom 
numbering used). Selected torsion angles (°), bond angles (°) and bond lengths (Å): 
C4-C3-C13-C12 = 4.2(2), C3-C4-C7-N1 = -38.4(2), N1-C12-C13-C3 = 44.4(2); 
C13-C12-N1 = 114.38(14), C3-C4-C7 = 116.31(15); C3-Mn1 = 2.0769(17), C4-Mn1 
= 2.1843(17), C12-Mn1 = 2.1060(18), C13-Mn1 = 2.0908(18) (Figure prepared by 
Ian Fairlamb). ........................................................................................................... 109 
Figure 26 Density functional theory (DFT) showing potential energy surface for the 
formation of 107; Energies are zero point-corrected electronic energies (top) and 
Gibbs free energies at 298.15 K (bottom) in kJ mol
-1
 at the PBE0-D3/def2-
TZVPP//BP86/SV(P) level with solvation corrections applied in Et2O (COSMO, = 
4.33 for Et2O at 25 °C). ............................................................................................ 110 
Figure 27; 
1
H NMR spectra of the manganese starting material 105a. and the 
solution after 15 min irradiation with UV light (above). New signals belong to the 
intermediate (III). .................................................................................................... 111 
Figure 28 Correlation methods (HMQC and HMBC) and selective nOe experiments 
confirmed intermediate (III) (Figure prepared by Kate Appleby and Ian Fairlamb).
 .................................................................................................................................. 112 
Figure 29 Density functional theory (DFT) showing Potential energy surface for the 
formation of IIIa; Energies are zero point-corrected electronic energies (top) and 
Gibbs free energies at 298.15 K (bottom) in kJ mol
-1
at the PBE0-D3/def2-
TZVPP//BP86/SV(P) level with solvation corrections applied in Et2O (COSMO,  = 
4.33 for Et2O at 25 °C) ............................................................................................. 113 
Figure 30 
1
H NMR spectroscopic data (700 MHz, CD2Cl2) for compound 108; (a) 
chemical shifts (in ppm) are followed by the multiplicity of the signal and the 
coupling constant in Hz. (b) Key nOe interactions for compound 108, confirming the 
stereochemistry around the 2-pyrone moiety. .......................................................... 116 
List of Figures 
11 
 
Figure 31 X-ray crystal structure of 108 (note: arbitrary atom numbering used; 
thermal ellipsoids set to 50%; H-atoms omitted). .................................................... 117 
Figure 32 
1
H NMR spectroscopic data (700 MHz, CD2Cl2) for compound 109; 
chemical shifts (in ppm) are followed by the multiplicity of the signal and the 
coupling constant in Hz. ........................................................................................... 119 
Figure 33 X-ray crystal structure of 109 (note: arbitrary atom numbering used; 
thermal ellipsoids set to 50%; H-atoms omitted). .................................................... 120 
Figure 34 ESI-MS of the reaction of alkenylation and Diels-Alder product .......... 121 
Figure 35 X-ray crystal structure of 110 (note: arbitrary atom numbering used) 
dotted lines have been used to show the Mn-coordination in complex for clarity 
(thermal ellipsoids set to 50%; H-atoms omitted). Selected torsion angles (°), bond 
angles (°) and bond lengths (Å): C4-C3-C13-C12 = 4.2(2), C3-C4-C7-N1 = -38.4(2), 
N1-C12-C13-C3 = 44.4(2); C13-C12-N1 = 114.38(14), C3-C4-C7 = 116.31(15); C3-
Mn1 = 2.0769(17), C4-Mn1 = 2.1843(17), C12-Mn1 = 2.1060(18), C13-Mn1 = 
2.0908(18) ................................................................................................................ 126 
Figure 36 Heteroaromatic ring systems used in this study ..................................... 130 
Figure 37 X-ray diffraction structures of compound 114c and 115c. Compound 114c 
left hand side, showing the packing between the atoms in the molecules. Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. ..... 136 
Figure 38 
1
H NMR spectra (400 MHz, CDCl3) of PKR compound 122 reaction 
mixture of 1:1, 122α and 122β which possess the same Rf value by TLC. ............. 141 
Figure 39 
1
H NMR spectra (400 MHz, CDCl3) of PKR compound 124 showing 
simulation at different  of 124 above and 124see Table 9. ............................... 142 
Figure 40 Single Crystal X-ray structure of PKR for 121β, 122, 124, 125, 126 
and 127 ................................................................................................................... 146 
Figure 41 Stack plot of
 1
H NMR spectra (400 MHz, CDCl3) of 114c, 130a and 131a 
(reaction conducted under various conditions along with reference spectra). ......... 151 
List of Figures 
12 
 
Figure 42 Thermal vs photochemical Symmetry allowed induced cyclization ...... 155 
Figure 43 Mechanism and possible regioselective C3 and C5 paths for the formation 
of 121B from 121A .................................................................................................. 158 
Figure 44 UV analysis; monitoring the 6-photo-electrocyclization and 
aromatization of 121 with respect to time.............................................................. 160 
Figure 45 Stacked spectra plot showing the pre-cyclised 121A over complete 
cyclised product 121B and of some new signals ................................................ 161 
Figure 46 Stack spectral plot of irradiation cycles showing conversion of the pre-
cyclised 121A to cyclised product 121B over a period of 28 min. at 1 min. 
intervals ( = 400nm) ............................................................................................... 162 
Figure 47 Stack spectral plot of irradiation cycles showing the heated (35 oC) pre-
cyclised 121A to cyclised product 121B over a period of 28 min. at 4 min. 
intervals ( = 400nm) ............................................................................................... 163 
Figure 48 Single crystal X-ray diffraction structure of complex 74a ..................... 167 
Figure 49 An irradiation system using the 400 nm 5W LED drawing a current of 20 
mA. ........................................................................................................................... 180 
Figure 50  Single crystal X-ray diffraction structure of complexes 60, 70, 74a and 
74b. Hydrogen atoms removed for clarity. Thermal ellipsoids shown with 
probability of 50%.................................................................................................... 263 
Figure 51 Single crystal X-ray diffraction structure of chloromonomer complexes 
85, 89, 91 and 93. Hydrogen atoms removed for clarity. Thermal ellipsoids shown 
with probability of 50%. .......................................................................................... 265 
Figure 52 Single crystal X-ray diffraction structure of complexes 88, 90 and 92. 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown with probability of 
50%. ......................................................................................................................... 267 
List of Figures 
13 
 
Figure 53 Single crystal X-ray diffraction structure of complexes 105a, 105b, 107 
and 110. Hydrogen atoms removed for clarity. Thermal ellipsoids shown with 
probability of 50%.................................................................................................... 269 
Figure 54 Single crystal X-ray diffraction structure of compound 108 and 109. 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown with probability of 
50%. ......................................................................................................................... 271 
Figure 55 Single crystal X-ray diffraction structure of complexes 114c, 115c and 
130a. Compound 114c bottom, showing the packing between the molecules. 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown with probability of 
50%. ......................................................................................................................... 273 
Figure 56 Single crystal X-ray diffraction structure of PKR compound containing 2-
pyrone for 121, 122 and 124. Hydrogen atoms removed for clarity. Thermal 
ellipsoids shown with probability of 50%. ............................................................... 275 
Figure 57 Single crystal X-ray diffraction structure of PKR compound of 125, 
126 and 127. Hydrogen atoms removed for clarity. Thermal ellipsoids shown with 
probability of 50%.................................................................................................... 277 
Figure 58 UV–visible spectroscopic data for compound 108 ................................. 279 
Figure 59 UV–visible spectroscopic data for compound 109 ................................. 280 
Figure 60 An irradiation system using the 400 nm 5W LED drawing a current of 20 
mA ............................................................................................................................ 281 
Figure 61 UV–visible irradiation spectroscopic data for compound 113A to form 
113B ....................................................................................................................... 282 
Figure 62 UV–visible irradiation spectroscopic data for compound 121A to form 
121B ......................................................................................................................... 283 
Figure 63 UV–visible irradiation spectroscopic data for compound 124A to form 
124B ....................................................................................................................... 284 
 14 
 
Figure 64 UV–visible irradiation spectroscopic data for compound 124Ato form 
124B....................................................................................................................... 285 
Figure 65 UV–visible irradiation spectroscopic data for compound 125A to form 
125B ....................................................................................................................... 286 
Figure 66  UV–visible irradiation spectroscopic data for compound 126A to form 
126B ......................................................................................................................... 287 
 
List of Schemes 
15 
 
List of Schemes 
Scheme 1 Typical oxidative acetoxylation reaction mediated by Pd. ....................... 24 
Scheme 2 A timeline of cross-coupling processes .................................................... 27 
Scheme 3 Intermolecular Suzuki–Miyaura coupling exemplified in the total 
synthesis of gymnocin A ............................................................................................ 29 
Scheme 4 Different uses of the Sonogashira coupling in cascade reactions en route 
to dynemicin A ........................................................................................................... 31 
Scheme 5 C–H bond acetoxylation reaction reported by Sanford et al. .................... 34 
Scheme 6 Linkage isomerisation in a palladacycle containing a Pd
II
 centre. ............ 34 
Scheme 7 Nitrite adduct of [Pd3(OAc)5NO2]. ........................................................... 35 
Scheme 8 Water adduct of [Pd3(OAc)6·H2O] ............................................................ 35 
Scheme 9 MnCl2/2LiCl-catalyzed homocoupling of alkenyllithium derivatives ...... 36 
Scheme 10 MnCl2-catalysed homocoupling of Grignard reagents with low 
chemoselectivity ......................................................................................................... 37 
Scheme 11 Mn/Cu catalytic systems for the N-arylation of benzamide in H2O ....... 37 
Scheme 12 Mn-catalysed amination of aryl iodides with aliphatic amines............... 38 
Scheme 13 Mn-catalyzed dehydrogenative carbonylation of primary alkylamines .. 38 
Scheme 14 Proposed mechanism for Mn-catalysed formation of 2-pyrones ............ 39 
Scheme 15 Mn-catalysed aromatic C–H bond alkenylation using terminal alkynes 41 
Scheme 16 Transition-mediated Pauson-Khand reaction .......................................... 41 
Scheme 17 Cobalt-mediated Pauson-Khand reactions .............................................. 42 
Scheme 18 Magnus’s Mechanism for the intermolecular PKR ................................ 44 
List of Schemes 
16 
 
Scheme 19 Intermolecular Pauson-Khand reaction ................................................... 48 
Scheme 20 Norbornene effect on the regioselectivity which is completely selective, 
despite the sterically hindered group (example 1) ..................................................... 50 
Scheme 21 Norbornene effect on the regioselectivity which is completely selective, 
despite the sterically hindered group (example 2) ..................................................... 50 
Scheme 22 Summary of two reported studies probing the effect of alkene 
substituents in reactions of trifluoromethyl-substituted internal alkynes with 
norbornene and norbornadien. ................................................................................... 51 
Scheme 23 PKRs of heteroaromatic diarylalkynes reported by Fairlamb et al.
105
 .... 53 
Scheme 24 Formation of one regioisomeric product. ................................................ 54 
Scheme 25 6π-electrocyclisation/oxidative aromatisation reaction .......................... 54 
Scheme 26 Thermal vs photochemical induced cyclisation ...................................... 55 
Scheme 27 Potential products from the reaction of (a) benzene with Pd/O2/NOx and 
(b) [Pd]-NO2 for acetoxylation/nitration
14
 ................................................................. 58 
Scheme 28 Synthesis of palladacyclic complexes of 2-phenylpyridine .................... 60 
Scheme 29 Pd
III
/Pd
IV
 species implicated in acetoxylation reactions starting at Pd
II
 . 63 
Scheme 30 Synthesis of novel Pd
II
 nitrito complexes of 2-phenylpyridine and 
different nitrite geometries ......................................................................................... 64 
Scheme 31 General synthetic pathway to novel Pd
II
 nitrito complexes of 2-
phenylpyridine............................................................................................................ 70 
Scheme 32 Synthesis of novel nitrite palladacycles containing 2-phenylpyridine.... 71 
Scheme 33 Metastable Pd(η1-ONO)(C^N)PR3 and an unusual Pd
(II)
 dimer structure
 .................................................................................................................................... 73 
Scheme 34 Effect of bulky phosphine on nitrito cyclopalladated complexes 
containing phenylpyridine open crystallisation ......................................................... 74 
List of Schemes 
17 
 
Scheme 35 Synthesis of cyclopalladated 2-benzylpyridine complexes .................... 79 
Scheme 36 Synthesis of palladacycles of 2-benzylpyridine containing a pyridine 
ligand .......................................................................................................................... 81 
Scheme 37 Synthesis of cyclopalladated 4-(2'-pyridyl)-6-methyl-2-pyrone 
complexes ................................................................................................................... 84 
Scheme 38 Possible syn / anti vs C3 / C5  isomers of 82 .......................................... 85 
Scheme 39 Synthesis of Pd
II
 nitrito-cyclopalladated complex of 2-benzylpyridine . 88 
Scheme 40 General synthetic pathway to novel Pd
II
 nitrito complexes of 2-
benzylpyridine 75 ....................................................................................................... 89 
Scheme 41 Synthesis of novel nitrite-containing palladacycles of 2-benzylpyridine90 
Scheme 42 Anticipated reductive elimination via complex 60 with CuI .................. 98 
Scheme 43 Example demonstrating the catalytic nitration reaction by Liu and 
co-workers,
124
 ............................................................................................................. 99 
Scheme 44 Acetoxylation of 1 to 2 and a possible nitration side product 97 .......... 100 
Scheme 45 Chen and co-workers alkenylation process
69
 ........................................ 102 
Scheme 46 Novel five-membered manganacycle 100 ............................................. 103 
Scheme 47 Possible pathways for E/Z isomerization .............................................. 104 
Scheme 48 Negishi cross-coupling reactions of 4-bromo-6-methyl-2-pyrone 103 
with pyridyl zinc reagents 102a and 102b ............................................................... 106 
Scheme 49 Stoichiometric reaction of MnBn(CO)5 with 2-pyrone 104 affording 
five-membered manganacycle 105a and 105b ........................................................ 106 
Scheme 50 Unexpected alkyne insertion giving cyclomanganesiated complex 107
 .................................................................................................................................. 108 
List of Schemes 
18 
 
Scheme 51 Reaction of 105a with neat phenyl acetylene 16 at 100 °C afforded 
alkenylated product 106a and Diels-Alder products 106b, 108 and 109 ................. 114 
Scheme 52 Control Diels-Alder reaction in the absence of Mn .............................. 118 
Scheme 53 Proposed mechanism for the formation of Diels-Alder product 108. ... 118 
Scheme 54 proposed route for alkenylation/Diel-Alder Product. ........................... 124 
Scheme 55 Double alkyne insertion into cyclomanganesiated complex 110 and 
alkenylated product 111 ........................................................................................... 125 
Scheme 56 Sterically, near-equivalent, heteroaromatic-substituted alkynes in PKR
 .................................................................................................................................. 129 
Scheme 57 Postulated mechanism for the Sonogashira cross-coupling reaction .... 131 
Scheme 58 Synthesis of initial alkyne 114a using the Sonogashira cross-coupling 
reaction ..................................................................................................................... 131 
Scheme 59 Deprotection of silyl-protected alkynes to deliver terminal alkynes for 
Sonogashira cross-coupling ..................................................................................... 132 
Scheme 60 Synthesis of sterically and electronically near-equivalent terminal alkyne 
using Sonogashira cross-coupling reaction .............................................................. 134 
Scheme 61 PKR via the intermediate 2-alkynyl-pyrone-phenyl-Co2(CO)6 complex
 .................................................................................................................................. 138 
Scheme 62 PKR with norbornene and norbornadiene showing the significance of 
alkene structure in the affecting the regiochemical outcome of 121 and 128. ......... 147 
Scheme 63 Possible mechanism showing effect of alkene insertion on the 
regioselectivity outcome .......................................................................................... 149 
Scheme 64 Coogan lactone 129 as a side product in the PKR ................................ 150 
Scheme 65 Novel alkyne hydrogenation observed during microwave-assisted PK 
reaction ..................................................................................................................... 150 
List of Schemes 
19 
 
Scheme 66 Synthesis of Coogan-type lactones using two different alkenes. .......... 153 
Scheme 67 General synthesis route for cyclisation and aromatisation of PK 
cycloadduct. ............................................................................................................. 154 
Scheme 68 α-Pyrone photolysis: electrocyclic opening of α-pyrone and formation of 
cyclobutadiene V and cyclooctatetraene VII. .......................................................... 155 
Scheme 69 Photochemical reactions of PKR the cycloadducts .............................. 156 
Scheme 70 Synthesis of novel Pd
(II)
-nitrito-cyclopalladated complexes by a general 
synthetic route .......................................................................................................... 166 
Scheme 71 Unprecedented alkyne insertion into cyclomanganesiated complex and 
alkenylation / Diels-Alder rearrangement ................................................................ 168 
 
List of Tables 
20 
 
List of Tables 
Table 1 Comparison of selected 
1
H NMR shifts for compounds 62A and 62B ........ 62 
Table 2 Physical properties of complexes 60 and 67-73 2-phenylpyrine 
palladacycles (dimers to monomers) .......................................................................... 72 
Table 3 Selected bond lengths (Å) and bond angles (º) for complexes 60, 70, 74a 
and 74b ....................................................................................................................... 78 
Table 4 1H and 13P NMR chemical shift () data from the spectra of complexes 79 
and 89-96 .................................................................................................................... 93 
Table 5 Selected bond lengths (Å) and bond angles (º) for complexes 88-93 .......... 96 
Table 6 Comparison of selected 
1
H NMR shift data for the compounds 108 and 109
 .................................................................................................................................. 122 
Table 7 Synthesis of heteroaromatic ethynyl substrates, all substrates were 
synthesised using a standard Sonogashira protocol ................................................. 133 
Table 8 PKR of nitrogen and pyrone containing (heteroaromatic alkynes) 
compounds. .............................................................................................................. 140 
Table 9 The
 1H δ shift of PKR product involving 2-pyrones with regiochemical 
outcome supported by COSY, nOe 
1
H-
1
H and HMQC 
1
H-
13
C coupling experiments.
 .................................................................................................................................. 144 
Table 10 Study on the formation of side-products in PKR ..................................... 152 
Table 11 Synthesis of PKR cyclic adduct and respective  and regio-isomers (note 
the regioisomer is w.r.t cyclopentanone) ................................................................. 164 
Table 12 Summary of X-ray data for complexes 60, 70, 74a and 74b ................... 264 
Table 13 Summary of X-ray data for complexes 85, 89, and 91............................. 266 
Table 14 Summary of X-ray data for complexes 88, 90 and 92.............................. 268 
Table 15 Summary of X-ray data for complexes 105b, 107 and 110 ..................... 270 
 21 
 
Table 16 Summary of X-ray data for compound 108 and 109 ................................ 272 
Table 17 Summary of X-ray data for complexes 114c, 115c and 130b .................. 274 
Table 18 Summary of X-ray data for complexes 121, 122 and 124 ................. 276 
Table 19 Summary of X-ray data for complexes 125, 126 and 127 ................. 278 
1  
Acknowledgements 
22 
 
2 Acknowledgements  
First I would like to thank my supervisors, Professors Ian Fairlamb and Simon 
Duckett, for giving me the opportunity to work under their intensive care in their 
respective laboratory (both academically and otherwise). I am specifically very 
indebted to Professor Ian Fairlamb for absolute support especially during the 
difficult times and also for giving me the freedom in my research project and 
flexibility on working hours, I have learn a lot from you (Ian Fairlamb).  
I would also like to thank all the good people in both the Fairlamb and Duckett 
groups, especially the Fairlamb group, who I have been working with in the 
Laboratory and made my time so easy in York. I would especially like to thank past 
and present Fairlamb group whom have shared their experience with me in group 
meetings and lab work over the past 4 years, particularly Tom Williams (for showing 
me the way in and around the department),  
Special thanks to Lyndsay, Tom, Kate, Josh and Ben for giving their time to 
proofread this thesis. I am grateful for the technical support from Dr. Karl Heaton 
(Mass Spectrometry), Dr. Adrian Whitwood (X-Ray Crystallography), Dr. Pedro 
Aguiar and Heather Fish (NMR), Chris Rhodes (Electrical LED system), Chris 
Mortimer (Mechanical LED system), Graeme McAllister (Elemental Analysis) and 
Dr. Charlotte Elkington (IJSF Lab. motivator). 
Finally I am deeply thankful to my family, especially my parents, my wife and son 
(Abdulrahaman) and uncle; it would not have been possible without their support 
and encouragement, and I am very grateful to them for everything they have done for 
me, and of course the rest of them.  
Author’s Declaration 
23 
 
3 Author’s Declaration  
The work presented in this thesis is my own except where referenced or clearly 
indicated in the body of the text. This work has not previously been presented for an 
award at this, or any other, University. The work was carried out at the University of 
York between November 2011 and November 2015.  
Chapter 1: General Introduction 
24 
 
Chapter 1: General Introduction 
3.1 Transition metal mediated C–C, C–O and C–N bond formation 
Transition metal complexes are employed extensively as catalysts in modern organic 
chemistry, natural product synthesis, therapeutics, advanced materials and chemical 
biology. They allow the production of high value chemicals for use in manufacturing 
drugs and specialised chemicals,
1-5
 through cross-coupling reactions which are 
powerful methods for the construction of C–C, C–O and C–N bonds.6-8 Researchers 
have used a variety of ligand types to promote catalytic activity at Pd and high 
turnover numbers (TONs) are obtained with many phosphine ligands.
9, 10
  The 
development of metal-catalysed methods for converting sp
3
-C–H bonds (e.g. 1) into 
C–O bonds (e.g. 2), using dioxygen as a terminal oxidant, remains a grand challenge 
in organometallic chemistry
11
 (Scheme 1).   
 
Scheme 1 Typical oxidative acetoxylation reaction mediated by Pd. 
Furthermore, the use of acyl anion equivalents in the formation of C–C and or C–O 
bonds is a powerful strategy used widely in chemical synthesis.
12
 Interesting effects 
of nitrate/nitrite anions at Pd has been reported recently.
11, 13, 14
 
3.1.1 Palladium in C-X/C-H cross-coupling bond functionalisation 
Metal-catalysed cross-coupling, particularly using Pd, continues to grow, as 
evidenced by the total number of publications/patents
15
 recoded by a SciFinder 
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search (Figure 1).
15
 Pd-catalysed cross-coupling reactions comprise of one of the 
most important classes of transformations in synthetic chemistry, providing chemists 
with an exceptionally powerful tool for the construction of C-C and C-X bonds (X = 
heteroatom).
16
 These, and many related transformations, are indispensable reactions 
used widely in modern industry and academia. 
 
Figure 1 Trend in discovery and number of publications 1999, 2000, 2010 and 2014 of Pd-catalysed 
cross-coupling reactions (Based on SciFinder searches, May 2014). 
A direct C–H bond functionalisation reaction (Scheme 2) is widely attractive to the 
organic community, although it is considered to be limited by two fundamental 
issues:  
(i) the inert nature of most carbon-hydrogen bonds, and; 
(ii) the requirement to control site selectivity in molecules that contain diverse 
C–H groups. 
Chapter 1: General Introduction 
26 
 
Many studies have addressed the first challenge by demonstrating that transition 
metals can react with C–H bonds to produce C–M bonds in a process known as C–H 
bond activation, which occurs by distinct mechanisms (exemplified in Scheme 2 ).
17
 
The resulting C–M bonds are far more reactive than their C–H counterparts, and in 
many cases they can be converted to new useful functional groups under mild 
reaction conditions. The latter are typically reactions conducted at or below 40 ºC, 
although it does depend on the system. 
3.1.2 Recent developments in metal C–C bond formation via C–H bond 
activation – examples from natural product synthesis 
Suzuki–Miyaura cross-coupling remains the most widely used Pd-mediated 
reaction
18
 (Figure 1) Heck shared the 2010 Nobel Prize for Pd-catalysed cross-
coupling with both Suzuki and Negishi. Mizoroki and Heck, first reported 
functionalisation of a terminal alkene,
19, 20
 using Pd catalysts to enable reactions with 
aryl, benzyl or vinyl halides (Scheme 2). The Stille (coupling organopseudohalides 
with organotin reagents),
21-23
 Suzuki-Miyaura (coupling organopseudohalides with 
organoboronic acids),
24
 Sonogashira (coupling organopseudohalides with terminal 
alkynes),
25, 26
 Kumada-Corriu (coupling organopseudohalides with Grignard 
reagents) and Hiyama (coupling organopseudohalides with organosilanes) reactions 
are also well developed, taking advantage of the unique reactivity of Pd, usually 
shuttling between Pd
0
 and Pd
II
.
18
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Scheme 2 A timeline of cross-coupling processes 
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Sasaki and Tsukano
27-30
 examined how the Suzuki-Miyaura reaction can be used in 
the total synthesis of gymnocin A,
31-33
 using a highly complex synthetic strategy as 
highlighted in Scheme 3. The exocyclic enol ether (3A) was transformed with 9–
borabicyclo[3.3.1]nonane (9-BBN); the resultant alkyl borane adduct was treated 
with cyclic ketene acetal phosphate (3B), under Johnson’s conditions, to afford a 
trisubstituted enol ether product (3C) in good yield (72 %). Illustration of the 
coupling product (3C), via a cyclic ketene acetal triflate (3D) resulted in the second 
key β-alkyl Suzuki–Miyaura fragment coupling reaction of an alkyl borane species, 
derived from hydroboration of the ABCD-ring exocyclic enol ether unit (3E), to give 
compound (3F) in 81 % yield. Intermediate (3F) was then used to complete of the 
total synthesis of gymnocin A 3G.
34
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Scheme 3 Intermolecular Suzuki–Miyaura coupling exemplified in the total synthesis of gymnocin A 
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Schreiber et al. used inter- and intramolecular Sonogashira reactions to prepare the 
core structure of dynemicin A (Scheme 4).
35, 36,
 
37, 38
 The potential viability of two 
different strategies to prepare the putative macrocyclic transannular Diels–Alder 
precursor 4B was investigated. In the first of these, it was proposed that the 
macrocyclic ring could be generated via a terminal alkyne and the bromide-bearing 
vinyl carbon atom in ester 3A through a Sonogashira coupling reaction (Scheme 4). 
Surprisingly, when ester 4A was treated under Sonogashira conditions in toluene, it 
was found that the Diels–Alder cycloadduct 4C was formed as a single stereoisomer 
in 25 % yield, via a transient intermediate of macrocycle 4B. The second approach 
made use of an intermolecular Sonogashira coupling between enediyne 4D and 
bromoacrylate 4E, followed by basic ester hydrolysis, to generate the corresponding 
polyunsaturated carboxylic acid with retention of the alkene geometry. When the 
acid was subjected
39
 to a Yamaguchi macrocyclisation protocol, cyclisation gave a 
lactone 4B which spontaneously participated in a transannular Diels–Alder reaction 
at room temperature to give 4C. Such cascade processes serve to highlight the utility 
and potential of the Sonogashira reaction in generating molecular complexity. 
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Scheme 4 Different uses of the Sonogashira coupling in cascade reactions en route to dynemicin A 
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3.1.3 C-H bond activation methodologies 
Pd-catalysed C–H activation/C–C bond forming reactions excel as promising new 
catalytic transformations; however, development in this field is still at an early stage 
compared to the state-of-the-art in classical cross-coupling reactions using aryl and 
alkyl halides (note: involving two substrates which are both preactivated by 
functional groups). Direct arylation reactions via C–H bond functionalisation has 
become economically attractive (Figure 2), although one should bear in mind the 
formation of stoichiometric side-products, which are not necessarily green.
40
   
 
Figure 2 Classical vs modern pathways for metal-catalysed C-H bond functionalisation 
There are typically four modes of activation for forming C–C or C–O bonds from C–
H bonds at Pd. They use various redox couples, e.g. Pd
(II)/(0)
, Pd
(II)/(IV)
, Pd
(0)/(II)/(IV)
 and 
Pd
(II)/(III)
.
11, 13
 Each catalytic manifold offers something quite different – PdIV is hard, 
whereas Pd
0
 is soft.  Pd
II
 can be hard or soft, although is usually consider harder than 
soft.  Pd
III
 is usually seen in bimetallic species and is likely hard too.  
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Chapter two of this thesis focuses on the synthesis of Pd
II
-nitrito complexes, which 
are of potential significance in C-H bond functionalisation. Indeed, nitrite linkage 
isomerisation and associated ligand effects, e.g. Pd–NO2 → Pd–ONO, are interesting 
to study.
41
 This has enhanced significance, as the anionic nitrate or nitrite ligands 
offer potential as co-catalysts/oxidants in oxidative processes mediated by Pd
II
 
salts,
11, 41
 particularly when the NOx species are redox-active under the reaction 
conditions (Figure 3).
42
 
 
Figure 3 Synthesis methodology using NOx with Pd 
A variety of substrates containing both oxime ether- and pyridine-directing groups 
undergo aerobic Pd(OAc)2/NaNO3-catalysed sp
3
-C–H bond acetoxylation42 at sites 
adjacent to the directing group. Sanford et al. hypothesised that these 
transformations proceed via decomposition of nitrate to NO2(g), 
11
 which can lead to 
a NOx redox cycle. They reported that NO2 and 2 equiv. of AcOH react with a 
cyclopalladated intermediate to form Pd
II
 along with NO and H2O.
43
 This is followed 
by carbon–oxygen bond-formation via reductive elimination, with the NO being 
oxidized by O2 to regenerate NO2.
44, 45
 Sanford proposed that generation of NO is a 
key intermediate in this reaction (Scheme 5).  
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Scheme 5 C–H bond acetoxylation reaction reported by Sanford et al.  
Pd–NO2 coordination and “Pd–NO2”→“Pd–ONO” linkage isomerisation has been 
investigated within the Fairlamb group in York (Scheme 6),
41
 although other 
examples are known.
11
 
 
Scheme 6 Linkage isomerisation in a palladacycle containing a Pd
II
 centre. 
Previously a complex, Pd(OAc)2(pip)2 (where pip = piperidine), was synthesised 
within the group.
41
 The synthesis of this complex was accompanied by the surprising 
formation of Pd(OAc)(NO2)(pip)2, which also proved to be catalytically competent.
41
 
The source of the NO2 then was a mystery in this chemistry, but further investigation 
revealed that NO2 ligand came from a nitrite impurity found in commercial batches 
of Pd(OAc)2, which was able to replace one of the acetate ligands in Pd3(OAc)6 
giving Pd3(OAc)5NO2 (Scheme 7).
46
 The impurity arises from the synthesis: Pd + 
4HNO3 → Pd(NO3)2 + 2NO2 + 2H2O and Pd(NO3)2 + 2CH3COOH → Pd(OAc)2 + 
2HNO3.
41, 42
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Scheme 7 Nitrite adduct of [Pd3(OAc)5NO2]. 
The nitrite anion replaced one acetate anion bridging ligand between two Pd atoms; a 
similar process was reported by Murillo et al.,
46
 in which one acetate bridging ligand 
was replaced by H2O from the wet CDCl3 solvent used (Scheme 8).
46
  
 
Scheme 8 Water adduct of [Pd3(OAc)6·H2O] 
It is not obvious that the hydrolysis is consistent with the well-established reactivity 
of Pd3(OAc)6 toward ligands such phosphines and arsines,
47
 but recent work has 
shown that alcoholic solvents have a profound effect in a similar way to water.
48
  
3.2 Mn-catalysed cross-coupling processes  
3.2.1 Mn catalysed cross-coupling with organolithium and Grignard reagents  
Manganese was first used as a catalyst for cross-coupling reactions by Cahiez, 
Normant in 1976.
49 
They found that the homo-coupling of alkenyl lithium reagents 
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(generated in situ from alkenyl iodides and n-BuLi), gave conjugated 1,3-dienes with 
excellent E-selectivity and high yield (Scheme 9)  
 
Scheme 9 MnCl2/2LiCl-catalyzed homocoupling of alkenyllithium derivatives 
The reaction is catalysed by simple MnCl2 or MnBr2, but for preparative purposes, 
they utilised MnCl2/2LiCl was initialised. Their choice of ether as a solvent was 
crucial since more polar solvents like THF favour an undesirable alkylation of 
alkenyl iodides with n-BuLi, even in the absence of the manganese catalyst.
50
 
Daugulis reported the application of a similar
51
 synthetic protocol in the dimerisation 
of aryl and heteroaryl Grignard reagents generated
52
 in situ upon aromatic 
deprotonation with the super-base
51
 TMPMgCl/LiCl. The coupling of activated alkyl 
Grignard reagents can also be achieved with higher catalyst loadings;
51-55
 but the 
reaction suffers poor chemoselectivity
52
 (Scheme 10). 
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Scheme 10 MnCl2-catalysed homocoupling of Grignard reagents with low chemoselectivity  
3.2.2 Cross-coupling processes leading to carbon-heteroatom bond formation 
Mn-based catalysis can be effective for the amination of aryl and heteroaryl halides 9 
with a broad variety
56-59
 of nucleophiles, e.g. benzamide 10 (Scheme 11). The 
reactions work well in water, while in other polar (DMF, DMSO, THF, MeCN) or 
apolar (toluene) solvents, the yields were considerably lower.  
 
Scheme 11 Mn/Cu catalytic systems for the N-arylation of benzamide in H2O 
The presence of a chelating diamine ligand is crucial for the success of the reaction 
using MnF2 (20 mol%) or a mixed MnF2 (20 mol%)/ CuI (10 mol%) catalyst system. 
For nucleophilic heterocyclic amines such as pyrazoles, indazole and 7- azaindole, 
the reaction can be performed using MnCl2,
58
 whereas for less nucleophilic amines 
and amides the catalytic system based on MnF2 provides the best results.
56, 57,56, 60
 
Aryl bromides such as PhBr, m-ArBr, and p-ArBr can be coupled as well, giving 
similar product yields as their iodide counterparts.  
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Scheme 12 Mn-catalysed amination of aryl iodides with aliphatic amines 
3.2.3 Mn-catalysed carbonylation reactions 
Calderazzo reported a Mn-catalysed reaction of amines
61
 to give ureas and hydrogen, 
at high temperature and high CO pressure (Scheme 13). Both Mn2(CO)10 and 
MnMe(CO)5, are equally effective catalysts in heptane, showing TONs of 94 and 
102 respectively.
61
  
 
Scheme 13 Mn-catalyzed dehydrogenative carbonylation of primary alkylamines 
The most important example involves the methylene moiety of a β-ketoester. The 
reaction of these substrates types affords 2-pyranones (2-pyrones)
62-64
 in good yields, 
instead of the expected tetra-substituted arenes (Scheme 14). The reaction was found 
to work well for aryl- and alkenyl-substituted terminal alkynes.
65
 
The proposed catalytic cycle begins with complex A bearing both the coordinated 
alkyne and enol form of the β-ketoester (Scheme 14). It then rearranges 
intramolecularly to metallacyclopentene B, which undergoes a reductive elimination 
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liberating cyclobutenol C and regenerating A. The cyclobutenol C undergoes a ring-
opening rearrangement to give δ-ketoester E, followed by a sequence of base-
catalysed double bond migrations, deprotonation of F and intramolecular cyclisation 
of enolate G to give 2-pyranone H. 
 
Scheme 14 Proposed mechanism for Mn-catalysed formation of 2-pyrones 
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3.2.4 Mn-catalysed C–H bond activation processes 
Hartwig et al.
66
 reported the catalytic C–H bond activation reaction based on an 
organometallic manganese complex. The study consisted of a borylation of pentane 
and benzene with PinB–BPin, promoted by Cp'Mn(CO)3 (10%) at RT under UV 
irradiation and in the presence of CO (2 atm) to give PentBPin, and PhBPin in 36%, 
and 76% yields respectively. Later, Kuninobu,
67, 68
 reported the catalytic C–H 
activation of phenyl and alkenyl moieties bearing a directing nitrogen donor group, 
in the presence of an aldehyde and tertiary silane. The imidazole and imidazoline 
moieties were good directing groups, giving excellent yields of the silyl ethers 
products. Interestingly, Mn2(CO)10 and MnMe(CO)5 exhibited the same efficiency as 
MnBr(CO)5. More recently it was shown by Chen and Wang
69
 that MnBr(CO)5 
induces the selective insertion of terminal alkynes into the C–H bond of ortho-
phenylpyridines, in the presence of co-catalytic Cy2NH (Scheme 15). Terminal 
alkynes are considered as tricky reaction partners in C–H alkenylation reactions, due 
to their tendency to undergo competitive cyclotrimerisation to give arenes. Here, the 
reaction shows good scope and provides alkenylated products in moderate to good 
yield, with excellent chemo- and stereoselectivity. When two ortho C–H bonds are 
available, typically the less hindered site is activated selectively. 
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Scheme 15 Mn-catalysed aromatic C–H bond alkenylation using terminal alkynes 
The work by Chen and Wang led our research group to investigate the use of the 
electron-deficient 2-pyrone ring, containing a pyridyl directing group at the 4-
positions. In this context, chapter three will give details about this work, involving 
C-H alkenylation reactions of a 2-pyrone derivative containing a 2-pyridyl directing-
group at Mn
I
, including a plethora of other types of chemistry. 
3.3 Introduction to Pauson-Khand reaction 
Ihsan Ullah Khand (1935-1980), working as a postdoctoral associate with Peter L. 
Pauson,
70
 first reported the Pauson-Khand Reaction (PKR) in 1973.
71
 The reaction 
consists of a transition metal-catalysed [2+2+1] cycloaddition of an alkene, alkyne 
and carbon monoxide to give cyclopentenone (Scheme 16).
70-73
 
 
Scheme 16 Transition-mediated Pauson-Khand reaction 
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The cyclopentenone ring is an important structural unit found in natural products and 
pharmaceuticals.
74, 75
 This one-pot reaction, which can be both intermolecular and 
intramolecular, can display regiochemical preferences, depending on the substituents 
on the alkene and alkyne substrates. Despite the successes of the intramolecular 
PKR,
71 
the intermolecular PKR suffers from less predictable regioselectivity, 
especially in new substrates (Scheme 17). Here, unsymmetrical alkynes and alkenes 
give rise to various regioisomeric products. The link to the work described within 
this thesis examines intermolecular PKRs and the regiochemical outcome 
specifically. 
 
Scheme 17 Cobalt-mediated Pauson-Khand reactions  
The PKR reaction was first mediated by cobalt and this is still the most common 
transition metal used; however, PKRs can also be mediated with rhodium
76
, 
iridium
77
, iron
78, 79
, chromium
80
, molybdenum
81, 82
, tungsten
83, 84 
and palladium
85, 86
. 
This thesis focuses on intermolecular Co
0
-mediated reactions, as there are interesting 
regiochemical observations that require more detailed understanding.  
3.3.1 Mechanism of Pauson-Khand reaction 
The general PKR mechanism starts with the formation of a stable alkyne-cobalt 
complex I. A pentacarbonyl complex forms via a vacant coordination site, loses one 
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CO ligand in a reversible step which gives II. The free site reversibly occupied by 
coordination of an alkene (Scheme 18), followed by the regiochemical determining 
step through the cobaltacycle where alkene insertion occurs between cobalt and the 
original alkyne carbon, forming a five-membered ring IV.  Then, carbonyl insertion 
into the bond between the former alkene and the cobalt gives V. The next step is 
reductive elimination, in which a bond is formed between the carbonyl carbon and 
the other end of the alkyne, so that five-membered carbocycle is formed VI. The 
final step is decomplexation of the weakly-bonded cyclopentenone-cobalt complex, 
after which the PKR is complete. Several key intermediates were characterised 
within the literature by IR, UV and NMR, e.g. II
87-90
, III
91-93
 and IV
94
. 
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Scheme 18 Magnus’s Mechanism for the intermolecular PKR  
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The mechanism originally proposed by Magnus was based on general organometallic 
knowledge,
95, 96
 and supported by theoretical studies by Nakamura (Figure 4),
97
 
although the purpose of Magnus’s hypothesis was to explain the observed 
stereoselectivity of certain intramolecular reactions. Nevertheless, it fits well with 
other experimental findings. 
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Figure 4. Nakamura’s calculated of Energies in PKR using DFT methods. These values were for acetylene as an alkyne and ethene as an alkene 
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3.3.2 Regioselectivity in the Pauson-Khand reaction 
A total of four different isomeric products are possible in the PKR – two are related 
to the alkyne regioselectivity (R
1
 and R
2
) in Scheme 19, and two to the alkene 
regioselectivity, giving four regioisomers (racemic) in total (Figure 5). The number 
of possible stereoisomers is limited to two in this reaction mechanism, the alkene 
stereochemistry is significant, one alkene stereo-centre was used for clarity of the 
mechanism to show how alkene insertion plays a vital role in controlling selectivity. 
R +
O
RCo2(CO)8
Co Co
R
(CO)3(CO)3
alkene cis
to bulkier
alkyne group 
disfavored
alkene trans
to bulkier
alkyne group 
favored
Co Co
CO
CO
OC
OC
OC
R
Co Co
CO
CO
OC
OC
OC
R
Co Co
OC
OC
R
CO
COOC
Co Co
R
(CO) 3 (CO) 2
CoCo
R
(CO) 3(CO) 2
O
O
O
R
+
R
R
 
 
Figure 5 PKR regioselectivity regarding alkene insertion vs. steric effect 
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The alkene substituents R
3
 and R
4
 (Scheme 19) are on the same side of the ring. 
Choosing a symmetrical alkene starting material limits the possible isomeric 
products. However, regioselectivity is often a problem for synthetic applications of 
PKR and a great effort has gone into predicting and controlling the selectivity 
(Scheme 19). The regio and stereochemical outcome of the intermolecular PKR are 
substrate-controlled. The intermolecular reaction has been less exploited, mainly 
because of the small range of reactive alkene partners (Scheme 19).
98
 
 
Scheme 19 Intermolecular Pauson-Khand reaction 
3.3.3 Significance of alkene regioselectivity in intermolecular PKRs 
Gimbert and co-workers’ study, examining the reactivity of alkenes in the 
intermolecular PKR,
98, 99
 showed good reactivity for cyclohexene, cyclopentene and 
norbornene towards the intermediate hexacarbonyldicobalt(0) complex of 1-propyne. 
The reactivity of the alkenes is related to the extent of π-back donation of electrons 
from the d orbitals of the cobalt atom to the π*-orbital of the alkene (Figure 6).  
 
Figure 6 Alkene reactivity in the intermolecular PKR 
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The favourable back-donation from Co
0
 to the alkene is due to the highest 
energy occupied molecular orbital and lowest energy unoccupied molecular orbital 
interaction (HOMO-LUMO interaction) respectively.  The greater the back-donation, 
the higher the reactivity – a low energy LUMO gives rise to a lower energy barrier 
for PKRs.
98, 99
 The frontier-leading molecular orbitals are shown for the simplest 
alkene in Figure 7. 
 
Figure 7 HOMO-LUMO orbital interaction of a transition metal d-orbital with ethene 
99
 
An important property of the ethene molecule, and alkenes in general, is the 
existence of a high barrier to rotation about the C=C bond.  
3.3.4 Competition between steric and electronic factors 
The reported regiochemistry in a number of different systems is a complex issue, 
especially for intermolecular PKR. The dividing line between complete selectivity 
and non-selective reaction can be quite thin, depending on four variables: alkene 
reactivity, alkyne chemical structure (steric vs. electronic), CO insertion and the 
metal used (relating to π-back donation). Several research groups have been aiming 
to address these issues.
100-107
 As can be seen from Scheme 20 and Scheme 21, the 
electron-withdrawing ester group typically occupies the β-position in products 
employing internal disubstituted alkynes.
107
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Scheme 20 Norbornene effect on the regioselectivity which is completely selective, despite the 
sterically hindered group (example 1) 
If the methyl group is changed to a strongly electron-withdrawing and sterically 
similar trifluoromethyl group (Scheme 21), the reaction outcome still remains the 
same.
108
 For electronic reasons the trifluoromethyl might prefer the β-position. 
However, the electron-withdrawing ester group (by mesomeric effects) again prefers 
to go into the β-position, placing the electron-withdrawing CF3 group (by inductive 
effects) into the α-position (Scheme 21).  
 
Scheme 21 Norbornene effect on the regioselectivity which is completely selective, despite the 
sterically hindered group (example 2) 
Riera et al.
107
 have run a series of experiments (Scheme 22), varying the alkyne 
substituents. In reactions with NBD, the reaction was completely regioselective 
giving the product with a trifluoromethyl group in the α-position. On the other hand, 
Konno et al.
106
 reported another set of experiments, where regioisomeric mixtures of 
cyclopentenones α- and β-products formed. The reaction conditions for both 
experiments were close to each other, the main differences being the alkenes and 
solvents used (NBD vs. NBN and toluene vs. DCE, respectively) and the 
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temperature (70 °C vs. 84 °C). The reason for this unexpected difference in results is 
not obvious, but it might indicate that the more reactive NBD is, for some reason, 
affecting the regioselectivity outcome than NBN. This may be due to mono- versus 
bi-dentate coordination of NBN and NBD to Co
0
 respectively.  
 
Scheme 22 Summary of two reported studies probing the effect of alkene substituents in reactions of 
trifluoromethyl-substituted internal alkynes with norbornene and norbornadien. 
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3.3.5 Regiochemistry determination with sterically near-equivalent alkynes 
The examples above showcase the competition between steric and electronic factors 
and how they influence regiochemistry – clearly it is difficult to predict. In order to 
gain more information about the electronics guidance, the steric effect has to be 
minimised. A few studies with sterically equivalent or near-equivalent diarylalkynes 
have been reported. For example, Fairlamb et al.
104, 105, 109
 reported PKRs of 
heteroaromatic diarylalkynes, with interesting results.  To be critical, these results 
could not be fully explained by the electronic properties of the alkynes alone. The 
alkynes were classified by the types of heteroaromatics tested, e.g. as π-deficient (iv-
ix, Scheme 23) or π-excessive (i-iii and x-xii, Scheme 23). All π-deficient 
heteroaromatics preferred the β-position, but results varied with alkynes having 
π-excessive substituents. It was suggested that, aside from steric and electronic 
effects, that dynamic ligand effects and stabilisation provided by the aromatic or 
heteroaromatic group might subtly influence the regiochemical outcome of 
intermolecular PKR. This will be elaborated upon within Chapter 4. 
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Scheme 23 PKRs of heteroaromatic diarylalkynes reported by Fairlamb et al.
105 
 
Gimbert
103
 led a computational DFT study on the alkyne-dicobalt hexacarbonyl 
complexes
103
  to probe whether electronic differences in the acetylenic substituents 
could affect the regiochemistry of the PKR (Scheme 24). This provides an 
alternative to the “steric effect” for mechanistic interpretation of this important 
aspect of the PKR.  For example, the ethyl benzoate group was found exclusively in 
the β-position of the newly-formed cyclopentenone.58 The dichotomy between steric 
vs. electronic effects is still a subject of debate, which makes regiochemical 
predictions still difficult. 
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Scheme 24 Formation of one regioisomeric product.  
3.4 PKR/6π-electrocyclisation/aromatisation reactions 
Electrocyclisation, a subclass of pericyclic reactions, enable the formation of a ring 
system from an open-chain conjugated system, 
110
 with a σ-bond forming across the 
ends of a conjugated system on both sides.
111
 Intramolecular 6π-electrocyclisation of 
the PKR product of various heteroaromatic systems provided the stimulus for this 
part of the project (Scheme 25).
104
 
 
Scheme 25 6π-electrocyclisation/oxidative aromatisation reaction 
Electrocyclisation reactions
109
 can occur thermally or photochemically, via two 
possible modes known as conrotatory and disrotatory.  The simplest examples of 
photochemical electrocyclisation are illustrated in Scheme 25. 
Chapter 1: General Introduction 
55 
 
3.4.1 Examples of orbital symmetry and torquoselectivity in 6π–
electrocyclisations  
The Woodward–Hoffman rules were put forth over a series of publications in 1965, 
the first of which concerned itself with the stereochemistry of electrocyclic reactions, 
and the landmark synthesis of vitamin B12.
110
 Orbital symmetry rules state that the 
ground state of the HOMO controls the key bond forming steps of the reaction, thus 
the terminal substituents during a thermal 6π-electrocyclic reaction move in a 
disrotatory manner (Scheme 26).
112
  
 
Scheme 26 Thermal vs photochemical induced cyclisation 
Orbital symmetry rules predict that the thermal 6π-electrocyclisation is disrotatory, 
while the photochemical process is conrotatory (Scheme 26); thus two modes of 
disrotation exist for all thermal 6π-electrocyclisations.111  
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3.5 Project Aims and Objectives 
3.5.1 Aims  
The focus of the thesis is split principally into three parts.  The first aim is to 
synthesise Pd
II
-nitrito compounds, which are of potential relevance to catalytic C–H 
bond functionalisation reactions. The second aim is to examine Mn-mediated C–H 
bond alkenylation of substrates containing a 2-pyrone moiety with a pyridyl 
directing group.  The third aim of the project is to further examine the 
regioselectivity in selected intermolecular Co-mediated PKRs (PKR). A follow-on 
aim is to examine the light-induced 6π-electrocyclisation/oxidative aromatisation 
reactions of the PKR cycloadducts. A common thread throughout the whole thesis is 
the use of 2-pyrone ring systems and pyridyl directing groups, and their reactions 
and coordination to Mn, Co and Pd.   
3.5.2 Objectives 
The following objectives underpin the content of this thesis: 
I. To examine the reactivity of directed C–H bond activation by reaction of 
Pd(OAc)2 with 2-benzyl- and 2-phenyl-pyridines (Chapter 2). 
II. Prepare and characterise palladacyclic complexes containing NO2 ligands and 
establish nitrite linkage isomerisation at Pd
II
 (Chapter 2). 
III. To study the reactivity of a 2-pyrone-containing pyridyl group as a substrate 
for Mn-mediated C–H bond functionalisation (Chapter 3). 
IV. To examine secondary reactions from Mn-mediated C–H bond 
functionalisation processes, e.g. pyridyl fragmentation and Diels-Alder 
reactions of the 2-pyrone derivatives (Chapter 3). 
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V. To examine the regioselectivity in Co-mediated intermolecular PKRs, 
specifically the role of a pyridyl moiety and related heteroaromatic ring 
systems (Chapter 4). 
VI. Investigate the 6π-electrocyclisation/aromatisation of PKR cycloadducts 
mediated by light (400 nm) and air (Chapter 4).   
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4 Chapter 2: Synthesis and Characterisation of 
Cyclopalladated C^N Complexes  
4.1 Introduction 
Most Pd-catalysed mediated cross-coupling reactions require pre-functionalised 
carbon atoms in the organic substrate.
13
  These functional groups are usually 
halogens or oxygen-containing (Scheme 27),
14
 the challenge for direct C–H 
functionalisation is site-selectivity as there are usually many different C–H bonds in 
a single organic molecule. For this purpose, Pd
II
 complexes with acetate-bridged 
ligands, were prepared from 2-phenylpyridine, 2-benzylpyridine and 4-(2'-pyridyl)-
6-methyl-2-pyrone, in all cases acting as the C^N ligand backbone of the 
cyclopalladated derivatives, e.g. 60.  
 
Scheme 27 Potential products from the reaction of (a) benzene with Pd/O2/NOx and (b) [Pd]-NO2 for 
acetoxylation/nitration
14
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The pyridyl moiety serves as a directing group for Pd to harness the challenge of 
directing functionality at the ortho-C-H bond. Two of the key aims of this chapter 
are to understand the effect of phosphine substituents on the regio- and linkage 
isomerisation of Pd–NO2/Pd–ONO complexes – a fundamental study will pave the 
way for studying whether Pd–NO2 species are present and active in oxidative C–H 
bond functionalisation processes.
41
 If the geometry of the ‘Pd(C^N)X’ complexes 
with nitrite ligands does influence the reactivity, then their independent synthesis and 
characterisation could be important in defining a more specific role for the redox 
active ligands in catalysis. With this in mind, novel Pd
II
 complexes were prepared as 
part of this chapter. Also, within this chapter the effect of bulky phosphine 
substituents within the Pd
II
-nitrite dimer complexes containing 2-phenylpyridine 
have been examined.  
4.1.1 2-Acetate-bridged palladacyclic complexes of 2-phenylpyridine 
Pd
II
 complexes with acetate bridging ligands were prepared using 2-phenylpyridine 
as the C^N ligand. Cyclopalladated complexes were isolated in good yields via the 
reaction pathway shown in Scheme 28. Katsuma and co-workers
113
 demonstrated 
that similar syntheses of cyclopalladated derivatives proceed in good to excellent 
yields. The 2-acetato-bridged dimer 62 was prepared by the reaction of 2-
phenylpyridine with Pd(OAc)2 in acetic acid. An NMR study suggests that both syn- 
and anti-geometrical isomers are formed (Figure 8). 
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Scheme 28 Synthesis of palladacyclic complexes of 2-phenylpyridine 
The syn and anti-isomers are inseparable by conventional chromatographic methods, 
even though isomer 62B is only present in a small quantity; both isomers 62A and 
62B could be catalytically competent species. This was not elaborated upon in the 
work reported by Sanford and co-workers, who proposed a mechanism for the 
acetoxylation reaction (Scheme 29).
13  
 
Figure 8 Aromatic region of some 
1
H NMR spectra containing a mixture 62A and 62B 
The 
1
H NMR spectra shows that the pyridine ring within 62 is a useful diagnostic 
tool when distinguishing between 62A and 62B (Table 1). The proton α- to the 
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nitrogen atom in 62B is deshielded by 0.15 ppm with respect to its equivalent proton 
in 62A. In fact, with the exception of the phenyl moiety and methyl of the acetate 
bridge, all the protons of the pyridyl moiety in compound 62B are more deshielded 
compared to 62A (the proton attributes were confirmed by 
1
H COSY). The aromatic 
protons within the two isomers 62A and 62B appear in a similar chemical shift range 
(6.80 - 6.95 ppm) as shown in Table 1 and Figure 8; changing from trans 62B to cis 
62A causes an upfield shift of ca. 0.13 ppm.  
Although the geometrical isomerism has no effect when 62A/62B is transformed 
from a dimeric palladacycle in to a monomeric palladacycle, it is well established 
that a palladium-nitrogen (c.a Å = 1.985) bond is longer than a palladium-carbon 
bond (c.a Å = 1.855) in this type of C^N palladacycle system,
114
 which explains why 
the proton chemical shifts of the pyridyl system are so diagnostic (Figure 8).  
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Table 1 Comparison of selected 
1
H NMR shifts for compounds 62A and 62B 
 
Position Compound (62A) δ 
δ/ppm 
Compound (62B) 
δ/ppm 
Δ / ppm 
6 7.87 8.02 0.15 
4 7.37 7.51 0.14 
3 7.08 7.2 0.12 
6’ 6.67 6.71 0.04 
Note: multiplets are given by a centre point average; NMR standard is residual 
CD2Cl2. 
Efficient synthetic methods have been developed for ligand-directed C–H 
oxygenation in identical palladacyclic complexes (Scheme 29). The transformations 
generally involve reaction with oxidants such as IOAc,
11
 PhI(OAc)2,
115
 or 
Oxone®.
116
 However, formation of stoichiometric quantities of by-products means 
that there is a requirement for expensive or non-commercial reagents – poor atom 
economy has suppressed the use of these methods in large scale production. The 
ideal method is the use of O2 as the oxidant, especially from an atom economy 
perspective. The mechanism of Pd-catalysed C–H oxygenation, with acetate-
bridging Pd species, has been explored in detail by Sanford and co-workers.
1, 6 
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Scheme 29 Pd
III
/Pd
IV
 species implicated in acetoxylation reactions starting at Pd
II
 
4.2 Nitrido palladacyclic complexes of 2-phenylpyridine 
The main aim of this chapter was to synthesise novel nitrito–cyclopalladated 
complexes with sterically bulky phosphine ligands, enabling steric effects relating to 
nitrite linkage isomerisation to be studied. In view of this, a series of novel Pd-nitrite 
complexes were synthesised, following the literature procedures.
11,114,115
 The 
chloro-dimer was synthesised according to the method described by Hiraki et al.,
113
 
which involved treatment of 62 with an excess of lithium chloride to afford the 
insoluble chloride-bridged Pd dimer 66.
113
 This was then converted to the phosphine 
monomer 67 via addition of triphenylphosphine, and followed by reaction with silver 
nitrite to form compound 60 in excellent yield (Scheme 30). 
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Scheme 30 Synthesis of novel Pd
II
 nitrito complexes of 2-phenylpyridine and different nitrite 
geometries 
All the complexes prepared have been studied by electrospray ionization (ESI-MS) 
or liquid injection field desorption ionization (LIFDI-MS), infra-red (IR) and nuclear 
magnetic resonance (NMR) spectroscopic analysis (Table 2). An NMR study 
suggested the phosphine ligand has a profound effect on coupling with the proton of 
the C^N backbone ligand in the palladacycle owing to dramatic change on 
J-coupling splitting pattern. The JHP-coupling splitting patterns were diagnostic for 
the proton α to nitrogen within the pyridyl moiety (Figure 9).  
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Figure 9 Phosphorus coupling/de-coupling 
1
H NMR effect on monomeric palladacycle containing 
phosphine ligand 
Resolution enhancement by free induction delay (FID) modification allows the 
multiplicity of the peaks to be seen – here, a sine-bell apodisation function was 
employed. An example of the effect of their peaks is shown in Figure 10. The two 
stacked 
1
H NMR spectra, showing the 
31
P coupled and decoupled result gave a clear 
indication of the effect of phosphorus. 
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Figure 10 Sine-bell enhancement of 
1
H and 
1
H{
31
P} NMR spectra effect on complex illustrating the 
-N resonance of 67 (red 1H{31P} – green 1H) 
4.2.1 Geometry and linkage isomerism in Pd–NO2 and Pd–ONO species 
Following a successful synthesis of the novel nitrito cyclopalladated complex 60 a 
crystal suitable for X-ray diffraction was grown from a solution of dichloromethane 
with petroleum ether as the anti-solvent. The single crystal structure obtained is 
displayed in Figure 11. The crystal structure confirmed that the nitrite ligands 
occupy a coordination site trans to the Pd–C bond. A mixture of Pd–NO2 and Pd–
ONO isomers were evident. The bond lengths (Å) and bond angles (º) are all in 
agreement with those typical for complexes of this type. 
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Figure 11 Single crystal X-ray diffraction structure of complex 60 
Hydrogen atoms omitted for clarity. Thermal ellipsoids shown with probability of 50%. (left; a 
mixture of N- and O-bonded NO2 forms.) and (right; N-bond structure only shown for 
clarity). Selected bond lengths (Å); Pd(1) – C(11) 2.0083(18), Pd(1) – N(1) 2.0666(15), Pd(1) – P(1), 
Pd(1) – O(1) 2.1227(17), Pd(1) – N(2A) 2.2200(2) 
Previously the Fairlamb group worked on a similar complex with a different C^N 
backbone,
41
 showing that when the complex is exposed to light (400 nm) 150 K, a 
1:3 mixture of Pd–η1-NO2 and Pd–η
1
-ONO linkage isomers of Pd(η1-
ONO)(C^N)PPh3 (C^N = papaverine) converted fully into the Pd–η
1
-ONO species.
3
 
Irradiation of 60 revealed that only isomer remained, which supported the idea that 
linkage isomerisation in this type of complex is temperature and light dependent. 
This was further studied by Raithby et al.,
117
 who examined the nitro/nitrito 
photomediated linkage isomerisation of [Ni(dppe)(η1-ONO)Cl].117-119 
 
4.2.2 Geometry and linkage isomerism in Pd–NO2 and Pd–ONO species – a 
theoretical perspective 
An independent study was carried out within the Fairlamb group
41
 in order to 
ascertain the stability of the Pd–NO2 or Pd–ONO forms of the nitrite ligand and the 
geometry of the nitrito palladacycle complexes by DFT. For these complexes to 
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function as precatalytic species, their cis/trans geometry and the preferred linkage 
isomerism of the nitrite ligand could be of great importance. In a catalytic system, it 
is anticipated that the nitrite ligand could undergo reductive elimination, along with 
an organic substrate, to form a C–NO2 or C–ONO contains products, the ratio of 
these products could be determined by the relative geometry of the Pd–C and Pd–
NO2/ONO bonds; typically the two anionic ligands would need to be cis- to each 
other to form a product via a concerted reductive elimination process. The stability 
of Pd–NO2 or Pd–ONO species could determine whether the ligand is likely to be 
involved in reductive elimination or act as a spectator ligand. The density functional 
theory (DFT) were computed by Dr. Jason Lynam in York, the purpose being to 
determine single point energies at 298 K for the O-bound and N-bound isomers of 
[Pd(C^N)(NO2)PR3], where C^N = 2-phenylpyridine, 2-benzylpyridine and PR3 = 
PPh3. Calculations were also performed on cis- and trans-isomers. The Gibbs free 
energies of each substituent at the pbe0/TZVPP level of theory are shown in Figure 
12.
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Relative free energies (ΔE) at 
TZVPP /kJ mol-1 
n = 0 1 
N-bound 
isomer 
0 0 
O-bound 
isomer 
-1 +13 
 
 
Relative free energies (ΔE) at 
TZVPP /kJ mol-1 
n = 0 1 
N-bound 
isomer 
+15 +17 
O-bound 
isomer 
+44 +48 
Figure 12 Single point energies of complexes of the type [Pd(Ligand)(NO2)PPh3]  
These values suggest that in any species that is set-up for reductive elimination, the 
nitrite ligand would be likely to be bound through the nitrogen atom. For this 
geometry, the DFT results showed that the difference in free energy between O- and 
N- bound forms of the complex is negligible. For the trans-isomer, as the length of 
the alkyl linker, and therefore the steric bulk of the C^N ligand, increases, the O-
bound isomer was found to increase in energy.  
This suggests that the N-bound form of the nitrite ligand has less steric clash with the 
neighbouring ligands, and therefore is preferred over the O-bound when a bulky C^N 
ligand is present (Figure 12). However, the lower energy forms of complex 60 
contain a nitrite ligand which is trans- to the Pd–C bond. Therefore the likely-hood 
for complex 60 to participate in catalytic C-H bond activation is hindered by the 
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geometry it possesses (Figure 11). A series of related Pd(η1-ONO/NO2)(C^N)PR3 
were synthesised to ascertain the effect of the ligand substituent.  
Pd(OAc)2 was added to the C^N ligand in the presence of LiCl. Subsequently the 
phosphine and nitrite were added according to Scheme 31.  
 
Scheme 31 General synthetic pathway to novel Pd
II
 nitrito complexes of 2-phenylpyridine 
Although nitrite chemistry is under investigation for its role in catalysis
11, 41, 42, 117-120
 
as well as anthropogenic toxicity,
121, 122
 their coordination with N^C bound Pd has 
received less attention, which has caught the attention of the Fairlamb group in 
York.
41, 42
 
Table 2 summarises the novel palladacycles synthesised in this study. Changing 
phosphine from a less sterically hindered to more bulky / sterically hindered 
phosphine proved to not change the nitrite linkage isomerisation, studying these 
complexes by single crystal diffraction reveals unusual structural changes in 
complexes 74a and 74b (Figure 13 and Figure 14), which result from the elimination 
of the bulky phosphine (PPh2Cy and PPh2(t-Bu)) and transformation into dimeric 
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complexes containing 2-NO2 bridging ligand. The effect of phosphine substituents 
on the nitrite palladacycle is therefore significant as revealed in Scheme 33.  
 
Scheme 32 Synthesis of novel nitrite palladacycles containing 2-phenylpyridine 
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 Table 2 Physical properties of complexes 60 and 67-73 2-phenylpyrine palladacycles (dimers to monomers)  
 
Compound L1 L2 M.P / 
o
C C:H:N (cal. / observed) MS m/z Yield (%) 
67 PPh3 Cl 220–223 62.38:4.15:2.51 / 63.03:4.71:2.62 558.99 95 
60 PPh3 NO2 215–216 61.23:4.07:4.92 / 65.63:4.32:2.69 588.90 96 
68 PPh2Cy Cl 172 – 173 61.71:5.18:2.48 / 62.23:5.33:2.50 564.10 99 
69 PPh2Cy NO2 195–196 60.58:5.08:4.87 / 65.81:5.50:2.69 574.08 99 
70 PPh2(t-Bu) Cl 160 – 161 60.24:5.06:2.60 / 61.13:5.44:3.01 538.11 94 
71 PPh2(t-Bu) NO2 163–167 -- 548.07 99 
72 P(n-Bu)3 Cl -- -- 497.12 >99 
73 P(n-Bu)3 NO2 -- -- 508.17 >99 
Some of the experimental CHN values were found to be outside of the error limits of the calculated values, which may be 
due to the presence of CH2Cl2 in the samples. 
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4.2.3 Metastable Pd(η1-ONO)(C^N)PR3 and an unusual Pd dimer structure 
(C^N = ligand) 
Raithby  and co-workers
117, 119
 studied similar low temperature, single crystal 
photocrystallography, suggesting that similar square planar complexes can be formed 
e.g. [Ni(PEt3)(NO2)2], [Pd(PPh3)2(NO2)2] and [Pd(AsPh3)2(NO2)2]. In their Pd 
complexes, the two nitro groups adopt a trans-configuration at the metal centre. 
Upon irradiation with UV light, at 100 K, photoisomerisation of η1-NO2 nitro to the 
η1-ONO nitrito form occurs. Under the same experimental conditions, 
[Pt(PPh3)2(NO2)2] showed no isomerisation. Based on these experimental details, our 
study suggests that complexes 69 and 71 dimerised via phosphine loss at low 
temperature (Scheme 33). 
 
Scheme 33 Metastable Pd(η1-ONO)(C^N)PR3 and an unusual Pd
(II)
 dimer structure 
In order to transform from the η1-NO2 to the η
1
-ONO nitrito complex, a lone pair of 
electrons on the nitrogen atom replaces the bulky phosphine according to Scheme 
34. Such transformation occurred only in complexes containing PPh2Cy (Figure 13) 
and PPh2(t-Bu) (Figure 14). The complex, containing the PPh3 ligand, gave the 
expected monomeric palladacycle linkage nitrite isomer (Figure 11).  
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Scheme 34 Effect of bulky phosphine on nitrito cyclopalladated complexes containing phenylpyridine 
open crystallisation  
The crystal structures of the monomeric and dimeric palladacycles 60 and 68-71 
(Scheme 32) have been unequivocally proven by X-ray diffraction studies example 
Figure 13 and Figure 14. The monomeric N^C palladacycles having monophosphine, 
chloro and or nitrite ligands 60 and 67-73 (Table 2) were initially studied by NMR 
spectroscopic analysis, which confirmed their expected structure in each case 
(Scheme 32, Table 2).  NMR also confirmed the formation of 74 (Scheme 34, Figure 
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13 and Figure 14). It is important to note that these complexes only formed during 
the process of growing crystals at low temperature (Scheme 34, Figure 13 and Figure 
14). For X-ray crystallographic analysis, complex 74 is described as 74a and 74b 
(different crystals from the separate reactions detailed above), as there is marginal 
increase in all bond lengths (Å), along with a decrease in bond angles (˚), although 
these can be considered within error.  
 
Figure 13 Single crystal X-ray diffraction structure of complex 74a; Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown with probability of 50%. Selected bond lengths (Å); Pd(1)–C(1) 
1.972(4), Pd(1)–O(3) 2.173(3), Pd(1)–N(1) 2.017(3), Pd(1)–N(3) 2.034(3), Pd(1)–Pd(2) 2.9802(5), 
Pd(2)–C(12) 1.964(4), Pd(2)–N(4) 2.027(3), Pd(2)–O(1) 2.172(3), Pd(2)–N(2) 2.024(3) 
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Figure 14 Single crystal X-ray diffraction structure of complex 74b; Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown with probability of 50%. Selected bond lengths (Å); Pd(1)–
C(1) 1.964(3), Pd(1)-N(1) 2.016(2), Pd(1)–N(3) 2.033(3), Pd(1)–O(3) 2.172(2), Pd(1)–
Pd(2) 2.9707(4), Pd(2)–C(12) 1.962(3), Pd(2)–N(2) 2.012(2), Pd(2)–N(4) 2.037(2), Pd(2)–
O(1) 2.184(2). 
Upon re-dissolving the crystal submitted for X-ray diffraction study, an unusual 
structure was ascertained in deuterated solvents and also in solid state NMR, in both 
cases the phosphine ligand was found to be in the complexes. These presumably 
dissolve the entire sample in phosphine and equilibrate the sample and phosphine in 
solution. However the crystal structure of chloro-monomers of this type of product 
did not deviate from that expected (Figure 15). 
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Figure 15 Single crystal X-ray diffraction structure of complex 70 showing two molecules (left – 
single molecule and right – showing the two independent molecules in the unit cell). Hydrogen atoms 
omitted for clarity. Thermal ellipsoids shown with probability of 50%. For selected bond lengths and 
bond angles see Table 3 page 78. 
Table 3 summarises the X-ray crystallographic data of these palladacyclic 
complexes. They adopt square planar geometries around palladium with the 
phosphorus atom trans to the donor N atom. The angle P–Pd–N bond angle in the 
nitrite isomer of 60 is 176.36(5)º, while that for the corresponding complex 70 is 
171.57(4)º. This suggested that the nitrite containing complex distorts the square 
plane less than the chloride counterpart. However the Pd–N bond length 70 
2.0982(15) Å is longer compared to 2.0666(15) Å of complex 60. As expected, 
complexes 74a and 74b (nitrite dimer) show a dramatic increase in the N–Pd–X 
bond angles and a decrease in the O–Pd–X bond angles, when compared to 60.
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Table 3 Selected bond lengths (Å) and bond angles (º) for complexes 60, 70, 74a and 74b 
Lengths/Angles 60 (ijsf1213) 70 (ijsf1219) 74a (ijsf1225) 74b (ijsf1226) 
Pd-C Å 2.0083(18) 2.0183(18) 1.972(4) 1.964(3) 
Pd-P Å 2.2447(5) 2.2846(5) 2.173(3)* 2.172(2)* 
Pd-N Å 2.0666(15) 2.0982(15) 2.017(3) 2.016(2) 
Pd-X Å 2.22(2) 2.3891(5) 2.034(3) 2.012(2) 
Pd-Pd Å -- -- 2.9802(5) 2.9707(4) 
C-Pd-N º 81.49(7) 81.13(7) 81.62(15) 81.85(10) 
C-Pd-P º 95.03(5) 92.57(5) 173.32(14)* 176.86(9)* 
C-Pd-X º 162.2(5) 170.15(5) 95.81(15) 94.45(11) 
P-Pd-N º 176.36(5) 171.57(4) 94.11(13) 95.02(9) 
P-Pd-X º 91.0(5) 96.842(16) 88.45(13)* 88.69(9)* 
N-Pd-X º 92.0(5) 89.77(5) 177.43(14) 176.04(10) 
C-Pd-Pd º -- -- 112.17(11) 117.20(8) 
X = Cl for 70; X = N for 60, 74a and 74b; * = (ligand change from Pd-P → Pd-O in 74a and 74b) 
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4.3 Palladacyclic complexes of 2-benzlpyridine 
An acetate-bridged cyclopalladated complex of benzylpyridine, 76 
[(Pd(OAc)(N^C)]2, was obtained by reaction of benzylpyridine 75 with Pd(OAc)2.
113
 
A chloro-bridged analogue 77, [PdCl(N^C)]2, formed by metathetical reaction of the 
μ2-acetato-bridged complex with LiCl, undergoes a bridge-exchange reaction to form 
77. Whereas treatment of 75 directly with PdCl2 in methanol yielded only 
mononuclear complex 78 (Scheme 35). 
 
Scheme 35 Synthesis of cyclopalladated 2-benzylpyridine complexes 
These Pd complexes were characterised by means of elemental analysis, IR and 
NMR spectroscopy. NMR study reveals that the acetato-cyclopalladated-bridged 
complex 76 prefers a higher energy boat conformation rather than a chair 
conformation, an observation reported by Hiraki and co-workers, who studied the 
geometry of these types of complexes
113
 with different substituents (Figure 16).  
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Figure 16 Geometry of cyclopalladation of 2-benzylpyridine  
 
4.3.1 Geometrical aspects of the Pd complexes 
NMR spectroscopic analysis suggested two isomers were present for complexes 76, 
A and B, with A being the major isomer. In consideration of the two coordination 
planes in an acetato-bridged cyclopalladated dimers which possess two mutually cis 
acetato ligands, 76 was expected to adopt two configurations A and B (Figure 16). 
The mixture of 76 was simplified by addition of deuterated pyridine (C5D5N) in 
CD2Cl2, giving the mononuclear cyclopalladated complex [Pd(OAc)(N^C)(C5D5N)] 
80 only (Scheme 36). This simplifies the NMR spectra as only one isomer is seen 
where the pyridine nitrogen of the cyclopalladated ligand and pyridyl donor ligand 
assume to be are mutually trans. One isomer was only observed for 80, as evidenced 
by the simplified proton signals within the 
1
H NMR spectra (Figure 17, page 82).  
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Scheme 36 Synthesis of palladacycles of 2-benzylpyridine containing a pyridine ligand 
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Figure 17 Comparison of 
1
H NMR spectra of 76A/B (positive spectra) and 80 (negative spectra) at (400 MHz, CD2Cl2). I- the negative spectra the protons of the pyridiyl 
group are highlighted 
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A similar acetate bridged complex was synthesised using 4-(2'-pyridyl)-6-methyl-2-
pyrone as the N^C backbone. Reaction of PdCl2 with a two-fold excess of 2-
benzylpyridine, in refluxing methanol, yielded 68 (Scheme 35, page 79), and the 
1
H 
NMR spectra of this complex suggested two isomers, present in an equimolar 
mixture. Hiraki and co-workers postulated that this is associated with the quenching 
of the rotation about the two bulky N^C ligands, about the Pd-N bond. 
4.4 Palladacyclic complexes of 4-(2-pyridyl)-6-methyl-2-pyrone  
4-(2'-Pyridyl)-6-methyl-2-pyrone 81 was prepared by Negishi cross-coupling in an 
excellent yield (Scheme 37). This provides a more bulky (N^C) ligand with respect 
to 2-phenylpyridine 18. Treatment of 81 with PdCl2 in methanol does not give a 
monomer complex 86, but rather gives chloro-bridged dimer complex 83. Refluxing 
ligand 81 with Pd(OAc)2 yielded acetate-bridged dimer complex 82, present as four 
possible isomers. Treatment of 83 with triphenylphosphine allowed the formation of 
monomeric palladacycle 84.  Dissolving 83 in deuterated pyridine at room 
temperature for ca. 5 min., gave complex 85. 
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Scheme 37 Synthesis of cyclopalladated 4-(2'-pyridyl)-6-methyl-2-pyrone complexes 
These complexes were characterised by MS (LIFDI and ESI) and NMR. The NMR 
spectra of complex 82 proved to be four different geometrical isomers (Scheme 38). 
The remaining proton of the 2-pyrone moiety in complex 82 is indicative when 
following the transformations between 82A, 82B, 82C and 82D by NMR (Scheme 
38). It appears that both C3 and C5 protons have been activated by Pd
II
 in these 
reactions. 
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Scheme 38 Possible syn / anti vs C3 / C5  isomers of 82 
This is illustrated by 
1
H NMR spectra in Figure 18 to support the structures proposed 
in Scheme 38, where the proton chemical shift at δ 5.95 (s, 1H) and 5.65 (s, 1H), 
correspond to C3 of 82B and 82D, whereas proton chemical shift at δ 5.79 (s, 1H) 
and 5.56 (s, 1H) correspond to C5 of 82A and 82C.respectively. This was further 
supported by COSY spectroscopy which confirmed the presence of four sets of 
protons α- to nitrogen in the pyridyl moiety. These correspond to the protons on each 
aromatic ring of the pyridyl moiety. These appear at proton chemical shift δ 8.54, 
8.52, 8.29 and 8.22 (Figure 18).   
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Figure 18 NMR spectroscopic analysis of complex 82 (400 MHz, CDCl3) – inset (top right) is the 
1
H COSY spectra
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For compound 85, crystals suitable for X-ray diffraction were grown by layering a 
solution of 83 in deuterated pyridine d6; the single crystal structure is displayed in 
Figure 19. This confirmed that chloride occupies the coordination site trans- to the 
Pd–C bond. 
The bond distance for a similar complex 70 was directly compared with 85 (Figure 
19). The Pd(1)–C(1) bond in 85 was 1.9931(18) Å, which is shorter than the same 
bond within 70, 2.0183(18) Å.  Similarly, the Pd(1)–N(1) bond in 85 was 2.0353(16) 
Å, slightly shorter than 70, with 2.0982(15) Å. While, Pd(1)–Cl(1) was 2.3967(5) Å 
in 85 and 2.3891(5) Å in 70.   
 
Figure 19 Single crystal X-ray diffraction structure of complex 85. Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown with probability of 50%. Selected bond lengths (Å); Pd(1)–C(1) 
1.9931(18), Pd(1)–Cl(1) 2.3967(5), Pd(1)–N(1) 2.0353(16), Pd(1)–N(2) 2.0287(15).  
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4.5 Nitrito-palladacyclic complexes of 2-benzylpyridine 
The nitrito containing palladacycle with N^C backbone as 2-benzylpyridine was 
synthesised according to the method described by Hiraki et al. – treatment of 76 with 
an excess of LiCl gave give chloride-bridged dimer 77,
1
 which was then converted to 
the phosphine monomer 87 via addition of PPh3, followed by reaction with AgNO2 
to form 88 in excellent yield (Scheme 39) 
 
Scheme 39 Synthesis of Pd
II
 nitrito-cyclopalladated complex of 2-benzylpyridine 
The reaction mechanisms of cyclopalladation reactions of this type have been 
recently given due consideration with 2-phenylpyridines
2
, N-benzylideneamines
3
 and 
N-benzyltriamines
4
 as N-donor ligands. Although it is commonly assumed that the 
first step in the cyclopalladation reaction is coordinative bonding of the N^C 
nitrogen to the palladium atom,
5, 6
 this assumption being quite logical, direct 
experimental proof has been lacking. What remains clear is that N^C bounded 
nitrogen is a directing group in C-H bond activation/functionalisation, as shown in  
Scheme 40. The geometry of all the monomeric palladacycles under this study 
depend on the steric and electronic nature of the incoming ligands, for example 
complexes 76-87 gives preference to the N^C nitrogen of the pyridine moiety which 
direct the overall geometry. Earlier in the chapter the geometry of the Pd complexes 
containing 2-phenylpyridine as N^C ligand were found to be less sterically hindered, 
here was introduced a more sterically bulky N^C as 2-benzylpyridine to ascertain the 
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enhancement or suppressing outcome of the nitrite anion 88, with its various 
coordination modes that it can adopt at Pd
II
. A series of nitrito cyclopalladated 
complexes were synthesised with varying phosphines, all in excellent yields 
(Scheme 41, and Table 4). 
 
 
Scheme 40 General synthetic pathway to novel Pd
II
 nitrito complexes of 2-benzylpyridine 75 
The 
1
H-NMR spectra of 79 and 87-96, recorded in CD2Cl2, are given in Table 4. The 
signal assignments are based on the chemical shifts and spin/spin couplings, 2D 
NMR experiments and by comparison of the 
1
H chemical shifts of related 
compounds (Scheme 41and Table 4).  
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Scheme 41 Synthesis of novel nitrite-containing palladacycles of 2-benzylpyridine
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4.5.1 NMR study of nitrito-palladacyclic complexes of 2-benzylpyridine 
Coordination of the metal atom with a phosphine in complexes 87-96 (Scheme 41, 
and Table 4) results in a CH2 protons splitting from a singlet within the ligand to a 
doublet (diastereotopic protons) with a large downfield shift seen for the equatorial 
proton at HCHeq (δ 4.71-5.01 ppm) and large upfield shift for the axial proton HaxCH 
(δ 3.97 – 4.08 ppm) with respect to complex 79. Here, both protons of CH2 are 
observed as a broad signal at upfield (δ 4.30 ppm). 
 However the dichotomy between complexes with 2-phenylpyridine with respect to 
2-benzylpyridine is that, the 
1
H coupling phosphorus has no profound effect on 2-
benzylpyridine ligand compared to the 2-phenylpyridine, this may be due to the 
bulky nature of 2-benzylpyridine, see Table 4, where the proton α to nitrogen Py-H1 
shows the expected attribute of doublet (d) with the exception of complex 88 broad 
singlet (br.s) and 81 doublet of doublet (two doublet, dd), which is not observed in 2-
phenylpyridine. 
In the complexes 79 and 87-96 the protons on pyridyl moiety (py-H
1
, py-H
2
, py-H
3
 
and py-H
4
) and phenyl moiety (ph-H
1
, ph-H
2
, ph-H
3
 and ph-H
4
) are matching the 
expected attribute with the exception of complex 90 where multiplets dominates the 
attributes. The proton α to nitrogen Py-H1 of chloromonomer complexes are 
de-shielded with respect to their corresponding nitrito monomers (ca 0.60 ppm).  
The δ of phosphorus in chloro bound complexes observed at lowfield with respect to 
nitrite complexes displays a profound difference between complexes containing 
chloro and ntrito with similar phosphine was observed in the complexes 87 and 88 (δ 
35.26 ppm and 32.45 ppm, Δ 2.81 ppm), 89 and 90 (δ 36.83 ppm and 34.60 ppm, Δ 
2.23 ppm), 91 and 92 (δ 54.75 ppm and 52.94 ppm, Δ 1.81 ppm), 93 and 94 (δ -
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19.24 ppm and -22.17 ppm, Δ 2.93 ppm) and 95 and 96 (δ 21.14 ppm and 19.01 
ppm, Δ 2.13 ppm) respectively.  
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Table 4 1H and 13P NMR chemical shift () data from the spectra of complexes 79 and 89-96 
 
Comolexes piph-CH2 py-H
1  py-H2 py-H3 py-H4 ph-H5 ph-H6 ph-H7 ph-H8 13P 
79 4.30 s 9.29 dd 7.14 7.68 t 7.41 d 7.07 dd 6.91 td 6.70 td 6.56 dd -- 
87 4.90 d, 4.01 d 9.17 d 7.24 ddd 7.74 ddd 7.46 d 6.95 dd 6.66 td 6.62 dr. s 6.25 td 35.26 
88 5.01 d, 4.08 d 8.55 br. s 7.15 t 7.74 td 7.50 d 7.02 d 6.74 t 6.33 t 6.48 d 32.45 
89 4.91 d, 4.07 d 9.04 d 7.18 dd 7.71 td 7.45 d 7.06 dd 7.00 ddd 6.82 td 6.61 t 36.83 
90 4.93 d, 4.07 d 8.40 d 7.15 m 7.73 m 7.73 m 7.03 m 6.88 dd 6.66 t 6.83 d 34.60 
91 4.84 d, 3.95 d 9.25 dd 7.25 dd 7.72 td 7.41 d 6.77 d 6.4s8 dd 6.04 t 6.44 ddd 54.75 
92 4.93 d, 3.99 d 8.52 d 7.73 td 7.13 dd 7.47 d 6.79 d 6.52 td 6.13 t 6.45 ddd 52.94 
93 4.90 d, 4.00 d 9.24 d 7.22 ddd 7.70 td 7.42 d 6.99 d 6.78 td 6.48 td 6.84 d -19.24 
94 4.98 d, 4.05 d 8.75 d 7.23 d 7.75 dd 7.49 d 7.06 d 6.82 m 6.56 dd 6.87 d -22.17 
95 4.71 d, 3.97 d 9.00 d 7.18 t 7.69 t 7.40 d 7.04 d 7.28 dd 6.85 m 6.90 d 21.14 
96 4.80 d, 401 d 8.53 d 7.13 m 7.71 td 7.44 d 7.04 dd 7.23 ddd 6.71 m 6.92 dd 19.01 
Note: multiplets, are given as a centre point average; NMR standard (5.32 ppm) is residual CH2Cl2.  
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The 
13
P NMR chemical shift is indicative of the phosphine ligand within the 
complexes (Figure 20) – complexes containing P(Fu)3 93 and 94 appeared at higher 
field (upfield)   = -19.24 and -22.17 ppm with difference of chloro- to nitrito-  = -
2.93, complexes 95 and 96 containing [P(n-Bu)3] appeared at 21.14 and 19.01 ppm 
and  of Cl- to NO2- = 2.13, while complexes 91 and 92 containing [PPh2(t-Bu)] 
appeared at low field (downfield)  = 54.75 and 52.94 with  = 1.81. However, 
complexes containing PPh3 and PPh2Cy show similar properties, which both 
coordinated to phosphine with a cyclic six membered ligand through a quaternary 
carbon – complexes 89 and 90  = 36.83 and 34.60 with  = 2.23, complexes 87 
and 88  35.26 and 32.45 with  = 2.81. These values differentiate between the 
complexes containing Cl- and NO2- (Figure 20). 
 
Figure 20 
13
P NMR chemical shift () data from the spectra of complexes 87-96 
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4.5.2 Single crystal study of nitrito-palladacyclic complexes of 2-
benzylpyridine 
From the X-ray crystallographic data it can be noticed that the palladacyclic 
complexes are square planar geometries at the palladium centre and the phosphorus 
atom is in trans position to the donor N atom. The angle P–Pd–N varies from 166.79 
to 174.73˚ and Pd–N bond length varies from 2.093-2.1119 Å, complex 91 bond 
length of Pd centred are longer with respect to its nitrito counterpart 92 (Table 5). 
When the phosphine ligand is similar, e.g. complexes 91 and 92, there is an increase 
in the P–Pd–N bond angles 171.57˚ and 173.25˚ and a decrease in the N–Pd–X bond 
angles (89.77˚ and 87.72˚). For complex 93, having a P(Fu)3 ligand, the C-Pd-X 
175.13˚ and P-Pd-N 174.73˚ increase by a margin of ca. 3˚ and 2 ˚ respectively and a 
decrease in N-Pd-X (92.98˚) bond angles by ca. 5˚, with respect to complexes 88-92. 
See the crystallographic data for the complexes 88-94, are also summarised in Figure 
21.  
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Table 5 Selected bond lengths (Å) and bond angles (º) for complexes 88-93 
Lengths/Angles 88 (ijsf1209) 
 
89 (ijsf1215) 90(ijsf1217) 91 (ijsf1216) 92 (ijsf1218) 93 (ijsf1314) 
Pd-C Å 2.017(2) 2.0183(18) 2.0004(18) 2.0077(12) 2.0070(18) 2.006(2) 
Pd-P Å 2.2568(6) 2.2846(5) 2.2667(5) 2.2791(3) 2.2743(5) 2.2413(7) 
Pd-N Å 2.1166(17) 2.0982(15) 2.1067(16) 2.1119(11) 2.081(12) 2.093(2) 
Pd-X Å 2.219(3) 2.3891(5) 2.1332(19) 2.4046(4) 2.1061(15) 2.3978(6) 
C-Pd-N ˚ 86.60(8) 81.13(7) 86.18(7) 84.55(5) 84.51(7) 85.61(9) 
C-Pd-P ˚ 92.02(6) 92.57(5) 90.69(6) 87.06(4) 87.20(5) 91.88(7) 
C-Pd-X ˚ 171.69(9) 170.15(5) 173.88(8) 171.32(4) 169.1(4) 175.13(7) 
P-Pd-N ˚ 175.79(5) 171.57(4) 173.25(5) 166.79(3) 166.93(5) 174.73(6) 
P-Pd-X ˚ 93.08(7) 96.842(16) 95.42(5) 100.978(12) 100.9(4) 92.98(2) 
N-Pd-X ˚ 88.75(8) 89.77(5) 87.72(7) 88.09(3) 88.7(4) 89.51(6) 
X = Cl for 89, 91 and 93; X = N for 88, 90 and 92 
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A Single crystal X-ray diffraction structure of 88 
with a mixture of N- and O-bonded NO2 forms 
 
A Single crystal X-ray diffraction structure of 90 
with only N- bonded NO2 forms 
 
A Single crystal X-ray diffraction structure of 92 
with only N- bonded NO2 forms 
 
A Single crystal X-ray diffraction structure of 93 
 
A Single crystal X-ray diffraction structure of 89 
 
Single crystal X-ray diffraction structure of 91 
Figure 21 Single crystal X-ray diffraction structures of complexes 88-93. 
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4.5.3 Pd-catalysed C–H bond functionalisation processes  
Nitroaromatic compounds are of great importance to both the pharmaceutical 
industry and academia.
123
 The C-H bond activation/functionalisation of ligands 
involved in this study is the key test to catalytic activity of the Pd complexes 
synthesised in this thesis. The potential C-H bond acetoxylation reaction process 
with the complexes prepared in this thesis is under investigation within the Fairlamb 
group in York, and believed to proceed via a Pd
(II/III)
 or Pd
(II/IV) 
C-H bond 
functionalisation pathway as shown in Scheme 44. However, the potential 
application of these complexes is the formation of C–N bonds (sp2 C-H bonds to 
form nitroaromatic compounds) via reductive elimination of Pd–NO2 complexes was 
noted. It was anticipated that reductive elimination is the key to forming carbon–
carbon and carbon–heteroatom in the majority of metal-catalysed transformations, 
and reductive elimination processes from both Pd
(II)
 and Pd
(IV)
 (Scheme 42) 
 
Scheme 42 Anticipated reductive elimination via complex 60 with CuI 
4.5.4 Pd Cat. C-H bond activation the dichotomy between nitration vs 
acetoxylation  
Liu and co-workers,
124
 reported palladium-catalyzed nitration of 8-methylquinolines 
1 with t-BuONO to give 8-nitromethylquinolines 2 in a good yields, involving sp
3
 
C−H bond activation, their report examined the nitrite source and atmospheric 
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conditions; NaNO2, AgNO2 and KNO2 supressed the formation of product with 
respect to t-BuONO under an atmosphere of dioxygen at 1 atm. (Scheme 43). 
 
 
Scheme 43 Example demonstrating the catalytic nitration reaction by Liu and co-workers,
124
 
The above observation Liu and co-workers,
124
 proves that the nitrite source has 
profound effect in enhancing the nitration reaction. The Fairlamb group (Dr. Margot 
Wenzel and Philippa Owens) set Pd(OAc)2  (c) as the benchmark catalyst to evaluate 
the aerobic oxidation of 1 to give 2 in Scheme 44.  Although the catalyst has 
excellent activity, using 1 eq. of NaNO3 (Figure 22), complexes (a) to (d) are less 
catalytically competent with respect to NaNO3. The dinuclear Pd
(II)
 complexes (d) 
and (c) showing a relatively similar reactivity profile. The PPh3-containing complex 
(a) is also a viable catalyst, with (b) being more active under the conditions using 0.1 
eq. of NaNO3 with respect to (a) (Figure 22). 
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Scheme 44 Acetoxylation of 1 to 2 and a possible nitration side product 97 
 
Figure 22  Catalytic activity of Pd complexes. (a) and (b) with respect to (c) and (d) (5 mol%) with 
varying equivalents of NaNO3, in the aerobic oxidation of compounds 1- 2. 
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4.6 Conclusion 
A series of novel palladacyclic complexes have been prepared, with differing C^N 
ligands 60, 68 - 73, 82-85 and 88-96. The work allowed a greater understanding of 
the cyclopalladation behaviour of several C^N ligands to be gained. Furthermore, the 
successful synthesis and characterisation of a series of C^N palladacyclic complexes 
containing nitrite and nitrite ligands has paved the way into understanding how NO2 
interacts with Pd
(II)
. When assessing the role that such ligands can play in catalysis, 
and in particular the potential for reductive elimination of useful “C–NO2” type 
products, the geometry and linkage isomerism of the complexes is of paramount 
importance. However, for more bulky phosphine ligands, monomeric Pd
(II)
 
complexes could be characterised by NMR spectroscopy, however crystallisation of 
N^C (2-phenylpyridine) with bulky phosphines (PPh2Cy and PPh2(t-Bu)) 69 and 71 
upon crystallisation yielded novel Pd
(II)
 dimer complex 74, where the bulky ligand 
had been ejected and the 2-nitrito ligand is found bridging two Pd(II) centres. This 
was only seen where C^N = 2-phenylpyridine and not for 2-benzylpyridine (Figure 
13 and Figure 14)  
Calculated free energy values suggest that the energy difference between cis and 
trans geometric isomers with respect to the pyridyl moiety in the complexes studied 
increases with increasing steric bulk of the C^N ligand and reductive elimination 
experiments, where elimination of C–NO2 type products, which would normally 
require the two ligands being eliminated to be mutually cis, was not observed. The 
crystal structure of all the nitrite complexes prepared in this thesis showed a mixture 
of N- and O- bound linkage isomers. 
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5 Chapter 3 Manganese catalysed C-H alkenylation / 
Diels-Alder Reactions  
5.1 Introduction 
The nucleophilic addition of species generated by C-H activation,
125
 has been widely 
investigated at palladium,
126
 rhodium,
127
  rhenium,
128
 and nickel.
69
 It has however 
been difficult to mediate such reactions with first-row transition metals.
 
In a recent 
report, Chen and co-workers
69
 showed that environmentally-friendly Mn
I
 mediates a 
catalytic C-H alkenylation of 2-phenylpyridine derivatives, by a highly chemo-, 
regio- and stereoselective reaction with terminal alkynes in diethyl ether at 100 °C 
(Scheme 45).  
Indeed, intermediate structures proposed by Chen and co-workers (Scheme 45) in 
Mn
I
-mediated C-H bond activation reactions (intermediate) are often speculative and 
unsubstantiated by experimental evidence. 
 
Scheme 45 Chen and co-workers alkenylation process
69
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A number of related manganese-mediated C-H functionalisation processes have been 
reported,
69
 which have been proposed to proceed via the intermediacy of 
manganacycles related to 98. Complex 98 has been of interest to the Fairlamb group 
because it acts as a source of therapeutic CO,
129
 in addition to synthetic 
applications,
130 
specifically the regioselective alkenylation of biologically-relevant 2-
pyrones, which is currently limited to Pd.
131
 Structural details on reaction 
intermediates relating to protonation and reductive elimination, from 18 to 19, has 
been missing. The pyridyl-directing group exerts a profound effect in determining 
alkenylation regioselectivity.  2-Phenylpyrazine 99 is altered by a second nitrogen 
atom para to the nitrogen-directing group.  
Compound 99 was synthesised via a Suzuki cross-coupling reaction. The five-
membered manganacycle 100 was formed in a 62 % yield by cyclometallation of 99 
with BnMn(CO)5 – the reaction confirmed that the nitrogen in the ortho-nitrogen 
acted as the directing atom (Scheme 46).    
 
Scheme 46 Novel five-membered manganacycle 100  
 
The E/Z isomerisation is possible in manganese-catalysed alkenylation, as it often 
occurs in the transition metal catalysed hydroarylation of alkynes.
131, 132
 A proposed 
mechanistic scheme is shown in Scheme 47, involving several intermediates (I-
III/III'). Isomerisation is possible within the key seven-membered manganacycle 
Chapter 3 Manganese catalysed C-H alkenylation / Diels-Alder Reactions 
104 
 
III. This could equilibrate with a manganese carbene complex II, via path A. This 
can afford a E-isomer by protonation with alkyne.
133
 Another possibility is the 
homolytic cleavage of the Cvinyl-Mn bond in I, followed by isomerisation giving 
III'.  Reformation of the Cvinyl-Mn bond I (path B) can also deliver the E-isomer.  
 
Scheme 47 Possible pathways for E/Z isomerization 
 
Chen and co-workers also reported, based on DFT calculations,
69
 that the step of 
insertion of phenyl acetylene into the Mn-Caryl bond, leading to III, favoured the 
anti-Markovnikov addition product Iva, which is more stable than the Markovnikov 
addition product IVb by 5.1 kcal/mol (Figure 23).
69
 Alkyne insertion mediated by 
Cy2NH2
+
 IVd, to generate the final alkenylation product, is disfavoured due to a 
higher energy barrier (2.3 kcal/mol) with respect to direct insertion with phenyl 
acetylene IVc (Figure 23b).
69
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Figure 23 Markovnikov and anti-markovnikov addition vs protonation by terminal alkyne and 
CyNH2
+
 possibilities 
5.2 Synthesis of 4-(2'-pyridyl)-6-methyl-2-pyrone derivatives 81 
and 104 
Based on the experimental evidence above, the investigation focused on the use of 
the 4-(2'-pyridyl)-6-methyl-2-pyrone 81 moiety as the nitrogen-directing group. This 
novel compound is available via Negishi cross-coupling of 4-bromo-6-methyl-2-
pyrone
134
 103 with PhZnCl 102, formed by lithiation of 101, mediated by Pd(PPh3)4 
(Scheme 48). 
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Scheme 48 Negishi cross-coupling reactions of 4-bromo-6-methyl-2-pyrone 103 with pyridyl zinc 
reagents 102a and 102b 
5.3 Synthesis of five membered manganacycles  
Given the intermediates proposed in Scheme 45 (page 102) the related complexes 81 
and 104 were synthesised. Compounds 81, 104a and 104b were used in a 
mangana-cyclometallation reaction with BnMn(CO)5, in a stoichiometric reaction to 
give a five membered manganacycle 105a and 105b (Scheme 49). The direct 
reaction of 81 with BnMn(CO)5 in hexane at 75 °C gave 105a in 96% and 105b 98% 
yield. The complexes were characterised by spectroscopic methods, and a single 
crystal was subjected to X-ray diffraction (Figure 24), which showed that 
regioselective C3 C-H bond activation had taken place. 
 
Scheme 49 Stoichiometric reaction of MnBn(CO)5 with 2-pyrone 104 affording five-membered 
manganacycle 105a and 105b 
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Figure 24 X-ray crystal structures of 105a and 105b (note: arbitrary atom numbering used and thermal ellipsoids set to 50%; H-atoms omitted for clarity). 
Chapter 3 Manganese catalysed C-H alkenylation / Diels-Alder Reactions 
108 
 
5.3.1 C-H bond alkenylation 
Chen et al.
69
 described their conditions for the 2-phenylpyridine alkenylation by 
heating 2-phenylpyridine 18 and phenylacetylene 16, catalysed by BrMn(CO)5, with 
or without amine in Et2O.
69
 Using the pyrone moiety surprisingly, these conditions 
did not produce the expected product 106.  In work initially conducted by an 
Erasmus exchange student, Conrad Wagner, the product obtained was a stable six 
membered manganacycle 107 (Scheme 50). The 
1
H NMR spectra of 107 (acetone-d6, 
400 MHz) exhibited a new resonance at δ 5.79 as a singlet. An equivalent reaction, 
run with PhC≡13CH, confirmed that this proton was directly connected to the 13C 
label (
1
JCH = 181 Hz). The most characteristic information was obtained from the 
13
C 
NMR spectra of the unlabelled product which showed four unusual but characteristic 
carbon environments (at δ 62.0, 77.2(*), 85.8 and 92.0) (* denotes enriched in 13C- 
label). The observation indicates that the Mn atom is bound to four contiguous 
carbon centres in an η4-coordination mode 107.  
 
Scheme 50 Unexpected alkyne insertion giving cyclomanganesiated complex 107 
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Crystallisation of 107 from acetone-d6 gave single crystals suitable for X-ray 
diffraction, which confirmed its structure (work conducted by a summer project 
student, Magdalene Teh, Figure 25). 
 
Figure 25 X-ray crystal structure of 2-methyl-4-oxo-6-phenyl-4H-3,75-pyrano[4,3-a]quinolizin-7-
ylium-η4-3,3a,5,6-tricarbonylmanganesuide 107 (note: arbitrary atom numbering used). Selected 
torsion angles (°), bond angles (°) and bond lengths (Å): C4-C3-C13-C12 = 4.2(2), C3-C4-C7-N1 = -
38.4(2), N1-C12-C13-C3 = 44.4(2); C13-C12-N1 = 114.38(14), C3-C4-C7 = 116.31(15); C3-Mn1 = 
2.0769(17), C4-Mn1 = 2.1843(17), C12-Mn1 = 2.1060(18), C13-Mn1 = 2.0908(18) (Figure prepared 
by Ian Fairlamb). 
5.3.2 Density functional theory (DFT) evaluation for 107 
The mechanistic steps leading to the formation of 107 were evaluated using density 
functional theory by Dr. Jason Lynam in York. Starting from I (Figure 24), formed 
via loss of a CO ligand from 19a, insertion of the coordinated alkyne into the Mn-
C(pyrone) bond proceeds through a low energy transition state II to give III. 
Carbon-nitrogen reductive elimination from II, via transition state IV, results in the 
formation of the 2-methyl-4-oxo-6-phenyl-4H-3,75-pyrano[4,3-a]quinolizin-7-
ylium ring system. An analysis of IV revealed that the imaginary eigenvector led to 
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107' (coordination isomer of 107); a -slip (not modelled) would lead to 107(Figure 
26). 
 
 
Figure 26 Density functional theory (DFT) showing potential energy surface for the formation of 
107; Energies are zero point-corrected electronic energies (top) and Gibbs free energies at 298.15 K 
(bottom) in kJ mol
-1
 at the PBE0-D3/def2-TZVPP//BP86/SV(P) level with solvation corrections 
applied in Et2O (COSMO, = 4.33 for Et2O at 25 °C). 
A series of experiments were conducted to gain evidence for reaction intermediates. 
Taking 10 mg of 105a with 1.1 equivalents of phenylacetylene, dissolved in d8-THF 
(0.5 mL), the reaction mixture was cooled to 243 K. UV light was used to irradiate 
the sample at 243 K for 15 mins. NMR simulation of the reaction mixture reveals 
signals corresponding to 107. However further irradiation reveals new signals. These 
may be due to the formation of the intermediate (III). The intermediate (III) 
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detection was conducted in collaboration with Kate Appleby, who did the NMR 
analysis and photochemical measurements (Figure 27). 
9 8 7 6 5 4 3 2 1 ppm 
Figure 27; 
1
H NMR spectra of the manganese starting material 105a. and the solution after 15 min 
irradiation with UV light (above). New signals belong to the intermediate (III). 
 
2D NMR paves the way in confirming the proposed intermediate (Figure 28).  
LIFDI-MS analysis confirmed a radical cation at m/z 427 [M]
+
. ESI-MS also showed 
a pseudomolecular ion [MH]
+
 at m/z 428, with MS-MS analysis revealing loss of CO 
m/z 400 [MH-CO]
+
. Warming of the solution of (III) to room temperature led to 
formation of 107, confirming (III) as a viable intermediate (Figure 28).  
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Figure 28 Correlation methods (HMQC and HMBC) and selective nOe experiments confirmed 
intermediate (III) (Figure prepared by Kate Appleby and Ian Fairlamb). 
 
DFT calculation of corresponding potential energy surface for the phenyl-substituted 
system (Figure 29) revealed similar pathway was viable. In this case insertion of 
alkyne remains a barrier between the two as 2-pyrone moiety is slightly greater in 
Gibbs energies relative to the respective compound I = +25 kJ mol
-1
 versus (Ia = 
+34 kJ mol
-1
) and that III was higher in energy than 111a (-76 kJ mol
-1
 versus -95 kJ 
mol
-1
). Therefore, the energetic spans for reductive elimination are 60 kJ mol
-1
 (2-
pyrone) and 129 kJ mol
-1
 (phenyl). When compared with the formation of Va and V, 
i.e. the next steps in forming of 19 and 106 respectively, it is evident that the 
reductive elimination to form 107 is competitive, but in the case of intermediate V in 
Figure 29, the much larger energetic span to reductive elimination allows for 
productive catalysis via Va. 
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Figure 29 Density functional theory (DFT) showing Potential energy surface for the formation of 
IIIa; Energies are zero point-corrected electronic energies (top) and Gibbs free energies at 298.15 K 
(bottom) in kJ mol
-1
at the PBE0-D3/def2-TZVPP//BP86/SV(P) level with solvation corrections 
applied in Et2O (COSMO,  = 4.33 for Et2O at 25 °C)  
5.3.3 Alkenylation reaction/Diels-Alder product 
The DFT results led us to believe that the reaction of 105 with higher concentrations 
of phenyl acetylene 16 could give product 106 by alkyne protonation (cf. similar to 
that proposed in Chen’s studies).69 Heating 105a in neat 16 at 100 °C for 5 h, gave 
four compounds (Scheme 51). 
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Scheme 51 Reaction of 105a with neat phenyl acetylene 16 at 100 °C afforded alkenylated product 
106a and Diels-Alder products 106b, 108 and 109  
The first compound was determined to be novel compound 106a, which was isolated 
in a yield of 28%. Rather remarkably, the second and major product from the 
reaction was found to be an entirely novel compound 108, isolated in a yield of 44%. 
Here, four new bonds have been formed, including C-C and C-N bonds, in addition 
to the cleavage of the pyridyl ring and elimination of the Mn(CO)n moiety. The final 
product from the reaction was found to be novel compound 109, isolated in a 21% 
yield, with a remarkable six new bond from three alkyne insertions in a systematic 
fashion by manipulating both the pyridyl and pyronyl moiety of the ligand and fourth 
compound 106b which was detected by (ESI-MS). 
Compound 106 was synthesised via a protonation reaction (Scheme 51). However 
compounds 106b, 108 and 109 are formed by a fragmentation and Diels-Alder 
reaction, involving the 2-pyridine group to give 108. A second Diels-Alder reaction 
at 108 via the 2-pyrone also occurs, regioselectively, giving compound 109, also was 
detected a Diels-Alder reaction at 106a via the 2-pyrone to form 106b. These 
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compounds were characterised by NMR and other spectroscopic technique, however 
compound 106 exhibited a precedented character at protons JHH coupling in the 
alkene region δ 7.88 (1H, d, JHH = 16.1) and 6.95 (1H, d, JHH = 16.1) which confirm 
the trans alkene formation as drawn in Scheme 51, typically the trans alkene gave 
JHH coupling constant 16 Hz while cis alkene 12 Hz. However surprisingly the 
proton geminal to phenyl in the alkene region 106a resonated at relatively low-field 
δ 7.88 with respect to corresponding geminal proton at the alkene region compound 
19 δ 7.05, (Scheme 45) with a  difference of ( = 0.83)  
The full NMR spectroscopic analysis of 108 and 109 was possible, using correlation 
methods (HMQC and HMBC) and selective nOe experiments, which confirmed that 
the proposed structure 108 had been formed regioselectively (Figure 30). It can be 
seen that the JHH coupling matched the typical structure, example (Figure 30a) 
proton (11’) δ 7.94 (1 H, td, JHH = 1.8, 0.6), (13’/15’) δ 7.78 (2 H, dt, JHH = 7.1, 1.8) 
and (14’) δ 7.67 (1 H, t, JHH 1.8) both in the same ring system and are coupled with a 
JHH value = 1.8 more detail coupling see Figure 30a. The selective nOe experiments 
further confirmed the proposed structure having observed the nOe of the protons that 
lie close in space especially nOe 
1
H-
1
H of (CH-8 and CH-11) and (CH-5 and 
CH-11’) (Figure 30b). ESI-MS analysis confirmed a radical cation at m/z [M+H]+ 
390.1484, [M+Na]
+ 
412.1304 (Figure 34).  
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Figure 30 
1
H NMR spectroscopic data (700 MHz, CD2Cl2) for compound 108; (a) chemical shifts (in 
ppm) are followed by the multiplicity of the signal and the coupling constant in Hz. (b) Key nOe 
interactions for compound 108, confirming the stereochemistry around the 2-pyrone moiety. 
Further evidence for a 2-pyrone was the characteristic UV absorption band at 262 
nm, and infrared bands at 1681, 1633, and 1596 cm
−1
, in addition to 
13
C NMR 
resonances at 162.26, 156.95 and 156.06 ppm, all of which were in agreement with 
an authentic reference compound, 4-(2’-pyridyl)-2-pyrone  81.  
Chapter 3 Manganese catalysed C-H alkenylation / Diels-Alder Reactions 
117 
 
Crystallisation of the product from dichloromethane and hexane gave single crystals 
suitable for X-ray diffraction, which confirmed the structure as 108 (Figure 31).  
 
Figure 31 X-ray crystal structure of 108 (note: arbitrary atom numbering used; thermal ellipsoids set 
to 50%; H-atoms omitted).  
It is important to note that the rearrangement occurred only in the presence of 
tricarbonylmanganesuide, in η4-coodination mode from 107, which was ascertained 
by treatment of 108 with excess 16 at 110 
o
C for several hours (ca. 24 h.); however 
reaction monitoring by TLC suggested that no reaction occurred (Scheme 52). 
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Scheme 52 Control Diels-Alder reaction in the absence of Mn 
A plausible mechanism for the formation of 108 and 109 (Scheme 53) is shown 
where 108 and 109 are formed by a fragmentation and Diels-Alder reaction 
involving the 2-pyridyl group. The Diels-Alder reaction may be caused by ionisation 
of nitrogen on the pyridyl moiety by coordination of tricarbonylmanganese. This 
may manipulate the bonds on the pyridyl moiety, especially the nitrogen, 
subsequently paving the way for phenylacetylene 16 cycloaddition via I, as shown in 
the proposed mechanism. This is a fragmentation process, proceeding via II to give 
III. Aromatisation gives 108. A second known Diels-Alder addition at the 2-pyrone 
also occurs, regioselectively, giving compound 109.  
 
Scheme 53 Proposed mechanism for the formation of Diels-Alder product 108. 
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Compound 109 was ascertained by NMR, IR, UV-vis and single crystal X-ray 
diffraction. The correlation methods (HMQC and HMBC) and selective nOe 
experiments, and UV absorption at 262 nm confirmed the proposed structure of 109. 
 
Figure 32 
1
H NMR spectroscopic data (700 MHz, CD2Cl2) for compound 109; chemical shifts (in 
ppm) are followed by the multiplicity of the signal and the coupling constant in Hz. 
 
A single crystal suitable for X-ray diffraction analysis was obtained from DCM and 
hexane, which confirmed the structure as 109 (Figure 33) 
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Figure 33 X-ray crystal structure of 109 (note: arbitrary atom numbering used; thermal ellipsoids set 
to 50%; H-atoms omitted). 
The hypothesis above is implicated by observing both the intermediate and product 
using mass spectrometry (ESI-MS) at m/z 530.0778 and the product 109 at m/z 
448.2035. The Diels-Alder reaction was also seen for 106 via addition to the 2-
pyrone moiety. Similarly, alkyne insertion was observed in 106b, where I was also 
observed by ESI-MS (Figure 34). 
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Figure 34 ESI-MS of the reaction of alkenylation and Diels-Alder product 
The 
1
H NMR spectroscopic data for compound 108, which contains a pyrone 
moiety, can be compared to that for 109, which does not have a pyrone but a 
sterically bulky phenyl (Table 1). Some selected 
1
H NMR (e.g. the H-7, H-11&15, 
H-12&14, H-13 and H-15 portion) match closely (Δδ < 0.1 ppm), however other 
parts do not. The largest chemical shift difference in this category arises for the 
proton at H-5, and is Δδ = 1.29 ppm, followed by H-8 where Δδ = 1.29 ppm. This 
confirms that the two double bonds in the enol ether are  more electron deficient in 
the pyrone-containing system, owing to the 
1
H NMR signals for compound 108 
observed at -Δδ ppm reported values with respect to compound 109, which is more 
electron-rich (Table 6)  
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Table 6 Comparison of selected 
1
H NMR shift data for the compounds 108 and 109 

Position Compound (109) 
δ/ppm 
Compound (108) 
δ/ppm 
/ ppm 
5 7.83 6.54 1.29 
7 2.37 2.28 0.09 
8 8.12 8.5 0.7 
11 & 15 8.23 8.2 0.03 
12 & 14 750 7.52 -0.02 
11' 8.06 7.94 0.12 
13' 7.79 7.78 0.01 
14' 7.81 7.67 0.14 
15' 7.68 7.64 0.04 
Note: multiplets are given as a centre point average; NMR standard (δ 5.32) 
was residual CH2Cl2. 
 
The proposed route to the final product ( 
Scheme 54) begins with MnBn(CO)5 which reacts  with 2-phenylpyridine 104a by 
reductively eliminating toluene and CO, affording a five-membered manganacycle 
105a. Next is the reaction of five-membered manganacycle 105a with phenyl 
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acetylene 16 to form manganacycle (II), via a fast regioselective alkyne insertion I. 
Interestingly, the seven-membered manganacycle intermediate III, was formed via 
selective alkyne migration into II. Transition state IV sets up reductive elimination 
from III. The dichotomy here is that alkenylated product 106 formed via protonation 
and the μ2-alkyne complex V to form 106; complex 107 forms via reductive 
elimination. Complex 107 then rearranges intramolecularly to manganacyclohexyl 
intermediate VII by a Diels-Alder addition of phenyl acetylene 16.  Intermediate VII 
undergoes pyridyl ring-opening and rearrangement to give VIII. H-loss and 
aromatisation affords 108 and regenerates HMn(CO)3, which feasibly can participate 
in further reaction. 
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Scheme 54 proposed route for alkenylation/Diel-Alder Product. 
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5.4 Effect of substituted 2-pyridine moiety with 6-methoxy-2-
pyridyl moiety on 2-pyrone 
Noticed was a profound effect when a substituted 2-pyridine 105b was used with a 
similar reaction conditions with respect to Scheme 50 (page 108) and Scheme 51 
(page 114) (Scheme 55). Although the alkenylated product 111 was only observed in 
trace amounds by ESI-MS, complex 110 was isolated in a good yield (76%). The 
structure of the double alkyne insertion product 110 was ascertained by NMR, IR 
and UV-vis. 
 
Scheme 55 Double alkyne insertion into cyclomanganesiated complex 110 and alkenylated product 
111 
A single crystal suitable for X-ray diffraction analysis was obtained from DCM and 
hexane, which gave the structure as can be seen in Figure 35. 
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Figure 35 X-ray crystal structure of 110 (note: arbitrary atom numbering used) dotted lines have been used to 
show the Mn-coordination in complex for clarity (thermal ellipsoids set to 50%; H-atoms omitted). Selected 
torsion angles (°), bond angles (°) and bond lengths (Å): C4-C3-C13-C12 = 4.2(2), C3-C4-C7-N1 = -38.4(2), 
N1-C12-C13-C3 = 44.4(2); C13-C12-N1 = 114.38(14), C3-C4-C7 = 116.31(15); C3-Mn1 = 2.0769(17), C4-
Mn1 = 2.1843(17), C12-Mn1 = 2.1060(18), C13-Mn1 = 2.0908(18)
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5.5 Conclusion 
This study has shown that a 2-pyridyl directing group can become directly involved 
in Mn
I
-mediated alkenylation reactions. Replacement of a phenyl group with a 2-
pyrone (more electron-accepting) group had a profound effect on the preferred 
reaction path, affording a stable and isolable manganese adduct 107. Critically, for 
the first time, evidence of a commonly proposed manganacyclic 16-electron 5-
coordinate intermediate III has been gathered, which is found to be the key 
intermediate controlling whether direct reductive elimination or protonation and 
metal de-coordination occurs, affording 106 or 107, as proposed in the catalytic 
chemistry. 
The stoichiometric reactions conducted in neat phenyl acetylene showed that other 
products such as 106b, 108, 109 and I, can be readily formed. Remarkably, this is an 
unprecedented C-H bond activation and Diels-Alder reaction, involving 2-pyridyl 
ring-cleavage and a recombination process to give 108, was observed. Related 
double Diels-Alder compound 109 was also isolated.  
An unprecedented complex 110 was isolated, using the 6-methoxy-2-pyridyl 
electron-donating group, which was found to have a profound effect on the preferred 
alkyne insertion reaction pathway, affording a stable and isolable manganese adduct 
110. 
The combined experimental and computational approach used in this study has 
allowed delineation of some of the reaction paths available in Mn
I
-mediated C-H 
bond activation. These findings could provide insight for the future design of Mn
I
-
mediated C-H bond activation processes, especially how relatively minor changes in 
substrate structure influence product selection – MnI-based metallocycles offer 
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interesting chemistry and reactivity which could be exploited in advanced chemical 
synthesis.  
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6 Chapter 4 Pauson-Khand / 6π-electrocyclisation 
reactions of internal alkynes possessing cobalt-directing 
groups 
6.1 Introduction 
Fairlamb and co-workers
105, 109
 reported a push-pull effect in the PKR with several 
sterically equivalent, heteroaromatic-substituted 112 alkynes containing π-electron 
deficient pyrones  113 (Scheme 56).
105
 
 
Scheme 56 Sterically, near-equivalent, heteroaromatic-substituted alkynes in PKR 
The π-deficient 2-pyrone moiety is found to preferentially occupy the β-position with 
respect to the enone of cyclopentenone product.
105
 The electronic factor is not 
enough to predict that the 2-pyrone electron donating group (EDG) favoured the β-
position, as for other more π-electron rich examples, e.g. furan and thiophene,105 the 
β-regioisomer predominated, which violates the notion, rule if you will, for internal 
alkynes that predicts placement of electron-donating groups (EDG) at the α-
regioisomer.
135
 It was thus necessary to study further PKR reactions of internal 
alkynes containing heteroaromatic rings to assess the regioselectivity outcome.   It is 
proposed that the ratio of different PKR cycloadducts will be sensitive to the 
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heteroaromatic rings used (a) to (e) (Figure 36). Also, it was anticipated that the 
position of the nitrogen atom within pyridyl-containing alkynes might control the 
regiochemical outcome of the PKR reaction. 
 
Figure 36 Heteroaromatic ring systems used in this study 
The internal alkynes required for the PKR study were prepared by a Sonogashira 
cross-coupling protocol. The precatalyst, PdCl2(PPh3)2 (1 mol %), was employed and 
the catalytic cycle involved Pd
0
 (I), oxidative addition of organic substrate (II), 
follow by Cu
I
 to activate the alkyne by π-coordination (IIIa), then cupration to form 
(IIIb).  On transmetallation (IV) is formed along with the regeneration of (IIIc). 
Isomerisation at Pd
(II) (II)
 (V), followed by reductive elimination, affords the internal 
alkyne product and also regenerates the Pd
0
 catalyst (Scheme 57).
25
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Scheme 57 Postulated mechanism for the Sonogashira cross-coupling reaction 
The pyridyl derivatives of ethynyltrimethylsilane, i.e. 2-[2'-(trimethylsilyl)ethynyl] 
pyridine 114a, 4-[4'-(trimethylsilyl)ethynyl]pyridine 115a and 2-[2'-
(trimethylsilyl)ethynyl]pyrazine 116a were prepared in excellent yields, with the 
exception of 2-[2'-(trimethylsilyl)ethynyl]thiophene 117a, which is satisfactory 
(Scheme 58).  
 
Scheme 58 Synthesis of initial alkyne 114a using the Sonogashira cross-coupling reaction 
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The terminal alkynes were accessed via deprotection of 114a-117a using NaOH in 
methanol / dichloromethane (1:1 v/v) under a N2 atmosphere for 2 h. The compounds 
2-ethynylpyridine 114b, 4-ethynylpyridine 115b, 2-ethynylpyrazine 116b and 2-
ethynylthiophene 117b in good yield, with the exception of 2-ethynylthiophene 117b 
which was isolated in 48% yield. 
 
Scheme 59 Deprotection of silyl-protected alkynes to deliver terminal alkynes for Sonogashira cross-
coupling 
Chapter 4 Pauson-Khand / 6π-electrocyclisation reactions of internal alkynes possessing cobalt-
directing groups 
133 
 
Table 7 Synthesis of heteroaromatic ethynyl substrates, all substrates were synthesised using a 
standard Sonogashira protocol 
Lebel ArX Akynes / Yield 
(%) 
Product / Yield (%) 
1 
 
 
 
3 
 
 
 
4 
 
 
 
5 
   
6 
   
7 
 
115b 
 
8 
 
114b 
 
9 
 
115b 
 
 
6.1.1 Synthesis of sterically and electronically near-equivalent alkynes 
The terminal alkyne was synthesised via a Sonogashira cross-coupling reaction of 
ethynyl pyridine with 4-bromo-6-methyl-2-pyrone, 2-bromopyridine and 2-
bromothiophene. These allowed access to the alkyne compounds, 6-methyl-4-(2'-
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pyridylethynyl)-2-pyrone 114c, 6-methyl-4-(4'-pyridylethynyl)-2-pyrone 115c, 6-
methyl-4-(2'-pyrazylethynyl)-2-pyrone 116c, 6-methyl-4-(2'-thienylethynyl)-2-
pyrone 117c, 4-(2'-thienylethynyl)pyridine, 118  2-(2'-thienylethynyl)pyridine and  
2-(4'-pyridylethynyl)pyridine 119. Compounds 114c–116c allow the relative position 
of the nitrogen atom to be probed with respect to 2-pyrones, whereas 2-thiophene 
derivatives 117c–119 offer a sterically distinct but electronically similar alternative 
to the pyridyl ring system.  
 
Scheme 60 Synthesis of sterically and electronically near-equivalent terminal alkyne using 
Sonogashira cross-coupling reaction  
A series of electron-deficient 2-pyrone derivatives 114c-116c and 2-thiophene 
derivatives -electron rich 116c–119 were prepared for comparison with reported 
alkynes from the Fairlamb group.
104, 105, 109
 These particular derivatives were 
synthesised to evaluate regiochemistry pertaining to the structure of the internal 
alkynes, containing a heteroaromatic ring moiety (pyridine) with respect to 2-pyrone 
in PKR , i.e. 114c–117c (Scheme 60).  
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Crystallisation of products 114c and 115c from dichloromethane and hexane gave 
single crystals suitable for X-ray diffraction study, which confirmed their postulated 
chemical structures (Figure 37).  
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Figure 37 X-ray diffraction structures of compound 114c and 115c. Compound 114c left hand side, showing the packing between the atoms in the molecules. Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%.
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6.2 Synthesis of sterically and electronically near-equivalent 
heteroaromatic PKR protocol 
The first step in the synthesis of the cyclopentanones was carried out by the reaction 
between the cobalt carbonyl complex, Co2(CO)8, internal alkyne at room 
temperature, ca. 23 
o
C for 30 min. follow by alkene alkene insertion via 
microwaving for about 60 min that lead to PKR.  However, reacting an equimolar 
quantity of Co2(CO)8 and alkyne in THF at room temperature under nitrogen 
atmosphere for 16 hours afforded the first intermediate complexes, which were 
isolable, e.g. complexes 121(I)-123(I) and 125(I), and formed in good yield (Scheme 
61). However on comparing the proton chemical shift of the internal alkyne 
114c-116c and alkynyl-Co2(CO)6 121(I)-123(I) suggested no significant difference 
in the heteroaromatic region containing pyridine, while a difference was observed at 
C5/H5 in all of the pyrone containing moieties, e.g.  6.28 for 114c and  6.10 for 
121(I),  0.18. The second step involved PKR reaction with norbornene under 
typical thermal conditions (microwave assisted synthesis at 90 
o
C for one hour). The 
reaction proceeded smoothly and gave the PK cycloadduct 121 in 68% yield as only 
one  isomer (Scheme 61 and Table 8).  
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Scheme 61 PKR via the intermediate 2-alkynyl-pyrone-phenyl-Co2(CO)6 complex 
6.2.1 Evaluation of heteroaromatic containing nitrogen atom or 2-pyrone in 
PKR 
Here the alkene was kept constant (norbornene), as other alkenes may alter the 
regiochemical outcome
98
 (Table 8). Previously Fairlamb and co-workers
105
 reported 
that the presence of a proximal nitrogen on the alkyne heteroaromatic group in 
pyridyl-containing alkyne substrates has a profound effect on the regiochemical 
outcome of the PK reaction.
105
 Compound containing 2-pyrone, 113 and 121-124 
(Scheme 61) were studied for their selectivity, however nitrogen containing atom at 
 position to the substituent compound 121 and 124 favour the β-position 
exclusively. The compound containing a nitrogen atom at the meta-position to the 
cyclopentenone substituent 122 shows no selectivity at all.  Selectivity towards the 
β-position was observed for the pyrone containing 2-thiophene 124. However 
nitrogen containing in both ring system 127 favoured the 2-pyridine at the β-position 
exclusively, suggesting that there may be an interaction of 2-pyridine with the cobalt 
complex. Further evidence is provided by 2-thiophene 125, where the 2-pyridine 
controls the regiochemical outcome, even though the α-isomer was observed 125. 
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The 2-thiophene was observed controlling the regioselectivity over 4-pyridine 126.  
This suggested that the position of the nitrogen atom in pyridyl-containing system 
(with respect to the 2-pyrone) dramatically affects the regiochemical outcome of the 
PKR. Remarkably, 2-pyridine shows unique behaviour by having a significant effect 
on the selectivity of both the -electron deficient 2-pyrone 121-124 and -electron 
rich 2-thiophene 125. 
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Table 8 PKR of nitrogen and pyrone containing (heteroaromatic alkynes) compounds. 
 
Entry Substrate β % α % Entry Substrate β %  % 
1 
 
71 11 
5 
 
55 12 
2 
 
68 -- 
6 
 
58 29 
3 
 
42 42 
7 
 
67 10 
4 
 
77 -- 
8 
 
76 -- 
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All PKR cycloadducts were characterised by NMR, IR, UV-Vis, and elemental 
analysis. The NMR spectroscopic study shows that the regioisomeric structures can 
be discerned by chemical shift, with the aid of 
1
H COSY, nOe interactions and 
13
C 
information, provided by HMQC and HMBC. The 
1
H NMR spectra (400 MHz, 
CDCl3) of the two protons α to the nitrogen atom in 122β (note: β is in respect of the 
pyridyl ring position within the cyclopentenone ring system) resonated at downfield 
δ 8.70, while the protonα to nitrogen in 122αregioisomeric resonated slightly 
upfield with respect to 122β at δ 8.63.  The proton β to nitrogen in 122β appears at δ 
7.22 (d, JHH = 5.9 Hz, 2H) and at 7.17 (d, JHH = 5.9 Hz, 2H) for 122 The C3 and 
C5 protons within the 2-pyrone moiety appeared at δ 6.18 (s, JHH = 3.1 Hz, 1H), 6.03 
(s, JHH = 3.1 Hz, 1H) for 122β and  δ 5.71 (s, JHH = 3.1 Hz, 1H) and 5.59 (s, JHH = 
3.1 Hz, 1H) for 122α (Figure 38). 
 
Figure 38 
1
H NMR spectra (400 MHz, CDCl3) of PKR compound 122 reaction mixture of 1:1, 122α 
and 122β which possess the same Rf value by TLC.  
The 
1
H NMR spectra of 124, containing 2-thiophene and 2-pyrone, with a relative α 
and β regioselectivity reveals significant chemical shift differences, especially the 
protons on the thiophene moiety α, β and  to sulphur 124β resonated at lower field  
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7.61 (dd, JHH = 5.1, 1.1 Hz, 1H), 7.49 (dd, JHH = 3.8, 1.1 Hz, 1H), 7.14 (dd, JHH = 
5.1, 3.8 Hz, 1H) respectively with respect to  124α  7.41 (dd, JHH = 5.1, 1.2 Hz, 
1H), 7.34 (dd, JHH = 3.8, 1.2 Hz, 1H), 7.03 (dd, JHH = 5.1, 3.8 Hz, 1H). The 
1
H-
1
H J 
coupling of thiophene moiety with respect to 124β1H JHH  to  = 1.1,  to  = 5.1 
and  to  =3.8 and 1241H JHH  to  = 1.2,  to  = 5.1 and  to  =3.8 is in 
agreement with the expected coupling constant in both regioisomers (Figure 39). The 
chemical shift of the of pyrone moiety C3H and C5H of 124α absorbed at low field  
6.18 (s, J = 2.6 Hz, 1H), 5.86 (t, J = 1.2 Hz, 1H) with respect to 124β 6.08 (dd, J = 
1.4, 0.7 Hz, 1H) and 5.84 – 5.82 (m, 2H) contrary to 122 (Figure 39 and Table 9). 
 
Figure 39 
1
H NMR spectra (400 MHz, CDCl3) of PKR compound 124 showing simulation at 
different  of 124 above and 124see Table 9.  
Table 9 summarises the NMR spectroscopic data of PKR compounds containing the 
2-pyrone moiety, i.e. 121, 122α, 122β, 123, 124α and 124β. 2D NMR analysis 
allowed the regiochemistry to be determined. The protons of the β-regioisomer 
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resonated at lower field in compound 122β, especially protons in the pyridyl and 
pyrone moiety.  
The protons of the α-regioisomer resonated downfield in 125α, especially the proton 
in the thienyl and pyrone moiety (Table 9). It is generally observed that in 2-pyrone 
moiety the C3H (proton) resonates downfield with respect to C5H (in most cases 
containing the 2-pyrone). The 
1
H-
1
H nOe of the PK cycloadducts are also diagnostic. 
The 
1
H () ortho to nitrogen in the pyridyl moiety shows a 1H-1H nOe contact with 
the CH4a of the cyclopentenone in 121β, while in compound 122β the 1H- to 
nitrogen show 
1
H-
1
H 2D nOe with C4a of cyclopentenone, likewise 1221H- to 
nitrogen show 
1
H-
1
H nOe with C3 of pyrone moiety is nOe the 
1
H C-H4a of 
cyclopentenone is said to be  region-selective isomer 122Table 9. The 
compound containing a pyrazine moiety 124 showed exclusively -selectivityIn 
the case of 125 the proton that is to sulphur within the thienyl moiety shows an 
nOe contact between H1-H4a. 
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Table 9 The
 1H δ shift of PKR product involving 2-pyrones with regiochemical outcome supported by COSY, nOe 1H-1H and HMQC 1H-13C coupling experiments. 
 
 
 
 
 
Entry -N -N 
1
H δ C5 1H δ C3 1H δ CH3 
1
H δ C7a 1H δ C7 1H δ C4a 1H δ C4 1H-1H nOe 
121 8.72 7.39 5.77 6.01 2.17 3.41 2.50 2.58 2.20 (C-H-C-H4a 
122 8.71 7.22 6.03 6.18 2.17 3.15 2.52 2.60 2.23 (C-H-C-H4a 
122 8.65 7.17 5.59 5.71 2.15 3.01 2.52 2.60 2.23 C-H5-C-H4a 
123 8.57 8.64 5.72 5.99 2.18 3.41 2.52 255 2.18 (C-H-C-H4a 
124 7.61
*
 7.14
*
 5.83 6.08 2.22 3.16 2.48 2.48 2.48 (C-HS-C-H4a 
124 7.39
*
 7.02
*
 5.84 6.22 2.24 2.88 2.47 2.59 2.23 C-H5-C-H4a 
1
H NMR (400 MHz, CDCl3) Note: multiplets are given as a centre point average. (121) X
1
 = N, X
2
 = C, X
3
 = C. (122), X
1
 = C, X
2
 = N, X
3
 = C. (123), X
1
 = N, X
2
 = C, X
3
 = N
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Crystallisation of the major regioisomeric product of PKR adducts from 
dichloromethane and hexane gave single crystals suitable for study by X-ray 
diffraction, which confirmed the structure, consistent with NMR spectroscopic 
analysis (Figure 40). 
The crystal structures of 121 and 127 exclusively β, and 126β as a major isomer 
which predict that the position of the nitrogen atom has a greater influence to the 
substituent presumably due to the interaction of nitrogen α to the substituent with the 
cobalt intermediate. Substituting the 2-pyridyl ring with 2-pyrazine, in a system 
containing 2-pyrone, 123, led to exclusive formation of the β-regioisomer. his 
supports the prediction that the position of the nitrogen atom in the pyridine ring 
system exerts greater influence in controlling the regiochemical outcome of the PKR. 
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Figure 40(I) Single Crystal X-ray structure of 121 
showing exclusive β selectivity 
 
Figure 40(II) Single Crystal X-ray structure of 
122showing β selectivity 
Figure 40(III) Single Crystal X-ray structure of 
124 showing β selectivity as a major isomer 
 
Figure 40(IV) Single Crystal X-ray structure of 
127 showing exclusive  β selectivity 
Figure 40(VI) Single Crystal X-ray structure of 
125disordered thiophene deleted for clarity  
 
Figure 40(VIII) Single Crystal X-ray structure of 
126 one thiophene deleted for clarity  
Figure 40 Single Crystal X-ray structure of PKR for 121β, 122, 124, 125, 126 and 127
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6.2.2 Significance of the alkene in determining PKR regioselectivity 
Kanno et al.
102, 106, 108
  and Riera et al. 
107
 explained that it is difficult to ignore the 
fact that the alkyne and solvent influence the regiochemical outcome of PKRs, while 
also acknowledging that the alkene can play a role. The findings in this project 
provide supporting evidence that varying alkene structure can have a profound 
influence on the PKR regio-selectivity, by using alkynes such as 114c (Scheme 62). 
Norbornadiene influenced the selectivity outcome quite dramatically, affording 
cycloadducts 128β in 57% and 128α in 35% yield.  While 128β was still the major 
regioisomer; previously the reaction with norbornene gave this particular 
regioisomer, exclusively, i.e. 121β– the results are summarised in Scheme 62 
 
Scheme 62 PKR with norbornene and norbornadiene showing the significance of alkene structure in 
the affecting the regiochemical outcome of 121 and 128. 
The regiochemical outcome of the PK reaction of 2-pyridylalkynyl-2-pyrone 114c 
with Co2(CO)8 and norbornadiene did not mirror the equivalent reaction with 
norbornene, presumably due to the former substrate being able to act as a bidentate 
ligand at Co.  
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The selectivity seen for 121 could also be explained based on bulky nature of the 
alkyne group toward alkene insertion. The alkene insertion toward bulky group 
favoured trans- II while cis- insertion is disfavoured III for compound 121, 
exclusively (Scheme 63). The regiochemical outcome of the PKR with Co2(CO)8 and 
norbornadiene behaved as expected, giving 128β as the major product not to ignore 
that the 128α is also significant. The alkene insertion to both cis- and trans- is 
possible for PKR 128 via IV to give both 128β and 128α through V and VI, it was 
precedented that 128β is the major product given that steric effect pay a vital role in 
controlling the selectivity outcome in PKR. Here is a speculative possibility for 128 
to dimerise to form a compound similar to VII even though it was not detected. This 
chapter classifies the effect of the different heteroaromatic moieties and alkene 
insertion. The results suggest that a subtle combination of steric, electronic and 
alkene insertion factors control the regioselectivity. 
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Scheme 63 Possible mechanism showing effect of alkene insertion on the regioselectivity outcome 
6.2.3 Microwave-assisted PKR – a tool for forming other cyclic products 
Besides the PKR cycloadducts, the microwave-assisted PKR protocol used in this 
study generated a by-product, e.g. Coogan lactone 129 via intermediate 129(I) in 
good yield (42%) – the limiting regent in this case was norbornene (Scheme 64). 
Coogan and co-workers first reported that “treatment of norbornene with either 
dicobaltoctacarbonyl or with preformed alkyne-dicobalthexacarbonyl complexes 
affording the enol-lactone dimer” 129.136 The Fairlamb group previously reported 
observing trace amounts of 129, under microwave-assisted PKR.
105
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Scheme 64 Coogan lactone 129 as a side product in the PKR 
An investigation was initiated to understand how and why these side products were 
forming, besides the desired PKR product. Three products were observed; Coogan 
lactone 129 and the formation of two hydrogenated alkynes 130 and 131 (Scheme 
65). Formation of 130 and 131 from high pressures of carbon monoxide and cobalt 
catalysts in an air free environment is precedented. However, this is believed to be 
the first observation of hydrogenated alkynes from a PKR. The initial thought was 
that wet conditions might assist the hydrogenation process (Scheme 65). 
 
Scheme 65 Novel alkyne hydrogenation observed during microwave-assisted PK reaction 
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These compounds were characterised by spectroscopic methods. An example is 
shown in Figure 41, showing the NMR spectra of starting material 114c, proton of 
C3 and C5 resonated at 6.07 and 5.30 ppm with  = 0.77,while 130a and 131a 
resonated at C3  = 5.92, C5  = 5.87 and C3  = 6.08, C5  = 5.77 and their  
0.31 and 0.05 respectively. 
 
Figure 41 Stack plot of
 1
H NMR spectra (400 MHz, CDCl3) of 114c, 130a and 131a (reaction 
conducted under various conditions along with reference spectra). 
The reaction conditions affected the formation of lactone 129, hydrogenated alkyne 
130a and double hydrogenated alkyne 131a. Entry 1 in Table 10 employed dried 
solvent, where there was no hydrogenated alkyne 130a or 131a product observed, 
with 129 formed in 40 % yield. When using normal DCE, as purchased without 
further drying (entry 2), both lactone 129 and hydrogenated product 130a and 131a 
were observed in 42, 9, and 5 % yields respectively. Entry 3 revealed the addition of 
water (DCE/H2O: 19/1 v/v) increased 129 (65%) and 131a (17%) but decreased 121 
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and 130a (Table 10). Entry 4 revealed an increase in yield in both hydrogenated 
products. Addition of benzoquinone which acts as a scavenger to take up hydrogen 
in hydrogenation process and is known for hydrogenating agent increases the yields 
of 129, 130a and 131a to 48, 15, and 18 % yields respectively. 
Table 10 Study on the formation of side-products in PKR 
 
 Compounds 121 129 130a 131a 
Entry Solvent condition (% yield) (% yield)
a
 (% yield)
b
 (% yield)
b
 
1 Dried DCE 76 40 00 00 
2 Normal DCE (AR) 73 42 9 5 
3 Wet DCE 46 65 trace 17 
4 Wet 
DCE/Benzoquinone 
60 48 15 18 
a
 Yield based on excess norbornene used in reaction (5 eq). 
b
 Yield based on alkyne 
starting material.  
In relation to alkene reactivity, Gimbert and co-workers,
98, 99
 reported the reactivity 
of alkenes in the PKR, which showed the reactivity of cyclohexene, cyclopentene, 
and norbornene towards the hexacarbonyldicobalt(0) complex, the reactivity of 
which is related to the back donation of electrons from the d orbitals of the cobalt 
atom to the π*-orbital of the alkene.  
Interaction of lower-lying LUMO alkenes give different lactones; an example is 
given in Scheme 66a, where norbornene reacts with dicobaltoctacarbonyl complex 
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by using (5 eq.) norbornene, Co2(CO)8 (1 eq.), in reagent grade DCE, this form 
compound 129 in a good yield (73%), higher than reported in literature.
136
 It is well 
established in the literature that the better the back-donation the greater the reactivity 
and the lower the angle of the alkene the lower the LUMO, so the lower the LUMO 
the lower the energy barrier
98, 99
 so using a larger angle (º) than norbornene, for 
example Scheme 66b cyclopentene (5 eq.), Co2(CO)8 (1 eq.), reagent grade DCE, 
gave lactone 132 although it was only characterised by ESI-MS. Reaction of 
norbornene and cyclopentene (Scheme 66c, in (1 eq.) norbornene, (4 eq.) 
cyclopentene and Co2(CO)8 (1 eq.), in DCE, gave cross-lactone 133, although again 
this was only characterised by ESI-MS. 
 
Scheme 66 Synthesis of Coogan-type lactones using two different alkenes. 
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6.3 Photochemical 6-electrocyclisation reaction 
Cyclopentene-2-one derived from the PKR readily undergo photochemically-
induced 6π-electrocyclisation reactions, especially with compounds containing 2-
pyrones, which on oxidation reveal benzo[h]indeno[1,2-f]isochromene type 
products.
109
 The reaction occurs readily in natural light, and this thesis is interested 
in why, and how structural changes affect the efficacy of the electrocyclisation 
reactions with a control UV-light especially with compound involving 2-pyrones and 
related ring systems (A) to (B) via the intermediate showing in Scheme 67.  
 
Scheme 67 General synthesis route for cyclisation and aromatisation of PK cycloadduct. 
McKendry and Barboiu
137, 138
 studied the light-induced electrocyclisation reactions 
of the 2-pyrone moiety giving encapsulated cyclobutadiene structures (V) via a 
suitable Dewar lactone (calixarene) (II) or to form extremely unstable 
aldehydeketene (III) (Scheme 68).
137
 Sequence of photofragmentation of (II) occurs 
via cyclobutenecarboxylate zwitterion intermediates by eliminating CO2, producing 
butadiene cyclo-compound (CBD) (V). The unstable (V) dimerizes to form (VI) that 
rearranges to cyclooctatetraene (VII).
137,138
 (Scheme 68). This type of 
photochemistry particularly, with PKR cycloadducts, stimulated further interest in 
the photochemistry of these compounds.  
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Scheme 68 α-Pyrone photolysis: electrocyclic opening of α-pyrone and formation of cyclobutadiene 
V and cyclooctatetraene VII. 
6.3.1 Orbital symmetry and thermal versus photochemical selective activation 
in 6π electrocyclisations of PKR compound containing 2-pyrone system 
 
Figure 42 Thermal vs photochemical Symmetry allowed induced cyclization 
A generally photochemical way of dihydrophenanthrene irreversibly converts to 
phenanthrene in the presence of air and oxygen, by hydrogen-elimination (loss of 
H2O).
139, 140
 It is proposed that the oxidant rapidly reacts with the 
dihydrophenanthrene intermediate to give 121B, even in sun light. 
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In order to accelerate the reaction, a solution of compound 121A in CD2Cl2 was 
irradiated using a purpose-built Amber LED UV lamp with a filter at 400 nm, in a 
reaction vessel with an air inlet. In ca. 40 min, the reaction was essentially complete 
with quantitative conversion >90%. The 
1
H NMR spectra confirmed the formation of 
121B (Scheme 69). 
 
Scheme 69 Photochemical reactions of PKR the cycloadducts 
The Fairlamb group in York conducted B3LYP density functional theory 
calculations (DFT) on a related system 113.
104,109
 It is proposed that a similar series 
of intermediates arise with 121A(I), given two local minima, relating to conformers 
121A(I) and 121A(II) (Figure 43). The rotation of the 2-pyrone group about the 
cyclopentanone single bond of both 121A(I) and 121A(II) possesses similar 
stabilities. Conformer 121A(I) is less stable by only 1.2 kcal/mol than 121A(II). 
Isolation of I was not successful. The only two possible routes are I→III and 
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I→II→III (Figure 43). It was of interest to study the effect of 2-pyridyl group, and 
other heteroaromatic moieties, to evaluate whether they possess similar 
characteristics (Figure 43). 
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Figure 43 Mechanism and possible regioselective C3 and C5 paths for the formation of 121B from 121A
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6.3.2 Spectroscopic analysis  
Exposure of 121A to ambient light leads to cyclisation and subsequent aromatisation 
to give 121B. This strategy was applied to PKR compounds 121-128 of both α and β 
respectively (Table 8). Although the aromatisation occurs very fast, it was hoped that 
the dihydrophenanthrene could be detected during the conversion of 121A to the 
aromatised 121B using the Signal amplification by reversible exchange (SABRE) 
technique. First there is a need to understand the timeframe for complete cyclisation 
and aromatisation, using controlled UV-vis light at a given intensity which would 
undergo 6π-electrocyclisation (Scheme 69). Irradiation of 121 gave complete 
cyclisation and aromatisation (Figure 44). Experiments were performed with an 
Amber LED (0.2 amp) (400 nm), to irradiate a 5 x 10
-6
 mol/dm
3
 solution in a quartz 
cuvette for 30 sec. followed by a hold period of 2 mins and 33 sec. The UV-Vis 
spectrometer was set to scan every 4620 sec.; the first scan was run before irradiation 
under air, in DCM. The photoconversion of 121A to 121B was monitored at a low 
concentration of 121A in DCM by UV-vis spectroscopy. The spectral changes upon 
irradiation of a solution of 121A, at 30 second intervals at 400 nm from 0 to 240 sec. 
suggested complete cyclisation; further irradiation shown no significant change 
(Figure 44). Furthermore, further data for 113, 124, 124, 125 and 126 can be 
seen in Appendix 2. 
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Figure 44 UV analysis; monitoring the 6-photo-electrocyclization and aromatization of 121 with 
respect to time 
The resulting irradiated solution of 121B was characterised by ESI-MS and NMR. 
The 
1
H NMR suggested complete cyclisation and aromatisation, determined by the 
disappearance of C3H of the pyronyl moiety for 121A and 
1
H α to the substituent in 
the pyridyl moiety of 121A. However, the C5 proton chemical shift
 
of 2-pyrone 
moiety resonated at  5.69 ppm for 121A and the cyclised product 121B resonated at 
 7.90 ppm with a difference  = 2.21 ppm, 1H  to the substituent in the pyridyl 
moiety of 121A  8.70 ppm and the cyclised product  10.01 ppm with  = 1.31 
also the 
1H’s of cyclopentanone showed significant  changes example 1H  to enone 
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of cyclopentanone for pre-cyclised compound 10A  3.42 ppm and cyclised product 
3.78 ppm with  = 0.36 confirmed the formation of product 121B (Figure 45). 
 
Figure 45 Stacked spectra plot showing the pre-cyclised 121A over complete cyclised product 121B 
and of some new signals  
A sample of 121A (10 mg) was dissolved in 0.6 mL CD2Cl2 in an NMR tube and the 
solution was then monitored by 
1
H NMR (Figure 46). After <30 minutes of 
irradiation (interval of 1 min.) at ambient temperature, a set of new peaks (Figure 46) 
can clearly be observed to be appearing next to the starting material example protons 
of pyridine group (especially proton to nitrogen) at time zero (0) relative 
integration 100% pre-cyclised 121A  8.70 ppm while 0 % cyclised product 121B 
10.01. However, after irradiation for 26 minutes at ambient temperature (ca. 23 oC) 
the relative integration changed completely to 0% pre-cyclised 121A  8.70 ppm 
while 100% cyclised product 121B  10.01. The time difference between UV and 
NMR analysis (3 min and 26 min for complete cyclisation) respectively, could best 
be explained based on concentration (Figure 46). 
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Figure 46 Stack spectral plot of irradiation cycles showing conversion of the pre-cyclised 121A to cyclised product 121B over a period of 28 min. at 1 min. intervals ( = 
400nm)  
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However, after heating the starting material 121A at 35 °C for 30 minutes there was 
no difference with respect to unheated 121A. Also, heating in a water bath to 35 
o
C, 
upon irradiating the sample, shows no relative integration decrease or increase in 
respect to unheated 121A to 121B at 4 min. intervals (Figure 47).  
 
Figure 47 Stack spectral plot of irradiation cycles showing the heated (35 oC) pre-cyclised 121A to 
cyclised product 121B over a period of 28 min. at 4 min. intervals ( = 400nm) 
Table 11 summarise the electrocyclisation and relative rate of the electrocyclisation 
– aromatisation reactions for 121 to 127 α- and β-, in CD2Cl2 solutions. Each 
compound was irradiated for between 1 min. to 1 h at 400 nm and monitored by 
UV-Vis. The 
1
H NMR after which time the relative ratios of the starting compounds 
to products 121-127 α and β, were determined by a relative integral ratio of 1H 
NMR spectroscopy with respect to starting material (Figure 44 and Figure 46,). It 
was noted that the rate of cyclisation of compound containing thienyl moiety at α to 
enone of cyclopentanone is significantly affected with respect to the β moiety, the 
β-thienyl moiety gave complete cyclisation within ca. 30 min. while the α-thienyl 
moiety gave ca. 25%, 55% and 50%, see entries 5, 8 and 9 respectively (Table 11). 
Also no cyclisation was observed in entries 3 and 10.  
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Table 11 Synthesis of PKR cyclic adduct and respective  and regio-isomers (note the regioisomer 
is w.r.t cyclopentanone) 
 
Entry Substrate α β  Entry Substrate α β  
1 
 
121B 
-- 
121B 
quant. 
6 
 
113B 
-- 
113B 
quant. 
2 
 
122B 
quant
. 
122B 
quant. 
8 
 
125B 
quant. 
15B 
ca. 55 
3 
 
123B 
-- 
123B 
-- 
9 
 
126B 
ca. 50 
126B 
quant. 
5 
 
124B 
ca. 25 
124B 
quant. 
10 
 
127B 
-- 
127B 
-- 
Concentration of reagents entry 1-10 (60 mM in CD2Cl2) irradiation for 30 min. and percentage yield given 
as starting material: to product as determined by 
1
H NMR spectroscopy (400 MHz). (-- = no cyclisation 
observed). 
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6.4 Conclusion 
This chapter has examined the regioselectivity of the PK reaction by substituting the 
heteroaromatic group, especially with the 2-pyrone group, using a series of 
unsymmetrical internal alkynes. The position of nitrogen α (ortho-) to the 
substituent prove to be useful in controlling the regioselectivity outcome, as seen 
with compounds 121, 123, 125 and 127 (Table 8, page 140). Furthermore 
compounds 122, 126 and 128, where the nitrogen is  (meta-) to the substituent 
depended on steric influence of the next nearest atom. This proved a useful 
dichotomy with respect to the position of nitrogen in the pyridyl (heteroaromatic) 
moiety, especially compound 127, where 2-pyridyl overrode the 4-pyridyl group. 
This chapter has also demonstrated that varying the alkene substrate affects the 
regiochemical outcome of 128 with respect to 121 which may be due to the “push–
pull” effect of internal alkynes and Co2(CO)8 (Scheme 62 and Scheme 63).  
For the first time an alkyne hydrogenation processes is reported as a side-product in 
the microwave-assisted synthesis of the PKR (Scheme 65 and Table 10). 
Mechanistic studies are required to fully understand the regiochemical observations 
made in this and in other studies. Further breakthroughs could be achieved if 
mechanistic studies reveal how the positions of nitrogen in the heteroaromatic group 
affects the Co-Co bond order in intermediate complexes such as 121(I) to 127(I) 
(Scheme 61) and subsequent intermediate species to the final product. 
The major and minor PKR regioisomeric products 121-128 readily undergo a 
photochemically-induced 6π-electrocyclisation–oxidative aromatisation reaction 
with the exception of 123 and 127 to reveal aromatised and functionalised type 
products 121B, 122B and 124B-126B α and β respectively.  
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7 Chapter 5 Over-arching conclusions 
7.1 General conclusions  
Chapter two: Palladacyclic complexes have been prepared with differing C^N 
backbones, and OAc, Cl, PPh3, PPh2Cy, PPh2(t-Bu), P(n-Bu)3, P(Fu)3 and NO2 
ligands. This has allowed a greater understanding of the cyclopalladation behaviour 
of several organic substrates (ligands) to be gained. Furthermore, the successful 
synthesis and characterisation of a series of C^N palladacyclic complexes containing 
nitrite ligands has paved the way into understanding how NO2 bonds to Pd with each 
showing a trans-geometry.  
 
Scheme 70 Synthesis of novel Pd
(II)
-nitrito-cyclopalladated complexes by a general synthetic route 
When assessing the role that such ligands can play in catalysis, and in particular the 
potential for reductive elimination of useful “C–NO2” type products, the geometry 
and linkage isomerism of the complexes is of paramount importance. However for 
more bulky phosphine (PPh2Cy and PPh2(t-Bu)) ligands with N^C = (2-
phenylpyridine), monomeric Pd
(II)
 complexes could be characterised by NMR 
spectroscopy, although crystallisation yielded a novel Pd
II
 dimer complex where the 
bulky phosphine ligand had been ejected and the nitrito ligand is now found bridging 
two Pd
II
 centres (Figure 48). 
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Figure 48 Single crystal X-ray diffraction structure of complex 74a 
Calculated free energy values (DFT) suggest that the energy difference between cis 
and trans geometric isomers with respect to pyridyl moiety in all the Pd complexes 
increases with increasing steric bulk of the C^N ligand and reductive elimination 
experiments, where elimination of C–NO2 type products, which would normally 
require the two ligands being eliminated to be mutually cis, was not observed. The 
crystal structure of all the nitrite complexes prepared in this thesis showed a mixture 
of N- and O- bound linkage isomers. The DFT calculations, suggest for this 
complexes to be catalytically active the nitrite ligand should be cis to pyridyl moiety 
in all the nitrite complexes, which suggested they are catalytically less active. 
Chapter three: A 2-pyridyl directing group can become directly involved in Mn(I)-
mediated alkenylation reactions.
69
 Replacement of a phenyl group with a 2-pyrone 
(more electron-accepting) group had shown a profound effect on the preferred 
reaction path, affording stable and isolable intermediate manganese adduct. 
Critically, for the first time evidence for a commonly-proposed manganacycle 16-
electron 5-coordinate intermediate has been gathered (Scheme 71, in work conducted 
in collaboration Kate Appleby from the Fairlamb/Duckett group), which is found to 
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be the pivotal intermediate controlling whether direct reductive elimination or 
protonation and metal de-coordination occurs affording the intermediate,  
alkenylated or Diels-Alder products (Scheme 71). 
 
Scheme 71 Unprecedented alkyne insertion into cyclomanganesiated complex and alkenylation / 
Diels-Alder rearrangement 
The stoichiometric reactions conducted in neat phenyl acetylene showed that other 
products in addition to 106 can be readily formed. Remarkably, unprecedented C-H 
bond activation and Diels-Alder adduct process involving 2-pyridyl ring-cleavage 
and a recombination process to give 108 and a plausible regioselective second 
Diels-Alder addition in to pyrone pave the way for six, C-H bond functionalisation 
in a single molecule 109. When the 2-pyridyl group replaced with a 6-methoxy-2-
pyridyl unprecedented complexed 110 was isolated, the anticipation was due to a 
more electron-donating group in the pyridine moiety and had shown a profound 
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effect on the preferred alkyne insertion reaction path, affording stable and isolable 
manganese adduct 110. 
The combined experimental and computational approach used in this study has 
allowed the delineation of a mechanistic dichotomy in Mn(I)-mediated C-H bond 
activation. These believe to be the findings in this study provide an insight into 
future design of Mn(I)-mediated C-H bond activation processes involving electron 
deficient compound like 2-pyrone. 
Chapter four: Here, the regioselectivity of the PKRs of alkynes containing 
heteroaromatic moieties, substituting with 2-pyrone especially, was examined with 
two alkenes (norbornene and norbornadiene). The position of nitrogen  (ortho-) to 
the substituent prove to be useful in affecting the regioselectivity outcome, e.g. 
compounds 121, 123, 125 and 127 (Table 8, page 140).  Furthermore, compounds 
122, 126 and 128, where the nitrogen is at  (meta-) to the substituent, depend on 
the steric influence of the next nearest substituent. This revealed a useful dichotomy 
with respect to the position of nitrogen in the pyridyl (heteroaromatic) moiety 
especially compound 127, where the 2-nitro overrides the 4-nitro group exclusively. 
This thesis also demonstrated that varying the alkene substrate affect the 
regiochemical outcome 128 with respect to 121 which may be due to push pull effect 
of internal alkynes and Co2(CO)8 (Scheme 62 and Scheme 63). For the first time an 
alkyne hydrogenation processes is reported as a side product in a microwave-assisted 
synthesise of PKR product (Scheme 65 and Table 10). Further mechanistic studies 
are required to fully understand the regiochemical observations, made in this and in 
other studies. Furthermore breakthrough could be achieved if, for example, a 
mechanistic study revealed how the positions of the nitrogen atom in the 
heteroaromatic group affect the Co-Co bond order in intermediate complexes such as 
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121(I)-127(I) (Scheme 61 page 138) and subsequent intermediate species to the final 
product.   
The major and minor PKR regioisomeric products 121-128 readily undergo a 
photochemically-induced 6π-electrocyclisation–oxidative aromatisation reaction, 
with the exception of 123 and 127, to reveal aromatised and functionalised type 
products, e.g. 121B, 122B and 124B-126B α and β respectively. The precise 
arrangement of atoms in 124B-126B suggested that the α-thienyl regioisomer 
supresses the photochemically-induced electrocyclisation process with respect to the 
β-regioisomer.  
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8 Chapter 6: Experimental section 
8.1 General experimental techniques 
Solvents and reagents  
All commercially sourced reagents were purchased and used as received unless 
otherwise noted from Alfa Aesar, Acros Organics, Sigma-Aldrich, or Fluorochem. 
Dry solvents used were obtained from a Pure Solv MD-7 solvent machine and stored 
under nitrogen. Trimethylamine was dried by the condensation method, under 
nitrogen or argon conditions, and THF was also deoxygenated by bubbling nitrogen 
gas though the solvent with sonication.  
All reactions requiring anhydrous or air-free conditions were carried out in dry 
solvents under an argon or nitrogen atmosphere  
Nuclear magnetic resonance spectroscopy  
Proton (
1
H), Carbon-13 (
13
C decoupled 
1
H) and Phosphorus-31 (
31
P decoupled 
1
H)  
spectra were recorded on a Jeol ECX400 or Jeol ECS400 spectrometer at 400 and 
100 MHz respectively, or on a Bruker AV500 operating at 500 and 125 MHz 
respectively. Chemical shifts are reported in parts per million (ppm) of 
tetramethylsilane using residual solvent as an internal standard CD2Cl2 δ H = 5.32 
ppm; CD2Cl2 δ C = 54.84 ppm or CDCl3 δ H = 7.26 ppm; CDCl3 δ C = 77.16 ppm). 
Multiplicities are described as singlet (s), doublet (d), triplet (t), quartet (q), pentet 
(p), multiplet (m), apparent (app.) and broad (br). Coupling constants (J) are quoted 
to the nearest 0.1 Hz. Spectra were processed using MestreNova; apodization 
(Sine-Bell 0
o
) was used to enhance the (J) couplings, where necessary. Spectra were 
Chapter 6: Experimental section 
172 
 
exported as JPEG (or similar format) images into the appropriate document. Copies 
of 
1
H and 
13
C NMR spectra for all compounds are given in a CD Appendix.  
Phosphorus-31 (
31
P) spectra are referenced externally to H3PO4 and reported in parts 
per million (ppm).  
Chromatography  
Thin layer chromatography (TLC) was carried out using Merck aluminium backed 
5554 plates. Spots were visualised by the quenching of ultraviolet light (λmax = 254 
nm) and then stained and heated with one of anisaldehyde, potassium permanganate 
or phosphomolybdic acid as appropriate. Flash column chromatography was 
ordinarily performed using Merck 60 silica gel. Preparatory TLC was carried out 
using Analtech UNIPLATE glass-backed silica plates.  
Melting points  
Melting points were determined using a Stuart SMP3 melting point apparatus using a 
temperature ramp of 3 °C min
-1
.  
UV–Visible spectroscopy  
UV–visible spectroscopy was performed on a Jasco V-560 spectrometer, with a 
background taken in the appropriate solvent prior to recording spectra, using a cell 
with a path length of 1 cm. The wavelength of maximum absorption (λmax) is 
reported in nm along with the extinction coefficient (ε) in mol dm−3 cm−1. Copies of 
the appropriate absorption spectra and Beer–Lambert plots are given in Appendix 6.  
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Elemental analysis  
Elemental analysis was carried out using an Exeter Analytical CE-440 Elemental 
Analyser, with the percentages reported as an average of two runs.  
X-Ray crystallography  
Diffraction data were collected at 110 K on an Agilent SuperNova diffractometer 
with MoKα radiation (λ = 0.7107 Å). Data collection, unit cell determination and 
frame integration were carried out with CrysalisPro. Absorption corrections were 
applied using face indexing and the ABSPACK absorption correction software 
within CrysalisPro. Structures were solved and refined using Olex2252 
implementing SHELX algorithms and the Superflip253-255 structure solution 
program. Structures were solved by charge flipping, Patterson or direct methods and 
refined with the ShelXL256 package using full-matrix least squares minimisation. 
All non-hydrogen atoms were refined anisotropically and structures presented were 
processed using X-seed soft wire. 
8.1.1 General procedures 
General procedures A: Synthesis of palladacycle dimers
113
 
 (A1) Procedures for [Pd(OAc)(N^C)]2: An acetic acid (30 mL) suspension 
containing palladium(II) acetate (1 eq.) and ligand (1 eq.) was refluxed for 1.5 h and 
then filtered. Water (150 mL) was added to the yellow filtrate, and the mixture was 
left standing overnight. Precipitated solid was filtered and then recrystallised from 
dichloromethane and hexane to afford the desired complex. 
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(A2) Procedures for [PdCl(N^C)]2: Lithium chloride (2.2 eq.) in water (10 mL) was 
added to an acetone (20 mL) suspension of [Pd(OAc)(N^C)]2 (1.0 eq.) and the 
resulting mixture was stirred for 48 h at room temperature. After filtration, the 
filtered residue was washed well with a methanol/water (1/1, v/v) mixed solvent, to 
afford the desired complex. 
(A3) Procedures for Pd[Cl(N^C)]2: A methanol suspension (10 mL) containing 
palladium(II) chloride (1 eq.) and ligand (2 eq.) was refluxed for 2 h. The resulting 
yellow solid was filtered off and then recrystallised from dichloromethane and 
hexane to afford the desired complex. 
General procedures B: Synthesis of palladacycle monomers
114
 
(B1) Procedures for [PdCl(N^C)(PPh3)]: A solution of μ
2
-chlorido-bridged 
complex, [PdCl(N^C)]2 (1 eq.) and triphenylphosphine (1.2 eq.) in dichloromethane 
(10 mL) was stirred at room temperature for 30 min, under nitrogen atmosphere. The 
reaction mixture was filtered through Celite and hexane was added to induce 
precipitation. The product was collected by filtration and recrystallised from 
dichloromethane/hexane to afford the desired complex.  
(B2) Procedures for [Pd(NO2)(N^C)(PPh3)]: A solution of [PdCl(N^C)(PPh3)] (1 
eq.) and silver nitrite (2.2 eq.) in dichloromethane (18 mL) was stirred at room 
temperature for 48 h. The reaction mixture was filtered and the filtrate concentrated 
in vacuo to afford the desired complex. 
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General procedure C: Negishi cross-coupling reaction 
(C) Procedure for 4-(2’-pyridyl)-6-methyl-2-pyrone 81 and its derivatives: To a 
flame-dried Schlenk tube under N2, equipped with a magnetic stirrer bar, was added 
2-bromopyridine (2.78 mmol, 440 mg, 1.05 eq.) in dry THF (30 mL). The solution 
was cooled to -110 
o
C and then n-BuLi (2.78 mmol, 1.2 mL, 1.05 eq.) was added 
dropwise over 10 min with stirring, which was left to continue stirring for a further 
30 min. To a separate, flame-dried Schlenk tube under N2, equipped with a magnetic 
stirrer bar, was added high vacuum line-dried ZnCl2 (2.91 mmol, 400 mg, 1.1 eq.; 
dried to constant weight, ca. 12 h).  The lithiated 2-pyridine was transferred via 
cannula at -110 
o
C to the ZnCl2, over 5 mins. The mixture was allowed to warm to -
40 
o
C, with constant stirring for 30 min.  
To a separate flame-dried Schlenk tube under N2, equipped with a magnetic stirrer 
bar, was added 4-bromo-6-methyl-2-pyrone (2.65 mmol, 500 mg, 1 eq.), Pd(PPh3)4 
(0.13 mmol, 150 mg, 5 mol%) sequentially and dry THF (20 mL). The zincated 2-
pyridine was rapidly transferred via cannula and the reaction mixture allowed to stir 
at 22 
o
C for 12 h. The reaction was monitored by TLC analysis. Upon completion, it 
was quenched with saturated NH4Cl (ca. 30 mL), and the mixture was filtered 
through Celite
TM
.  The mixture was extracted with EtOAc (2x25 mL). The crude 
product was purified by silica gel column chromatography (petroleum ether:EtOAc, 
60:40, v/v) to afford the product as a creamy solid (485 mg, 85 %). 
 General procedure D: Synthesis of manganacycle.
69
 
(D1) Synthesis of five membered manganacycle:
69
 To a flame-dried Schlenk tube 
was equipped with a magnetic stir bar. MnBr(CO)5 (0.05 mmol, 10 mol %, 13.75 
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mg), hexane (1.2 ml), 4-(2'-pyridyl)-6-methyl-2-pyrone 81  (1.0 mmol, 155 mg), 
phenyl acetylene 16 (0.5 mmol, 51 mg) and dicyclohexylamine (0.1 mmol, 18.1 mg) 
were added sequentially under nitrogen. The closed tube was put into a pre-heated 
oil bath at 80 
o
C and stirred for 6 h. After completion of the reaction, the resulting 
mixture was cooled down to room temperature, diluted with dichloromethane (10 
mL), filtered through a short pad of silica gel and washed with EtOAc (30 mL). The 
filtrate was pre-absorbed on silica gel and concentrated by rotary evaporation. The 
crude product was purified by silica gel column chromatography (petroleum 
ether:EtOAc = 40:1, v/v) to afford the product. 
(D2) Synthesis of six membered manganacycle via Alkyne insertion: a flame-dried 
Schlenck tube was equipped with a magnetic stir bar. [Mn(CO)4(C^N)] (0.57 mmol, 
200 mg), n-Bu2O (8.0 ml), phenyl acetylene 16 (0.68 mmol, 70 mg) was added 
sequentially under nitrogen. The closed tube was put into a pre-heated oil bath at 80 
o
C and stirred for 8 h. After completion of the reaction, the resulting mixture was 
cooled down to room temperature, filtered through Celite and washed with EtOAc 
(30 mL). The filtrate was pre-absorbed on silica gel and concentrated by rotary 
evaporation. The crude product was purified by silica gel column chromatography 
(petroleum ether:EtOAc = 60:40, v/v) that afforded the product as yellow solid of 
0.210 mg (87 %). 
General procedures E: Synthesis of Mn-catalyzed alkenylation/Diels-
Alder-product 
(E) To a flame-dried Schlenk tube equipped with a magnetic stir bar, 
[Mn(CO)4(C^N)] (1 eq.), in neat phenylacetylene 16 (100 eq., excess) were added 
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sequentially under nitrogen. The sealed tube was put into a pre-heated oil bath at 110 
o
C and stirred for 4 h. After completion of the reaction (monitored by TLC analysis), 
the resulting mixture was cooled to room temperature, filtered through Celite and 
washed with dichloromethane (30 mL). The filtrate was pre-absorbed on to silica gel 
and concentrated by rotary evaporation (with care). The crude product was purified 
by silica gel column chromatography, for which several fractions were identified. 
The column was eluted with petroleum ether / EtOAc:dichloromethane:MeOH = 
90:10:0:0 – 0:0:95:5, v/v. 
General procedures F: Synthesis of alkyne derivatives.
105
 
(F1) Sonogashira cross-coupling reaction; To an oven-dried Schlenk tube charged 
with a magnetic stirrer bar was added a solution of the bromopyridine derivative (1.0 
eq), CuI (0.03 eq.) and Pd(PPh3)2Cl2 (0.01 eq.) in dried acetonitrile (90 eq.) and dried 
trimethylamine (10 eq.). A solution of terminal alkyne (1.2 eq.) was then added 
dropwise via syringe under nitrogen. The resulting solution was refluxed for 3-4 h. 
The reaction mixture was allowed to cool to room temperature, filtered through 
Celite and the solvent was removed by rotary evaporation. The residue was treated 
with water and extracted with ethyl ether. The combined organic layer was washed 
with brine and dried over magnesium sulfate, the filtered. After the removal of 
solvent, the crude product was purified with silica gel column chromatography (ethyl 
acetate/petroleum ether, 20/80, v/v) affording the products. 
 (F2) Synthesis of pyridylacetylene derivatives via desilylation reactions; To a 
solution of trimethyl(pyridylethynyl)silane derivatives (1 eq.) in methanol (75 eq.) 
and dichloromethane (25 eq.) was added potassium carbonate (5 eq.) and stirred at 
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r.t. for 6 h. The resulting mixture was treated with water and extracted with ethyl 
ether. The combined organic layer was washed with brine and dried over magnesium 
sulfate, then filtered. The solvent was removed in vacuo and the residue was distilled 
carefully under reduced pressure or purified by silica gel column chromatography to 
afford the pure products. 
(F3) Synthesis of η4-alkynyl-derivatives-Co2(CO)6 complex; An equimolar mixture 
of dicobaltoctacarbonyl and the alkyne were added to a pre-dry Schleck tube charged 
with magnetic stirrer bar. Dry THF (6 mL per mmol) was added and the reaction 
mixture was stirred for 16 h., at room temperature. The resulting mixture was filtered 
through Celite
TM
 and washed with dichloromethane (12 mL). The filtrate was pre-
absorbed on to silica gel and concentrated by rotary evaporation. The crude product 
was purified by silica gel column chromatography; the column was eluted with 
EtOAc / petroleum ether: 80/20, v/v to afford the complex. 
General procedures G: Synthesis of cyclopentenones derivatives 
(Pauson-Khand reaction):
105
  
(G1) To a microwave tube charged with a magnetic stirrer bar and filled with argon 
was added alkyne derivatives (1.0 eq.), Co2(CO)8 (1.2 eq.) and a deoxygenated 
dichloroethane DCE (80 eq.). The mixture was stirred at room temperature for 30 
min., norbornene (5.0 eq.) was added in one portion and the reaction heated in the 
microwave (90 °C, 100 W) for 1 h. The resulting mixture was filtered through Celite, 
the filtrate was tested by TLC using ethyl acetate: petroleum ether (2/8, v/v), (in 
some reactions four distinct TLC sport was observed), this was pre-absorbed on to 
silica gel and concentrated by rotary evaporation (with care) and dry-loaded onto a 
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silica plug and eluted using ethyl acetate: petroleum ether (2/8, v/v). The eluted 
fractions were concentrated in vacuo, to afford the PKR products. 
For a typical reaction, where four distinct products were observed by TLC: Fraction 
F1 (test tube number 3 to 5 = Coogan enol-lactone), F2 (test tube number 7 to 11 = 
hydrogenated alkyne), F3 (test tube number 12 to 19 = α PKR product, with respect 
to cyclopentenone) and F4 (test tube number 20 to 27 = β PKR product, with respect 
to cyclopentenone). 
General procedure H: UV light controlled irradiation (cyclization / 
aromatization): 
An in house (York) new irradiation system has been developed to provide controlled 
irradiation in which the wavelength and intensity of the light can be adjusted when 
required. The system (device) uses a small 5W LED’s that attach directly on to the 
top of a cuvette.  The LED’s circuit is mechanically in-built in a special cuvette cap 
to a flexible wire, to allow the cuvette to be placed in the UV spectrometer for UV 
irradiation (Figure 49).  A heat absorbing system (device) was developed for 
irradiating the NMR sample in the NMR tube for NMR simulation. The current 
LEDs in the system irradiate at 400 nm. 
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Figure 49 An irradiation system using the 400 nm 5W LED drawing a current of 20 mA. 
(H1) UV vis. irradiation; The Amber LED (400 nm)  0.2A was set to irradiate 5*10
-6
 
mol/dm
3
 solution of an analyte in DCM,  in a quartz cuvette for 30 sec. followed by 
a wait period of 2 min and 33 sec. the UV Vis was set to scan every 9240 seconds). 
First scan was run before the irradiation. The analyte was irradiated for 4 to 5 minute 
to afford the required product. 
(H2) NMR sample irradiation; To a PKR cycloadduct (15 mg) was added DCM 0.6 
(mL) in to an NMR tube the resulting solution was irradiated for 40 minute in an air 
ventilated NMR tube. The resulting product was NMR and MS (ESI) simulated 
directly to confirm the required product (Figure 49). 
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8.2 Synthetic procedures and compound data 
 [Pd(NO2)(2-Phpy)(PPh3)] (60) 
 
Following the general procedure B2; 67 (50 mg, 0.100 mmol) and silver nitrite (30 
mg, 0.197 mmol) to afford the desired product as a pale orange solid crystals (51 mg, 
96 % yield). MP 215–216 °C. 
1
H NMR (400 MHz, CD2Cl2) δ 8.27 - 8.24 (br. s, 1H, H-1), 7.89 (dd, JHH = 7.4, 1H, 
H-3), 7.82 (dd, JHH = 7.4, 1.1, 1H, H-4), 7.79 – 7.73 (m, 4H, H-PPh3), 7.56 (d, JHH = 
1.1, 1H, H-7), 7.49 – 7.44 (m, 7H, H- PPh3), 7.42 – 7.36 (m, 4H, H- PPh3), 7.22 
(ddd, JHH = 7.4, 2.3, 1.1, 1H, H-2), 6.98 (ddd, JHH = 7.4, 5.7, 2.0, 1H, H-8), 6.55 – 
6.53 (m, 1H, H-10), 6.53 – 6.50 (m, 1H, H-7). 13C NMR (101 MHz, CD2Cl2) δ 
152.45 (C-5), 149.54 (C-1), 147.85 (C-6), 147.73 (C-11), 140.20 (C-10), 140.02 (C-
2), [135.55 (C-PPh3), 135.42 (C- PPh3), 134.33 (C- PPh3), 134.17 (C- PPh3), 132.35 
(C- PPh3), 131.66 (C- PPh3), 131.45 (C- PPh3), 130.78 (C- PPh3), 130.28 (C- PPh3), 
129.71 (C- PPh3), 129.60 (C- PPh3), 129.14 (C- PPh3), 128.93 (C- PPh3), 128.75 (C- 
PPh3), 128.64 (C- PPh3)], 125.12 (C-8), 124.36 (C-7), 123.30 (C-2), 119.22 (C-4). 
31
P NMR (162 MHz, CD2Cl2) δ 41.02. MS; LRMS (LIFDI-MS) m/z: calcd for 
C29H23N2O2PPd  588.90; Found 590.02, Elemental Analysis:  calcd C 61.23, H 4.07, 
N 4.92; Found C 65.63, H 4.32, N 2.69. The low carbon content is likely due to the 
presence of DCM in the final product.   
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Lab book reference number: NPY-2-128 
[Pd(OAc)(2-PhPy)]2
113
 cis- (62A) 
 
Following the general procedure A1; palladium(II) acetate (290 mg, 1.29 mmol) and 
18 (200 mg, 1.29 mmol) to afford the product as a pale greenish yellow solid crystal 
(721 mg, 88% overall yield).  
1
H NMR (400 MHz, CDCl3) δ 7.87 (dd, JHH = 5.7, 1.3, 2H, H-1), 7.37 (, td, JHH = 
7.3, 1.3, 2H, H-3), 7.08 (d, JHH = 7.3, 2H, H-4), 6.91 (dd, JHH = 7.4, 1.3, 2H, H-7), 
6.88 – 6.78 (m , 6H, H-8/9/10), 6.45 (ddd, JHH = 7.3, 5.7, 1.3, 2H, H-2), 2.27 (s, 6H, 
H-12).  
13
C NMR (101 MHz, CDCl3) δ 181.82 (C-13), 164.25 (C-5), 151.94 (C-11), 
150.18 (C-1), 144.50 (C-6), 137.59 (C-3), 131.88 (C-10), 128.55 (C-9), 124.00 (C-
7), 122.43 (C-8), 121.12 (C-2), 117.20 (C-4), 24.96 (C-12). IR (solid-state ATR, cm-
1
) 3042, 2361, 2337, 1605, 1559, 1567, 1484, 1415, 1407, 1023, 726, 682, 408. MS; 
Chapter 6: Experimental section 
183 
 
LRMS (LIFDI-MS) m/z: calculated (calcd) for C26H23N2O2Pd2 639.96; Found 
639.98, Elemental Analysis:  calcd C 48.85, H 3.47, N 4.38; Found C 48.55, H 3.38, 
N 4.09. 
Lab book reference number: NPY-1-51 
[Pd(OAc)(2-PhPy)]2 trans- (62B) 
 
Following the general procedure A1; palladium(II) acetate (290 mg, 1.29 mmol) and 
18 (200 mg, 1.29 mmol) to afford product as a pale greenish yellow solid crystals 
(10 % yield by 
1
H MNR with respect to cis- isomer).  
1
H NMR (400 MHz, CD2Cl2) 8.02 (d, JHH = 5.7, H-1), 7.51 (td, JHH = 7.9, 1.7, H-3), 
7.20 (d, JHH = 8.7, H-4), 6.88 (dd, JHH = 2.6, 1.5, 1H, H-7), 6.79 – 6.63 (m, 4H, H-
2/8/9/10), 2.22 (s, 6H, H-12).MS; LRMS (LIFDI-MS) m/z: calcd for C26H23N2O2Pd2 
639.96; Found 639.98, Elemental Analysis:  calcd C 48.85, H 3.47, N 4.38; Found C 
48.55, H 3.38, N 4.09. 
Lab book reference number: NPY-1-51 
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[PdCl(2-PhPy)]2 (66)
113
 
 
Following the general procedure A2; Lithium chloride (29 mg, 0.688 mmol), and 62 
(200 mg, 0.313mmol), to afford the desired product as a pale yellowish solid (170 
mg, 92% yield). MP >320 °C. NMR; Pyridine-d5 was added to an NMR tube 
containing a sample of complex [PdClPhPy)]2 in CD2Cl2 in order to increase its 
solubility in NMR solvents 3 Drops of pyridine-d5 a clear light yellow solution was 
formed and NMR spectra was taken immediately, keeping it longer resulted in a 
clear orange-yellow solution presumably due to the formation of the monomeric 
complex [PdCl(2-Phpy)(py-d5)]. Residual pyridine signals have been omitted from 
the reported 
13
C NMR data for clarity.  
1
H NMR (400 MHz, CD2Cl2) δ 9.47-9.43 (br. s, 2H, H-1), 7.80 (ddd, JHH = 8.0, 7.6, 
1.7, 2H, H-3), 7.67 (d, JHH = 7.7,  2H, H-4), 7.49 (dd, JHH = 7.7, 1.4, 2H, H-7), 7.16 
– 7.13 (m, 2H, H-2), 7.13 – 7.07 (m, 2H, H-8), 6.94 (td, JHH = 7.6, 1.4, 2H, H-9), 
6.25 (d, JHH = 5.9 Hz, 2H, H-10). 
13
C NMR (101 MHz, CD2Cl2) δ 165.99 (C-5), 
155.16 (C-11), 152.23 (C-1), 146.13 (C-6), 139.24 (C-3), 132.98 (C-10), 129.81 (C-
9), 125.05 (C-8), 123.71 (C-7), 122.47 (C-2), 118.80 (C-4). IR (solid-state ATR, cm-
1
) 3045, 1605, 1579, 1487, 1421, 1277, 1160, 1028, 737, 719. MS; LRMS (LIFDI-
MS) m/z: calcd for C22H16N2Cl2Pd2 591.87; Found 591.88, Elemental Analysis:  
calcd C 44.63, H 2.72, N 4.73, observed C 44.47, H 2.61, N 4.72. 
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Lab book reference number: NPY-1-52 
 [PdCl(2-Phpy)(PPh3)] (67)
114
 
 
Following the general procedure B1; 62 (100 mg, 0.169 mmol) and 
triphenylphosphine (97 mg, 0.372 mmol), to afford the desired product as light 
orange solid crystals (180 mg, 95 % yield). MP 220–223 °C  
1
H NMR (400 MHz, CD2Cl2) δ 9.58 (dd, JHH = 5.6, 1.3, 1H, H-1), 7.90 (dd, JHH = 
7.5, 1.4, 1H, H-3), 7.80 (d, JHH = 7.5, 1H, H-4), 7.74 (dd, JHH = 10.6, 8.0, 6H, H-
PPh3), 7.56 (dd, JHH = 7.6, 1.2, 1H, H-7), 7.49 – 7.43 (m, 3H, 1H, H- PPh3), 7.41 – 
7.35 (m, 6H, 1H, H- PPh3), 7.29 (ddd, JHH = 7.5, 5.6, 1.3, 1H, H-2), 6.97 (dd, JHH = 
7.6, 5.7, 1H, H-8), 6.56 – 6.49 (m, 2H, H-9/10). 13C NMR (101 MHz, CD2Cl2) δ 
165.30 (C-8), 155.67 (C-8), 150.76 (C-8), 147.87 (C-8), 139.61 (C-8), 139.44 (C-8), 
135.66 (C-8), 135.53 (C-8), 130.91 (C-8), 130.89 (C-8), 129.11 (C-8), 128.53 (C-8), 
128.43 (C-8), 124.74 (C-8), 124.22 (C-8), 122.68 (C-8), 118.80 (C-8). IR (solid-state 
ATR, cm-1) 3056, 1601, 1578, 1479, 1434, 1097, 743, 689, 531, 460. MS; LRMS 
(LIFDI-MS) m/z: calcd for C29H23ClNPPd  557.03; Found 558.99, Elemental 
Analysis:  calcd C 62.38, H 4.15, N 2.51; Found C 63.03, H 4.71, N 2.62. 
Lab book reference number: NPY-2-127 
Chapter 6: Experimental section 
186 
 
[PdCl(2-Phpy)(PPh2Cy)] (68) 
 
Following the general procedure B1; 66 (200 mg, 0.338 mmol) and 
Cyclohexyldiphenylphosphine (199 mg, 0.743 mmol) to afford the desired product 
as a white solid crystals (390 mg, 99 % yield). MP 172 – 173 oC.  
1
H NMR (400 MHz, CD2Cl2) δ 9.58 (d, JHH = 5.7, 1H, H-1), 7.72 – 7.78 (br. s, 1H, 
H-3), 7.88 – 7.81 (m, 4H, H- PPh2), 7.73 (d, JHH = 7.3, 1H, H-4), 7.50 (dd, JHH = 
5.5, 1.5, 1H, H-7), 7.49 – 7.39 (m, 6H, H- PPh2), 7.27 (ddd, JHH = 7.3, 5.7, 1.3, 1H, 
H-2), 6.95 (ddd, JHH = 7.5, 5.5, 1.5, 1H, H-8), 6.69 (d, JHH = 7.5, 1H, H-10), 6.61 
(dd, JHH = 7.5, 5.5, 1H, H-9), 2.10 – 1.92 (br. s, 2H, H-PCy), 1.72 – 1.55 (m, 3H, H- 
PCy), 1.42 – 1.31 (m, 2H, H- PCy), 1.05 – 0.81 (m, 3H, H- PCy). 13C NMR (101 
MHz, CD2Cl2) δ 164.99 (C-5), 155.99 (C-6), 150.39 (C-1), 147.66 (C-11), 139.43 
(C-3), 138.68 (C-10), 134.48 (C-PPh2), 134.37 (C- PPh2), 130.75 (C- PPh2), 129.22 
(C-9), 128.71 (C- PPh2), 128.61 (C- PPh2), 124.62 (C-8), 124.07 (C-7), 122.50 (C-2), 
118.68 (C-4), 29.18 (C-PCy), 27.34 (C- PCy), 27.21 (C- PCy), 26.58 (C- PCy), 
15.50 (C- PCy). 
31
P NMR (162 MHz, CD2Cl2) δ 42.36. MS; LRMS (LIFDI-MS) 
m/z: calcd for C29H29ClNPPd  563.08; Found 564.10, Elemental Analysis:  calcd C 
61.71, H 5.18, N 2.48; Found C 62.23, H 5.33, N 2.50. 
Lab book reference number: NPY-3-144 
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[Pd(NO2)(2-Phpy)(PPh2Cy)] (69) 
 
Following the general procedure B2; 68 (100 mg, 0.177 mmol) and silver nitrite (60 
mg, 0.390 mmol) to afford the desired product as pale orange solid crystals (101 mg, 
99 % yield). MP 195–196 oC .  
1
H NMR (400 MHz, CD2Cl2) δ 8.49 – 8.45 (m, 1H, H-1), 8.02 – 7.95 (m, 4H, H-
PPh2), 7.91 (td, JHH = 7.6, 1.5 Hz, 1H, H-3), 7.78 (d, JHH = 7.6 Hz, 1H, H-4), 7.76 – 
7.71 (m, 1H, H-PPh2), 7.55 – 7.43 (m, 6H, H-PPh2/8), 7.34 – 7.28 (m, 1H, H-2), 7.00 
– 6.94 (m, 1H, H-7), 6.68 – 6.58 (m, 2H, H-9/10), 2.66 – 2.49 (m, 1H, H-PCy), 1.93 
– 1.84 (m, 1H, H-PCy), 1.67 (dd, JHP = 14.2, 10.3 Hz, 3H, H-PCy), 1.37 – 1.23 (m, 
3H, H-PCy), 1.05 – 0.96 (m, 2H, H-PCy). IR (solid-state ATR, cm-1) 3050, 2924, 
2849, 1601, 1484, 1434, 1352, 1313, 1267, 1097, 1174, 999,745, 693, 518. MS; 
LRMS (LIFDI-MS) m/z: calcd for C29H29N2O2PPd  574.10; Found 574.08, 
Elemental Analysis:  calcd C 60.58, H 5.08, N 4.87; Found C 65.81, H 5.50, N 2.69. 
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Lab book reference number: NPY-2-105  
[PdCl(2-Phpy)(PPh2(t-Bu)] (70) 
 
Following the general procedure B1; 66 (200 mg, 0.338 mmol) and tert-butyl 
diphenylphosphine (180 mg, 0.743 mmol) to afford the product as white solid 
crystals (360 mg, 94 % yield). MP 160–161 oC.  
1
H NMR (400 MHz, CD2Cl2) δ 9.74 (d, JHH = 5.7, 1H, H-1), 8.39 – 8.28 (br. s, 3H, 
H-PPh2), 7.88 (ddd, JHH = 7.3, 5.7, 1.5, 1H, H-3), 7.74 (d, JHH = 8.0, 1H, H-4), 7.50 
– 7.39 (m, 7H, H-PPh2), 7.39 (d, JHH = 4.5, 1H, H-7), 7.33 (ddd, JHH = 7.3, 5.7, 1.5, 
1H, H-2), 6.78 (ddd, JHH = 7.7, 5.3, 1.3, 1H, H-8), 6.31 (d, JHH = 1.3, 1H, H-10), 
6.36 – 6.25 (m, 1H, H-9), 1.35 (d, JHP = 15.0, 9H, H-P(t-Bu)). 
13
C NMR (101 MHz, 
CD2Cl2) δ 165.43 (C-5), 156.44 (C-6), 149.87 (C-1), 146.95 (C-11), 139.41 (C-3), 
138.82 (C-10), 136.34 (C-PPh2), 136.21 (C-PPh2), 131.03 (C-PPh2), 128.74 (C-9), 
128.35 (C- PPh2), 128.25 (C- PPh2), 124.12 (C-7), 123.62 (C- PPh2), 122.34 (C-2), 
118.73 (C-4), 28.66 (C-P(t-Bu), 28.62 (C-P(t-Bu). 
31
P NMR (162 MHz, CD2Cl2) δ 
61.10. MS; LRMS (LIFDI-MS) m/z: calcd for C27H27ClNPPd  537.06; Found 
538.11, Elemental Analysis:  calcd C 60.24, H 5.06, N 2.60; Found C 61.13, H 5.44, 
N 3.01. 
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Lab book reference number: NPY-3-143 
[Pd(NO2)(2-Phpy)(PPh2(t-Bu)] (71) 
 
Following the general procedure B2; 70 (100 mg, 0.186 mmol) and silver nitrite (63 
mg, 0.409 mmol) to afford the desired product as off-white crystals (101 mg, 99 % 
yield). MP 163–167 oC.  
1
H NMR (400 MHz, CDCl3) δ 8.46 – 8.38 (m, 1H, H-1), 8.43 – 8.38 (m,  3H, H-
PPh2), 7.85 (dd, JHH = 7.4, 1.5, 1H, H-3), 7.73 (d, JHH = 7.4, 1H, H-4), 7.51 – 7.41 
(m, 7H, H-PPh2), 7.36 (dd, JHH = 7.7, 1.4, 1H, H-7), 7.21 (dd, JHH = 7.4, 5.7, 1H, H-
2), 6.89 – 6.80 (m, 1H, H-10), 6.34 (dd, JHH = 7.7, 5.6, 1H, H-8), 6.25 – 6.19 (m, 
1H, H-9), 1.22 (d, JHH = 15.1, 9H, H- P(t-Bu)). 
31
P NMR (162 MHz, CDCl3) δ 
59.28. MS; LRMS (LIFDI-MS) m/z: calcd for C27H27N2O2PPd 548.09; Found 
548.07. 
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 Lab book reference number: NPY-2-92 / NPY-145B 
 [PdCl(2-Phpy)P(n-Bu)3] (72) 
 
 Following the general procedure B1; 66 (60 mg, 0.100 mmol) and 
triphenylphosphine (45 mg, 0.223 mmol) to afford the product as a colourless liquid 
(50.1 mg, >99 % yield).  
1
H NMR (400 MHz, CD2Cl2) δ 8.83 – 8.80 (br. s, 1H, H-1), 8.20 (d, JHH = 7.7, 1H, 
H-4), 7.71 (td, JHH = 7.7, 1.6, 1H, H-3), 7.63 – 7.58 (m, 1H, H-8), 7.48 (dd, JHH = 
5.6, 1.6, 1H, H-7), 7.19 (dd, JHH = 7.7, 5.4, 1H, H-2), 7.02 (d, JHH = 1.6, 1H, H-10), 
7.01 (dd, JHH = 5.6, 1.6, 1H, H-9), 1.46 (d, JHH = 8.9, 14H, H-P(n-Bu)3), 1.34 – 1.19 
(m, 22H, H-P(n-Bu)3), 0.93 (dd, JHH = 8.8, 5.4, 2H, H-P(n-Bu)3), 0.83 (t, JHH = 7.0, 
16H, H-P(n-Bu)3). 
13
C NMR (101 MHz, CD2Cl2) δ 162.74 (C-5), 154.83 (C-6), 
149.39 (C-1), 145.54 (C-1), 137.74 (C-11), 136.59 (C-7), 127.99 (C-3), 127.70 (C-
9), 123.24 (C-10), 121.81 (C-2), 121.44 (C-4), 26.53 (C-1), 24.90 (C-P(n-Bu)3), 
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23.40 (C-P(n-Bu)3), 13.89 (C-P(n-Bu)3).
31
P NMR (162 MHz, CD2Cl2) δ 57.19, 
47.89, 34.33, 3.90. IR (solid-state ATR, cm-
1
) 3049, 2956, 2929, 2859, 1581, 1464, 
1413, 1377, 1302, 1247, 120, 1153, 1092, 1051, 1017, 905, 799, 740, 619. MS; 
LRMS (LIFDI-MS) m/z: calcd for C23H35ClNPPd  497.12; Found 497.12. 
Lab book reference number: NPY-2-77 
[Pd(NO2)(2-Phpy)P(n-Bu)3] (73) 
 
Following the general procedure B2; 72 (50 mg, 0.100 mmol) and silver nitrite (34 
mg, 0.221 mmol) to afford the desired product as  pale orange solid crystals (52 mg, 
>99 % yield).   
1
H NMR (400 MHz, CD2Cl2) δ 8.17 – 8.14 (br. s, 1H, H-1), 7.88 – 7.83 (m, 1H, H-
3), 7.79 (d, JHH = 8.0, 1H, H-4), 7.60 (dd, JHH = 7.4, 1.9, 1H, H-7), 7.19 (dd, JHH = 
4.0, 1.9, 1H, H-2), 7.17 (d, JHH = 1.9, 1H, H-10), 7.16 (t, JHH = 2.2, 1H, H-8), 7.12 
(dd, JHH = 9.5, 1.9, 1H, H-9), 1.86 (dd, JHH = 16.7, 9.3, 2H, H-P(n-Bu)3), 1.68 (dd, 
JHH = 16.2, 8.5, 4H, H-P(n-Bu)3), 1.59 (ddd, JHH = 14.1, 6.7, 3.4, 2H, H-P(n-Bu)3), 
1.52 – 1.37 (m 10H, H-P(n-Bu)3), 0.97 – 0.86 (m, 9H, H-P(n-Bu)3). 
31
P NMR (162 
MHz, CD2Cl2) δ 21.64, 10.14. MS; LRMS (LIFDI-MS) m/z: calcd for 
C23H35N2O2PPd 508.15; Found 508.17. 
Lab book reference number: NPY-2-79 
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[Pd(OAc)(piph)]2 (76) 
113
 
 
Following the general procedure A1; palladium(II) acetate (2.6 mmol) and 75 (2.6 
mmol) to afford product as pale greenish yellow crystals (1.65 g 93 %).  
1
H NMR (400 MHz, CD2Cl2) δ 8.45 – 8.41 (br. s, 2H, H-1), 7.61 (dd, JHH = 7.5, 
5.7, 2H, H-3), 7.20 (d, JHH = 7.5, 2H, H-4), 6.95 – 6.35 (m, 10H, H-2/8/9/10/11), 
3.90 (d, JHH = 13.6, 4H, H-6), 2.01 (d, JHH = 2.6, 6H, H-13). 
13
C NMR (101 MHz, 
CD2Cl2) δ 180.87 (C-14), 159.88 (C-5), 141.59 (C-1), 138.35 (C-3), 136.71 (C-7), 
134.24 (C-12), [125.68, 124.76, 124.22, 124.19 (C-8/9/10/11)], 121.99 (C-2), 48.83 
(C-6), 24.73 (C-13). IR (solid-state ATR, cm-
1
) 30441, 3019, 1603, 1577, 1484, 
1421, 1276, 1155, 1019, 741, 425. MS; LRMS (LIFDI-MS) m/z: calcd for 
C28H28N2O4Pd2 668.01; Found 668.00, Elemental Analysis:  calcd C; 50.24, H; 4.22, 
N; 4.19; Found C; 50.74, H; 4.22, N; 4.20. 
Lab book reference number: NPY-1-53 
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[PdCl(PiPh)]2 (77) 
113
 
 
Following the general procedure A2; Lithium chloride (110 mg, 2.60 mmol) and 76 
(200 mg, 1.182 mmol), to afford product as a pale yellow solid, (780 mg, 99% 
yield). For NMR measurement, Pyridine-d5 was added to an NMR tube containing 
the sample of complex [PdClPhPy)]2 in CD2Cl2, this was to increase its solubility for 
NMR measurement, a clear light yellow solution was formed and NMR spectra was 
taken immediately, keeping it longer resulted in a clear orange-yellow solution, 
presumably due to the formation of the monomeric complex [PdCl(2-Phpy)(py-d5)]. 
Residual pyridine signals have been omitted from the report. 
1
H NMR (400 MHz, CD2Cl2) δ 9.30 (dd, JHH = 5.7, 1.2, 1H, H-1), 7.68 (td, JHH = 
7.6, 1.2, 1H, H-3), 7.41 (d, JHH = 7.6, 1H, H-4), 7.14 (t, JHH = 5.7, 1H, H-2), 7.07 
(dd, JHH = 7.3, 1.2, 1H, H-8), 6.91 (td, JHH = 7.3, 1.2, 1H, H-9), 6.70 (td, JHH = 7.3, 
1.2, 1H, H-10), 6.56 (dd, JHH = 7.3, 1.2, 1H, H-11), 3.06 (s, 1H, H-6). 
13
C NMR 
(101 MHz, CD2Cl2) δ 160.00 (C-5), 159.55 (C-1), 154.74 (C-3), 138.78 (C-4), 
137.50 (C-12), 135.27 (C-7), 126.19 (C-8), 125.46 (C-10), 124.53 (C-9), 124.08 (C-
11), 122.01 (C-2), 49.68 (C-6). IR (solid-state ATR, cm-
1
) 3109, 3080, 3053, 3038, 
2870, 2962, 2822, 1708, 2168, 1606, 1559, 1484, 1443, 1338, 1156, 1028, 759, 619, 
448. 
Lab book reference number: NPY-1-54 
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 [PdCl2(Hpiph)2] (78)
113
 
 
Following the general procedure A3; palladium(II) chloride (147 mg, 0.827 mmol) 
and 75 (280 mg, 1.655 mmol) to afford product as lemon yellow crystals (85 mg >99 
%).  
1H NMR (400 MHz, ) δ 9.06 (d, JHH = 5.4 Hz, 1H, H-1), 8.89 (d, JHH = 5.4 Hz, 1H, 
H-1’), 7.65 (t, JHH = 7.7 Hz, 2H, H-3/3’), 7.50 – 7.30 (m, 10H, H-
8/8’/9/9’/10/10’11/11’/12/12’), 7.30 – 7.20 (m, 2H, H-2/2’), 7.02 (d, JHH = 7.9 Hz, 
1H, H-4’), 6.96 (d, JHH = 7.9 Hz, 1H, H-4), 5.41 (s, 2H, H-6’), 5.29 (s, 2H, H-6). 
13
C 
NMR (101 MHz, CD2Cl2) δ 163.94 (C-5), 163.68 (C-5’), 152.78 (C-1), 152.41 (C-
1’), 138.75 (C-3), 137.85 (C-7), 137.58 (C-7’), [130.54, 130.35, 129.30, 129., 
127.54, 127.43 (C-8/8’/9/9’/10/10’11/11’/12/12’)], 126.45 (C-4), 126.40 (C-4), 
123.04 (C-2), 122.94 (C-2), 46.56 (C-6), 45.83 (C-6). IR (solid-state ATR, cm-
1
) 
3086, 3060, 3027, 2905, 1601, 1568, 1478, 1433, 1411, 1328, 1218, 1154, 1066, 
1102, 1244, 1029, 969, 816, 768, 743, 721, 694, 620, 452. MS; LRMS (LIFDI-MS) 
m/z: calcd for C24H22Cl2N2Pd 514.02; Found 514.01, Elemental Analysis:  calcd C; 
55.89, H; 4.30, N; 5.43; Found C; 56.12, H; 4.33, N; 5.45. 
Lab book reference number: NPY-1-20 
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 [Pd(OAc)(PiPh)(Py-d5)] (80)
113
 
  
To a vial containing palladium complex 76 c.a. (10 mg) was added deuterated 
dichloromethane  c.a. (0.6 mL) the solution was yellowish, upon addition of 
pyridine-d5 (0.3 mL), the solution changed to light yellow immediately (100 % 
conversion by NMR). 
1
H (400 MHz, C5D5) δ 9.08 (d, JHH = 5.5, 1H, H-1), 7.69 (td, JHH = 7.6, 1.2, 1H, H-
3), 7.43 (d, JHH = 7.6, 1H, H-4), 7.19 – 7.14 (m,  1H, H-2), 7.04 (dd, JHH = 7.3, 1.2, 
1H, H-8), 6.89 (td, JHH = 7.3, 1.2, 1H, H-9), 6.69 (td, JHH = 7.3, 1.2, 1H, H-10), 6.57 
(dd, JHH = 7.3, 1.2, 1H, H-11), 4.46 (s,  2H, H-6), 1.88 (s, 3H, H-13). 
13
C NMR (101 
MHz, CD2Cl2) δ 160.06 (C-1), 153.69 (C-9), 138.72 (C-9), 138.22 (C-9), 135.99 (C-
9), 125.98 (C-9), 125.36 (C-9), 124.29 (C-9), 124.12 (C-9), 122.50 (C-9), 49.62 (C-
9), 24.95 (C-9). 
Lab book reference number: NPY-1-53 
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4-(2-Pyridyl)-2-Pyrone (81) 
 
Following the general procedure C1; 4-bromo-6-methyl-2-pyrone 103 (500 mg, 2.65 
mmol) was used to afford the product as a creamy solid (485 mg, 85 % yield). MP 
89-90 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.74 – 8.65 (m, 1H, H-12), 7.83 (td, JHH = 7.7, 1.5 
Hz, 1H, H-10), 7.76 (d, J = 7.7 Hz, 1H, H-9), 7.38 (ddd, JHH = 7.7, 4.8, 1.5 Hz, 1H, 
H-11), 6.81 (s, 1H, H-3), 6.68 (s, 1H, H-5), 2.32 (s, 3H, H-7). 
13
C NMR (101 MHz, 
CD2Cl2) δ 163.64 (C-2), 162.74 (C-4), 153.75 (C-6), 152.65 (C-8), 150.34 (C-12), 
137.46 (C-10), 125.27 (C-11), 121.76 (C-9), 109.16 (C-5), 102.31 (C-3), 20.41 (C-
7). IR (solid-state ATR, cm-1) 3073, 2952, 1702, 1632, 1551, 1432, 785, 842, 874. 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C11H9NO2 188.0633; Found
 
188.0685. 
Elemental Analysis:  calcd C 70.58, H 4.85, N 7.48; Found C 71.12, H 4.79, N 2.46.   
Lab book reference number: NPY-3-149 
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[Pd(OAc)((4-Py)-2-Pyr)]2 (82) 
 
Following the general procedure A1; palladium(II) acetate (314 mg, 1.40 mmol) and 
81 (100 mg, 0.64 mmol) were reacted to afford the product as a pale greenish yellow 
solid (490 mg, 54 % yield). 
1
H NMR (400 MHz, CD2Cl2) δ 8.26 (d, JHH = 5.7 Hz, 2H, H-12), 7.90 – 7.87 (m, 
2H, H-10), 7.51 (d, JHH = 8.2, 2H, H-9), 7.29 – 7.26 (m, 2H, H-11), 5.94 (s, 2H, H-
5), 2.11 (d, JHH = 0.9, 6H, H-7), 2.02 (s, 6H, H-13). IR (solid-state ATR, cm-
1
) 3080, 
2910, 7970, 2870, 1230, 1180, 1490, 1370, 1300, 1290, 1270, 1250, 1130, 1115, 
1050, 910, 820, 750, 710, 610, 580. MS; LRMS (LIFDI-MS) m/z: calcd for 
C26H24N2O8Pd2 calcd 707.96; Found 707.96. 
 Lab book reference number: NPY-4-266F3 
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[PdCl((4-Py)-2-Pyr)]2 (83) 
 
 
Following the general procedure A3; palladium(II) chloride (113 mg, 0.640 mmol) 
and 81 (100 mg, 0.534 mmol) to afford product as lemon yellow crystals (515 mg 73  
%).  
1
H NMR (400 MHz, C5H5N) δ 9.32 (br. s, 2H, H-12), 8.04 (td, JHH = 7.8, 1.6 Hz, 
2H, H-10), 7.66 (d, JHH = 7.8 Hz, 2H, H-9), 7.41 (ddd, JHH = 7.8, 5.7, 1.6 Hz, 2H, H-
11), 6.25 (d, JHH = 0.8 Hz, 2H, H-5), 2.15 (s, 6H, H-7). IR (solid-state ATR, cm-
1
) 
3067, 3182, 172, 1641, 1551, 1476, 1435, 1321, 1387, 1284, 1208, 1162, 1137, 
1071, 1024, 899, 842, 780, 682, 550, 456. MS; LRMS (LIFDI-MS) m/z: calcd for 
C21H13Cl2N2O5Pd2 calcd 656.83; Found [M – (NO2)]
 
653.82.  
 
Lab book reference number: NPY-4-270 
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[PdCl((4-Py)-2-Pyr)(PPh3)] (84) 
 
Following the general procedure B1; 83 (200 mg, 0.304 mmol) and 
triphenylphosphine (176 mg, 0.638 mmol) to afford the desired product as white 
solid crystals (151 mg, 84 % yield). MP 167–170 oC.  
1
H NMR (400 MHz, CD2Cl2) δ 9.46 (d, JHH = 4.8 Hz, 1H, H-12), 7.93 (td, JHH = 7.8, 
1.7 Hz, 1H, H-10), 7.74 – 7.67 (m, 6H, H-PPh3), 7.66 – 7.61 (m, 2H, H-9/PPh3), 7.45 
– 7.42 (m, 1H, H-2), 7.39 (t, JHH = 1.2 Hz, 2H, H-PPh3), 7.34 (t, JHH = 7.3 Hz, 6H, 
H-1), 6.08 (s, 1H, H-5), 2.06 (d, JHH = 1.0 Hz, 3H, H-7). 
13
C NMR (101 MHz, 
CD2Cl2) δ 164.22 (C-2), 159.54 (C-6/8), 151.20 (C-12), 143.50 (C-4), 139.53 (C-
10), [134.61, 134.49, 132.35, 132.25, 130.23 (C-PPh3)], 128.94 (C-11), [128.82, 
128.11, 128.02, 124.70 (C-PPh3)], 121.16 (C-9), 99.82 (C-5), 19.66 (C-7). IR (solid-
state ATR, cm-
1
) 3067, 3053, 2914, 1731, 1697, 1673, 1633, 1599, 1552, 1478, 
1433, 1387, 1320, 1286, 1256, 1208, 1186, 1160, 1096, 1071, 1025, 998, 920, 900, 
843, 781, 742, 691, 508, 455. MS; LRMS (LIFDI-MS) m/z: calcd for 
C29H23ClNO2PPd calcd 591.0194; Found [M – (Cl)]
+ 
556.0505. 
Lab book reference number: NPY-4-272 
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[PdCl(PiPh)(PPh3)] (87)
113
 
 
Following the general procedure B1; 77 (200 mg, 0.322 mmol) and triphenyl 
phosphine (186 mg, 0.709 mmol) to afford the product as white crystals (353 mg, 98 
% yield).  MP 210–211 oC.  
1
H NMR (400 MHz, CDCl3) δ 9.26 (d, JHH 5.7, 1H, H-1), 7.71 – 7.67 (m, 1H, H-3), 
7.67 – 7.60 (m, 6H, H- PPh3), 7.43 – 7.41 (m, 1H, H-4), 7.41 – 7.37 (m, 3 H, H-
PPh3), 7.35 – 7.29 (m, 6H, H- PPh3), 7.21 (dd, JHH 7.3, 5.7, 1H, H-2), 6.94 (dd, JHH 
7.6, 1.3, 1H, H-8), 6.68 (td, JHH 7.6, 1.3, 1 H, H-9), 6.63 (ddd, JHH 7.6, 5.7, 1.3, 1 H, 
H-10), 6.27 (d, JHH 7.6, 1H, H-11), 4.91 (d, JHH 13.7, 1H, H-6), 3.97 (d, JHH 13.7, 
1H, H-6). 
13
C NMR (101 MHz, CDCl3) δ 159.22 (C-5), 153.31 (C-1), 153.23 (C-3), 
138.49 (C-7), 138.18 (C-4), [135.08, 134.97, 131.63, 131.13, 130.35, 130.32, 
128.17, 128.06, 125.86, 125.29, 125.25, 123.52, 123.49, 123.38 (C-
PPh3/8/9/10/11/12/)], 122.01 (C-2), 50.34 (C-6). 
31
P NMR (162 MHz, CDCl3) δ 
35.47. IR (solid-state ATR, cm-1) 3420, 3047, 1607, 1573, 1480, 1435, 1096, 1183, 
1025, 747, 691, 532, 499. MS; LRMS (LIFDI-MS) m/z: calcd for C30H25ClNPPd  
571.05; Found 571.06, Elemental Analysis: calcd C 62.95, H 4.40, N 2.45; Found C 
63.13, H 4.77, N 2.33. 
Lab book reference number: NPY-1-56 
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[Pd(NO2)(PiPh)(PPh3)] (88) 
 
Following the general procedure B2; 87 (100 mg, 0.175 mmol) and silver nitrite (59 
mg, 0.384 mmol) to afford the desired product as pale orange crystals (101 mg, 97 % 
yield).  MP 201–204 °C.  
1
H MNR (500 MHz, CD2Cl2) δ 8.54 – 8.56 (br. s,  1H, H-1), 7.74 (td, JHH = 7.7, 1.6,  
1H, H-3), 7.61 – 7.53 (m, 7H, H-PPh3), 7.50 (d, JHH = 7.7, 1H, H-4), 7.44 (t, JHH = 
6.7, 3H, H-PPh3), 7.36 (d, JHH = 6.7, 8H, H-PPh3), 7.15 (t, JHH = 6.7, 1H, H-2), 7.02 
(d, JHH = 7.1, 1H, H-8), 6.74 (t, JHH = 7.1, 1H, H-9), 6.49 – 6.47 (d, JHH = 5.3, 1H, 
H-11), 6.33 (t, JHH = 7.1, 1H, H-10), 5.01 (d, JHH = 12.7, 1H, H-6), 4.08 (d, JHH = 
12.7, 1H, H-6). 
13
C NMR (126 MHz, CD2Cl2) δ 159.78 (C-5), 151.59 (C-1), 147.42 
(C-7), 139.53 (C-3), 137.82 (C-12), 137.75 (C-11), [135.04, 134.95, 132.39, 132.31, 
131., 130.87, 130.47, 128.95, 128.86, 128.69, 128.61 (C-PPh3)], 126.99 (C-8), 
125.34 (C-10), 124.59 (C-9), 124.48 (C-4), 122.55 (C-2), 50.52 (C-6). IR (solid-state 
ATR, cm-1) 3056, 2960, 2922, 2850, 1604, 1573, 1479, 1435, 1359, 1309, 1260, 
1093, 1021, 745, 693, 515. MS; LRMS (LIFDI-MS) m/z: calcd for C30H25N2O2PPd  
582.07; Found 582.07, Elemental Analysis:  calcd C 61.81, H 4.32, N 4.81; Found C 
66.63, H 4.71, N 2.69. The low carbon content is likely due to the presence of DCM 
in the final product.  
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Lab book reference number: NPY-1-42 
[PdClPiPh)(PPh2Cy)] (89) 
 
Following the general procedure B1; 77 (60 mg, 0.097 mmol) and 
cyclohexyldiphenylphosphine (57 mg, 0.213 mmol) to afford the desired product as 
white crystals (111 mg, >99 % yield). MP 172–173 °C.  
1
H NMR (500 MHz, CD2Cl2) δ 9.04 (d, JHH = 5.6, 1H, H-1), 7.88 – 7.82 (m, 2H, H-
PPh2), 7.71 (td, JHH = 7.6, 1.6, 1H, H-3), 7.56 – 7.46 (m,  5H, H-PPh2), 7.45 (d, JHH 
= 7.6, 1H, H-4), 7.43 – 7.39 (m, 1H, H-PPh2), 7.33 (td, JHH = 7.6, 1.7, 2H, H-PPh2), 
7.18 (dd, JHH = 7.6, 5.6, 1H, H-2), 7.06 (dd, JHH = 7.3, 1.2, 1H, H-8), 7.00 (ddd, JHH 
= 7.3, 5.1, 1.2, 1H, H-9), 6.82 (td, JHH = 7.3, 1.2, 1H, H-10), 6.61 (t, JHH = 7.3, 1H, 
H-11), 4.91 (d, JHH = 13.8, 1H, H-6), 4.07 (d, JHH = 13.8, 1H, H-6), 2.89 – 2.79 (m, 
1H, H- P(Cy)), 2.35 (s, 1H, H- P(Cy)), 1.72 – 1.61 (m,  2H, H- P(Cy)), 1.51 (s, 2H, 
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H- P(Cy)), 1.32 (dtd, JHH = 13.0, 9.8, 3.4, 1H, H- P(Cy)), 1.04 – 0.93 (m, 1H, H- 
P(Cy)), 0.90 – 0.62 (m, 2H, H- P(Cy)). 13C NMR (126 MHz, CD2Cl2) δ 159.63 (C-
5), 153.17 (C-1), 152.02 (C-7/12), 138.96 (C-3), 136.28 (C-9), [134.85, 134.78, 
134.47, 134.55, 130.49, 130.39, 130.04, 128.28, 128.20, 128.11, 128.03, 127.78 (C-
PPh2)], 126.95 (C-8), 125.52 (C-11), 124.18 (C-10), 123.96 (C-4), 122.16 (C-2), 
50.70 (C-6), [36.31 (C-1), 36.07, 29.50, 27.34, 26.47 (C-P(Cy))]. 
31
P NMR (162 
MHz, CD2Cl2) δ 36.83. IR (solid-state ATR, cm
-1
) 3051, 2929, 2849, 1605, 1573, 
1475, 1432, 1291, 1187, 1151, 1094, 1025, 997, 769, 738, 695, 519, 474. MS; 
LRMS (LIFDI-MS) m/z: calcd for C29H29ClNPPd  563.08; Found 564.10, Elemental 
Analysis:  calcd C 61.71, H 5.18, N 2.48; Found C 62.23, H 5.33, N 2.50.   
Lab book reference number: NPY-2-66 
[Pd(NO2)(PiPh)(PPh2Cy)] (90) 
  
Following the general procedure B2; 89 (50 mg, 0.175 mmol) and silver nitrite (59 
mg, 0.384 mmol) to afford the desired product as pale orange solid crystals (50 mg, 
98 % yield). MP 176–178 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.47 – 8.34 (m, 1H, H-1), 7.77 – 7.71 (m, 2H, H-
3/4), 7.70 – 7.61 (m,  3H, H-PPh2), 7.53 – 7.40 (m, 7H, H-PPh2), 7.13 – 7.08 (m, 1H, 
H-2), 7.05 – 7.01 (m, 1H, H-8), 6.88 (dd, JHH = 7.7, 5.5, 1H, H-9), 6.83 (d, JHH = 7.7, 
1H, H-10), 6.64 (t, JHH = 7.7, 1H, H-11), 4.93 d, JHH = 13.9, 1H, H-6), 4.07 (d, JHH 
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= 13.9, 1H, H-6), 2.14 (d, JHP = 37.0, 2H, H-PCy), 1.68 (dd, JHP = 58.9, 23.4, 2H, 
H- PCy), 1.50 (d, JHH = 10.6, 1H, H- PCy), 1.36 – 1.19 (m,  2H, H- PCy), 0.85 (d, 
JHH = 8.1, 3H, H- PCy), 0.56 (d, JHH = 12.6, 1H, H- PCy). 
31
P NMR (162 MHz, 
CD2Cl2) δ 34.60. IR (solid-state ATR, cm-
1
) 3056, 2934, 2849, 1601, 1578, 1483, 
1433, 1360, 1314, 1268, 210, 1160, 1119, 1097, 1065, 1001, 915, 891, 851, 750, 
704, 533, 473, 501, 414.5456. MS; LRMS (LIFDI-MS) m/z: calcd for 
C30H31N2O2PPd  588.12; Found [M – (NO2)]
 
542.02; Elemental Analysis:  calcd C 
61.18, H 5.31, N 4.76; Found C 66.33, H 5.67, N 2.50. 
 
Lab book reference number: NPY-2-67 
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[PdCl(PiPh)(PPh2(t-Bu))] (91) 
 
Following the general procedure B1; 77 (100 mg, 0.161 mmol) and tert-
butyldiphenylphosphine (86 mg, 0.355 mmol) to afford the desired product as white 
solid crystals (60 mg, 98 % yield). MP 162–165 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 9.25 (dd, JHH = 5.2, 1.7, 1H, H-1), 8.51 (dd, JHH = 
14.1, 6.3, 2H, H-PPh2), 7.72 (td, JHH = 7.6, 1.7, 1H, H-3), 7.67 – 7.62 (m, 3H, H-
PPh2), 7.41 (d, JHH = 7.6, 1H, H-4), 7.25 (dd, JHH = 7.6, 5.2, 1H, H-2), 7.21 (dd, JHH 
= 10.1, 1.5, 2H, H-PPh2), 7.11 (td, JHH = 7.2, 1.7, 1H, H-PPh2), 7.01 (td, JHH = 7.6, 
1.9, 2H, H-PPh2), 6.77 (d, JHH = 7.3, 1H, H-8), 6.48 (dd, JHH = 7.3, 1.2, 1H, H-9), 
6.44 (ddd, JHH = 7.3, 5.4, 1.2, 1H, H-10), 6.04 (t, JHH = 7.4, 1H, H-11), 4.84 (d, JHH 
= 13.7, 1H, H-6), 3.95 (d, JHH = 13.7, 1H, H-6), 1.38 (d, JHH = 15.2, 9H, H-P(t-Bu)). 
NMR (101 MHz, CD2Cl2) δ 159.94 (C-5), 154.54 (C-7), 153.12 (C-1), 138.89 (C-3), 
138.17 (C-9), 138.06 (C-12), [137.89, 137.74, 137.61, 133.13, 133.09, 133.00, 
132.70, 131.71, 129.04, 128.74, 127.61, 127.51 (C-PPh2)], 126.01 (C-9), 124.97 (C-
11), 123.66 (C-4), 123.27 (C-10), 122.12 (C-2), 50.55 (C-6), 36.09 (C-P(t-Bu)), 
35.84 (C-P(t-Bu)), 30.16 (C-P(t-Bu)), 30.11 (C-P(t-Bu)). 
31
P NMR (162 MHz, 
CD2Cl2) δ 54.75. IR (solid-state ATR, cm-
1
) 3064, 2987, 2954, 2901, 2863, 1602, 
1562, 1474, 143, 1363, 1292, 1328, 1261, 1183, 1159, 1097, 1014, 761, 744, 695, 
617, 587, 523. MS; LRMS (LIFDI-MS) m/z: calcd for C28H29ClNPPd  553.08; 
Found 553.08. 
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Lab book reference number: NPY-2-136 
[Pd(NO2)(PiPh)(PPh2(t-Bu))] (92) 
 
Following the general procedure B2; 91 (60 mg, 0.112 mmol) and silver nitrite (38 
mg, 0.245 mmol) to afford the desired product as pale orange solid crystals (60 mg, 
97 % yield). MP 182–187 °C.  
1
H NMR (400 CD2Cl2) δ 8.52 (d, JHH = 5.4, 1H, H-1), 8.49 – 8.42 (m, 2H, H-PPh2), 
7.73 (td, JHH = 7.7, 1.2, 1H, H-3), 7.64 (dd, JHH = 4.4, 2.5, 3H, H-PPh2), 7.51 (dd, 
JHH = 7.9, 7.8, 2H, H-PPh2), 7.47 (d, JHH = 7.6, 1H, H-4), 7.28 – 7.14 (m, 3H, H-
PPh2), 7.13 (dd, JHH = 5.4, 1.2, 1H, H-2), 6.79 (d, JHH = 7.3, 1H, H-8), 6.52 (td, JHH 
= 7.5, 1.2, 1H, H-9), 6.45 (ddd, JHH = 7.3, 5.4, 1.2, 1H, H-11), 6.13 (t, JHH = 7.3, 
1H, H-10), 4.93 (d, JHH = 13.6, 1H, H-6), 3.99 (d, JHH = 13.6, 1H, H-6), 1.16 (d, JHH 
= 15.2, 9H, H- P(t-Bu)). 
13
C NMR (101 MHz, CD2Cl2) δ 160.06 (C-5), 151.25 (C-
1), 139.37 (C-3), 138.55 (C-7), 138.11 (C-11), 138.01 (C-12), 137.15 (C-1), [137.02, 
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133.59, 133.49, 131.84, 129.66), 128.92, 128.82, 127.97, 127.87 (C-PPh2)], 126.26 
(C-8), 124.87 (C-10), 124.43 (C-4), 123.82 (C-9), 122.52 (C-2), 50.51 (C-6), [35.08, 
34.83, 28.92, 28.87 (C-P(t-Bu))]. 
31
P NMR (162 MHz, CD2Cl2) δ 52.94. MS; LRMS 
(LIFDI-MS) m/z: calcd for C28H29N2O2PPd  562.10; Found [M – (NO2)]
 
516.06. 
 
Lab book reference number: NPY-2-135 
[PdCl(PiPh)(P(2-Furyl)3)] (93) 
 
Following the general procedure B1; 77 (30 mg, 0.048 mmol) and tri-2-furyl 
phosphine (25 mg, 0.106 mmol) to afford the desired product as a light orange liquid 
(50 mg, 95 % yield). MP 145–147 °C.  
1
HNMR (400 MHz, CDCl3) δ 9.24 (d, JHH = 5.6, 1H, H-1), 7.70 (td, JHH = 7.6, 1.7, 
1H, H-3), 7.60 (br s, 4H, H-P(Fu)3), 7.42 (d, JHH = 7.6, 1H, H-4), 7.22 (ddd, JHH = 
7.6, 5.6, 1.4, 1H, H-2), 7.18 – 7.06 (m, 3H, H-P(Fu)3)), 6.99 (d, JHH = 5.9, 1H, H-8), 
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6.84 (d, JHH = 7.6, 1H, H-11), 6.78 (td, JHH = 7.5, 1.6, 1H, H-9), 6.48 (td, JHH = 7.5, 
1.6, 1H, H-10), 6.44 (dt, JHH = 3.3, 1.6, 4H, H-P(Fu)3), 4.90 (s, 1H, H-6), 4.00 (s, 
1H, H-6). 
13
C NMR (101 MHz, CDCl3) δ 159.05 (C-5), 153.14 (C-1), 150.13 (C-7), 
148.44 (C-P(Fu)3), 138.85 (C-3), 137.81 (C-12), 136.79 (C-11), 126.32 (C8), 125.19 
(C-10), 123.95 (C-9), 123.72 (C-3), 122.19 (C-2), 111.29 (C-P(Fu)3), 50.16 (C-6). 
31
P NMR (162 MHz, CDCl3) δ -19.24. MS; LRMS (LIFDI-MS) m/z: calcd for 
C24H19ClNO3PPd  542.98; Found 542.99, Elemental Analysis:  calcd C 53.16, H 
3.53, N 2.58; Found C 51.77, H 3.52, N 2.59. 
 
Lab book reference number: NPY-2-109 
[Pd(NO2)(PiPh)(P(Fu)3)] (94) 
 
Following the general procedure B2; 93 (20 mg, 0.037 mmol) and silver nitrite (13 
mg, 0.081 mmol) to afford the desired product as a colourless liquid (49 mg, 95 % 
yield). 
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1
H NMR (400 MHz, CDCl3) δ 8.75 (d, JHH = 2.5, 1H, H-1), 7.77 – 7.74 (m, 1H, H-
3), 7.68 (br s, 4H, H-P(Fu)3), 7.49 (d, JHH = 7.7, 1H, H-4), 7.23 (d, JHH = 6.0, 1H, H-
2), 7.06 (d, JHH = 7.2, 1H, H-8), 6.97 (t, JHH = 7.8, 4H, H-P(Fu)3), 6.87 (d, JHH = 
7.1, 1H, H-11), 6.85 – 6.80 (m, 1H, H-9), 6.56 (dd, JHH = 8.3, 6.7, 1H, H-10), 6.50 – 
6.40 (m, 4H, H-P(Fu)3), 4.98 (d, JHH = 13.5, 1H, H-6), 4.05 (d, JHH = 13.5, 1H, H-6). 
31
P NMR (162 MHz, CDCl3) δ -22.17. MS; LRMS (LIFDI-MS) m/z: calcd for 
C24H19N2O5PPd calcd 552.01; Found [M – (NO2)]
 
506.02. 
Lab book reference number: NPY-2-110 
[PdCl(PiPh)(P(n-Bu)3)] (95) 
 
Following the general procedure B1; 77 (50 mg, 0.081 mmol) and tri-n-
butylphosphine (36 mg, 0.177 mmol) to afford the desired product as a colourless 
liquid (83 mg, >99 % yield).  
1
H NMR (400 MHz, CD2Cl2) δ 9.09 – 8.98 ( m, 1H, H-1), 7.69 (t, JHH = 7.5, 1H, H-
3), 7.40 (d, JHH = 7.5, 1H, H-4), 7.28 (dd, JHH = 7.5, 2.4, 1H, H-9), 7.18 (t, JHH = 
7.5, 1H, H-2), 7.04 (d, JHH = 6.7, 1H, H-8), 6.90 (d, JHH = 6.7, 1H, H-10), 6.88 – 
6.82 (m, 1H, H-11), 4.71 (d, JHH = 13.7, 1H, H-6), 3.97 (d, JHH = 13.7 1H, H-6), 
1.81 (dd, JHH = 16.6, 8.9, 5H, H-P(n-Bu)
 
), 1.68 – 1.22 (m, 13H, H-P(n-Bu)  ), 0.98 – 
0.76 (m, 9H, H-P(n-Bu)). 
13
C NMR (101 MHz, CD2Cl2) δ 159.53 (C-5), 152.80 (C-
1), 152.33 (C-12), 138.80 (C-3), 137.14 (C-8), 126.70 (C-7), 125.65 (C-10), 124.10 
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(C-11), 123.89 (C-4), 122.06 (C-2), 50.38 (C-6), [26.75, 24.77, 24.64, 24.48, 13.83 
(C-P(n-Bu)3)]. 
31
P NMR (162 MHz, CD2Cl2) δ 21.14. IR (solid-state ATR, cm-
1
) 
3047, 345, 2955, 2927, 2869, 1605, 1573, 1442, 1378, 1291, 1209, 1156, 1091, 
1058, 1027, 904, 742, 724, 620, 451. MS; LRMS (LIFDI-MS) m/z: calcd for 
C28H29ClNPPd  511.13; Found 511.10. 
Lab book reference number: NPY-2-76 
[Pd(NO2)(PiPh)(P(n-Bu)3)] (96) 
 
Following the general procedure B2; 95 (50 mg, 0.098 mmol) and silver nitrite (33 
mg, 0.215 mmol) to afford the desired product as a colourless liquid (48 mg, 97 % 
yield).   
1
H NMR (400 MHz, CD2Cl2) δ 8.53 (d, JHH = 5.1, 1H, H-1), 7.71 (td, JHH = 7.7, 1.6, 
1H, H-3), 7.44 (d, JHH = 7.7, 1H, H-4), 7.23 (ddd, JHH = 7.2, 3.4, 1.5, 1H, H-9), 7.16 
– 7.10 (m, 1H, H-2), 7.04 (dd, JHH = 7.2, 1.5, 1H, H-8), 6.92 (dd, JHH = 7.2, 1.5, 1H, 
H-11), 6.90 – 6.84 (m, 1H, H-10), 4.80 (d, JHH = 13.8, 1H, H-6), 4.01 (d, JHH = 13.8, 
1H, H-6), 1.87 – 1.22 (m, 18H, H-P(n-Bu)3), 0.99 – 0.79 (m, 9H, H-P(n-Bu)3). 
13
C 
NMR (101 MHz, CD2Cl2) δ 159.72 (C-5), 151.00 (C-1), 149.21 (C-7), 140.49 (C-
12), 139.33 (C-3), 137.00 (C-9), 126.90 (C-8), 125.68 (C-10), 124.60 (C-11), 124.54 
(C-4), 122.46 (C-2), 50.31 (C-6),  [28.26, 26.47, 24.66, 23.39, 13.77 (C-P(n-Bu)3)]. 
31
P NMR (162 MHz, CD2Cl2) δ 19.01. IR (solid-state ATR, cm-
1
) 3049, 2956, 2956, 
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2928, 2870, 1606, 1571, 1442, 1345, 1282, 1212, 1155, 1092, 1026, 1050, 968, 905, 
745, 620, 447, 3436. MS; LRMS (LIFDI-MS) m/z: calcd for C24H37N2O2PPd calcd 
522.16; Found [M – (NO2)]
 
476.17. 
Lab book reference number: NPY-2-78 
2-Phenylpyrazine (99)
141
 
  
A mixture of 2-chloropyrazine (29 mg, 0.25 mmol), arylboronic acid (46 mg, 0.375 
mmol), K2CO3 (70 mg, 0.5 mmol), Pd(OAc)2 (1 mg, 0.00375 mmol), distilled water 
(1 mL) and ethanol (3 mL) was stirred at 80 °C in air for 20 min. The reaction 
mixture was added to brine (15 mL) and extracted with ethyl acetate (4 × 15 mL). 
The reaction mixture was filtered through Celite and washed with EtOAc (30 mL). 
The filtrate was pre-absorbed on silica gel and concentrated by rotary evaporation. 
The crude product was purified by silica gel column chromatography (petroleum 
ether:EtOAc = 40:60, v/v) and the filtrate concentrated in vacuo to afford the desired 
product as a shiny reddish brown solid (34 mg, 86% yield). MP 60–61 ºC. 
1
H NMR (400 MHz, CDCl3) δ 9.03 (d, J = 1.5 Hz, 1H), 8.64 (dd, J = 2.5, 1.5 Hz, 
1H), 8.51 (d, J = 2.5 Hz, 1H), 8.02 (dd, J = 8.0, 1.5 Hz, 2H), 7.62 – 7.40 (m, 3H). 
13
C NMR (101 MHz, CDCl3) δ 152.96, 144.30, 143.04, 142.36, 136.46, 130.05, 
129.18, 128.86, 127.27, 127.06. 
Lab book reference number: NPY-3-201 
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[Mn(CO)4(2-Phenylpyrazine)] (100) 
 
Following the general procedure D1; MnBn(CO)5 (183 mg,  0.64 mmol), hexane (8 
ml), 2-phenylpyrazine (100 mg, 0.64 mmol), to afford the desired product as a sticky 
solid yellow (142 mg, 68% yield). MP 97–100 ºC.  
1
H NMR (400 MHz, CDCl3) δ 9.17 (br. s, 1H, H-3), 9.17 (br. s, 1H, H-1), 8.68 (br. s, 
1H, H-2), 8.34 (br. s, 1H, H-7), 8.00 (d, JHH = 7.4 Hz, 1H, H-6), 7.93 (d, JHH = 7.9 
Hz, 1H, H-8), 7.33 (d, JHH = 7.9 Hz, 1H, H-9). MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C14H8MnN2O4 322.9820; Found
 
322.9787. 
Lab book reference number: NPY-4-210F6-9 
 4-(3-Methoxy-2-pyridyl)-2-Pyrone (104) 
 
Following the general procedure C1; 4-bromo-6-methyl-2-pyrone 103 (500 mg, 2.65 
mmol) with 2-Bromo-6-methoxypyridine 101b (547 mg, 2.91 mmol) to afford the 
compound as a Creamy solid (496 mg, 86 % yield). MP 80-82 °C.  
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1
H NMR (400 MHz, CD2Cl2) δ 7.69 (dd, JHH = 8.3, 7.3, 1H, H-10), 7.36 (d, JHH = 
7.3, 1H, H-9), (d, JHH = 8.3, 1H, H-11), 6.78 (s, 1H, H-3), 6.71 (s, 1H, H-5), 3.99 (s, 
3H, H-13), 2.32 (s, 3H, H-7). 
13
C NMR (101 MHz, CD2Cl2) δ 193.21 (C-2), 164.28 
(C-4), 162.54 (C-6), 153.33 (C-12), 149.83 (C-8), 139.77 (C-10), 114.85 (C-9), 
113.35 (C-11), 108.87 (C-3), 102.08 (C-5), 53.79 (C-13), 20.44 (C-7). IR (solid-state 
ATR cm-1) 3110, 2080, 2075, 1750, 1700, 1680, 1550, 1480, 1330, 1291, 1030, 988, 
830, 805, 514. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C12H12NO3 218.0739; 
Found
 
218.0772.  Elemental Analysis: calcd C 66.35, H 5.10, N 6.45; Found C 
67.15, H 5.22, N 6.46. 
Lab book reference number: NPY-5-Mn-OMe C-HF5 
 [Mn(CO)4(4-(2-pyridyl)-2-Pyrone)] (105a) 
 
Following the general procedure D1; MnBn(CO)5 (764 mg,  2.67 mmol,), hexane 
(20 ml), 81  (500 mg, 2.67 mmol), to afford the desired product as a yellow 
powdered (943 mg, 96% yield). MP 155–156 ºC.  
1
H NMR (400 MHz, CDCl3) δ 8.86 (d, JHH = 5.0 Hz, 1H, H-12), 7.91 (td, JHH = 7.8, 
1.6 Hz, 1H, H-10), 7.71 (d, JHH = 7.9 Hz, 1H, H-9), 7.33 – 7.27 (m, 1H, H-11), 6.27 
(s, 1H, H-5), 2.30 (s, 3H, H-7).  
13
C NMR (101 MHz, CDCl3) δ 167.62 (C-2), 162.66 
(C-6), 159.16 (C-4), 158.31 (C-8), 157.50 (C-3), 155.51(C-12), 139.46 (C-10), 
125.80 (C-11), 122.80 (C-9), 99.94 (C-5), 19.22 (C-7). IR (solid-state ATR cm-1) 
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2081, 1966, 1927, 1681, 1633, 1596, 1259, 1015, 783, 629, 545, 449. MS; HRMS 
(ESI
+
) m/z: [M + H]
+
 calcd for C15H9MnNO6 353.9766; Found
 
353.9769. 
 
Lab book reference number: NPY-5-313 
[Mn(CO)4(4-(3-methoxy-2-pyridyl)-2-Pyrone)] (105b) 
 
Following the general procedure D1; MnBn(CO)5 (395 mg,  1.38 mmol,), THF (15 
ml), 104  (300 mg, 1.38 mmol) to afford the desired product as a sticky yellow solid 
(52 mg, 98% yield). MP 159–160 ºC.  
1H NMR (400 MHz, CD2Cl2) δ 7.92 – 7.86 (m, 1H, H-10), 7.37 (d, JHH = 7.5, 1H, 
H-9), 6.79 (d, JHH = 8.0Hz, 1H, H-11), 6.27 (s, 1H, H-5), 4.07 (s, 3H, H-13), 2.27 (s, 
3H, H-7). 
13
C NMR (176 MHz, CD2Cl2) δ 212.84 (C-2), 168.96 (C-4), 167.15 (C-5), 
164.01 (C-6), 163.45 (C-12), 158.10 (C-8), 141.46 (C-9), 114.90 (C-10), 105.66 (C-
11), 100.00 (C-5), 56.56 (C-13), 19.94 (C-7). IR (solid-state ATR cm
-1
) 3084, 3020, 
2957, 2923, 2853, 2073, 1993, 1946, 1685, 1633, 1473, 1597, 1569, 1509, 1425, 
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1368, 1318, 1286, 1260, 1093, 1049, 1016, 929, 883, 799, 745, 659, 631. MS; 
HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C16H11MnNO7 382.9838; Found
 
382.9872. 
 
Lab book reference number: NPY-5-[Mn]-OMe 
4-[(2-Pyridyl)-3-(ethenylphenyl)-2-pyrone (106) 
 
Following the general procedure E1; 105a (0.28 mmol, 100 mg), in neat 
phenylacetylene 16 (1.5 mL., excess) to afforde the third (fraction) product as a pale 
orange viscous liquid (23.3 mg, 28 %)   
1
H NMR (400 MHz, CD2Cl2) δ 8.76 (ddd, JHH =  4.8, 1.8, 1.0 Hz, 1H, H-12), 7.87 
(d, JHH = 16.1 Hz, 1H, H-14), 7.81 (td, JHH = 7.7, 1.8 Hz, 1H, H-10), 7.50 – 7.47 (m, 
1H, H-9), 7.38 (ddd, JHH = 7.7, 4.8 Hz, 1.0, 1H, H-11), 7.35 – 7.31 (m, 2H, H-
16/20), 7.31 – 7.25 (m, 2H, H-17/19), 7.24 – 7.19 (m, 1H, H-18), 6.95 (d, JHH = 16.1 
Hz, 1H, H-13), 6.31 (s, 1H, H-5), 2.30 – 12.34 (s, 3H, H-7). 13C NMR (101 MHz, 
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CD2Cl2) δ 161.91 (C-2), 159.33 (C-6), 155.39 (C-4), 150.48 (C-8), 150.13 (C-12), 
137.92 (C-3), 136.41 (C-10), 134.32 (C-14), 128.61 (C-17/19), 127.87 (C-18), 
126.70 (C-16/20), 124.94 (C-9), 123.66 (C-11), 121.08 (C-13), 117.65 (C-15), 
106.43 (C-5), 19.73 (C-7). IR (solid-state ATR, cm-
1
) 340, 288, 269, 2970, 3015, 
1739, 1367, 1263, 1216, 836, 795, 687, 738, 613, 567, 539, 463.2464. UV Vis. 
max. = 262 and 364. MS; HRMS (ESI+) m/z: [M + H]+ calcd for C19H16NO2 
290.1176; Found 290.1177, [M + Na]
+ 
312.0990. 
Lab book reference number: NPY-5-315/316 F4F2 
6-Methylpyrano-4,3-quinolizin(14-phenyl)-8-ylium-η4-tricarbonylmanganesuide 
(107) 
 
Following the general procedure C2; 105a (200 mg, 0.57 mmol), phenyl acetylene 
16 (70 mg, 0.68 mmol) to afford the product as yellow powder (210 mg, 87 %). MP 
89 - 90 °C. 
1
H NMR (400 MHz, CD2Cl2) δ 7.62 (d, JHH = 7.6 Hz, 1H, H-12), 7.55 – 7.41 (m, 
4H, H-16/17/19/20), 7.36 (t, JHH = 7.5 Hz, 1H, H-18), 7.26-7.31 (m, 1H, H-10), 6.98 
(d, JHH = 8.2 Hz, 1H, H-9), 6.72 (s, 1H, H-13), 6.69 – 6.60 (m, 1H, H-11)  5.46 (s, 
1H, H-5), 2.03 (s, 3H, H-7). 
13
C NMR (101 MHz, CD2Cl2) 170.85 (C-2), 157.98 (C-
8), 146.67 (C-6), 139.45 (C-10), 137.39 (C-12), 135.91 (C-15), 129.55 (C-16/20), 
128.82 (C-17/19), 128.36 (C-18), 119.54 (C-11), 119.33 (C-9), 101.44 (C-5), 85.19 
(C-4), 76.47 (C-13), 75.13 (C-14), 60.67 (C-3), 18.79 (C-7). IR (solid-state ATR, 
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cm
-1
) 3073, 2952, 2080, 1965, 1702, 1632, 1551, 1432, 1015, 785, 842, 874, 783, 
630, 544. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C22H15MnNO5 427.0252; 
Found
 
430.0320.  
 
Lab book reference number: NPY-5-314 
8-Biphenyl-6-methyl-9-phenyl-4,3-isoquinolizin-2-pyrone (108) 
 
Following the general procedure E1; 105a (0.28 mmol, 100 mg), in neat 
phenylacetylene 16 (1.5 mL., excess) to afforde the second (fraction) product as dirty 
white solid (47.10 mg, 44 %). MP 115–116 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.50 (d, JHH = 1.0 Hz, 1H, H-10), 8.22 – 8.18 (m, 
2H, H-12/16), 7.94 (td, JHH = 1.8, 0.6 Hz, 1H, H-18), 7.78 (dt, JHH = 7.1, 1.8 Hz, 1H, 
H-22), 7.71 – 7.68 (m, 2H, H-25/27), 7.67–7.62 (m, 2H, H-20/21), 7.52 (qd, JHH = 
2.9, 1.8 Hz, 2H, H-24/28), 7.39–7.48 (m, 4H, H-13/14/15/26), 6.54 (6.59 – 6.45 (m, 
1H, H-5), 2.28 (d, J = 1.0 Hz, 3H, H-7). 
13
C NMR (176 MHz, CD2Cl2) δ 162.26 (C-
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2), 156.95 (C-8/19), 156.06 (C-6), 155.02 (C-9), 141.94 (C-23), 140.99 (C-17), 
139.38 (C-13/15), 138.46 (C-3), 129.84 (C-25/27), 129.35 (C-26), 129.29 (C-11), 
129.23 (C-24/28), 128.90 (C-20), 128.68 (C-18), 128.31 (C-4), 128.08 (C-22), 
127.99 (C-21), 127.61 (C-14), 127.19 (C-12/16), 116.53 (C-10), 100.84 (C-5), 20.37 
(C-7). IR (solid-state ATR, cm-
1
) 2081, 1966, 1927, 1681, 1633, 1596, 1259, 1015, 
783, 629. UV Vis. max. = 252, 304 and 372. MS; HRMS (ESI+) m/z: [M + H]+ 
calcd for C27H20NO2 389.1416; Found 390.1484, [M + Na]
+ 
412.1304,  Elemental 
Analysis:  calcd C; 83.27, H; 4.92, N; 3.60; Found C; 82.27, H; 4.60, N; 3.23. 
 
Lab book reference number: NPY-5-315/316 F2F2 
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7-methyl-2,6-diphenyl-10-(benzo-3-phenyl)isoquinoline (109) 
 
Following the general procedure E1; 105a (0.28 mmol, 100 mg), in neat 
phenylacetylene 16 (1.5 mL., excess) to afforde the First (fraction) product as a light 
orange solid (39.15 mg, 32 %). MP 150.5–152.0 °C.  
1
H NMR (700 MHz, CD2Cl2) δ 8.23 (d, JHH = 7.7 Hz, 2H, H-17/21), 8.12 (s, 1H, H-
14), 8.06 (s, 1H, H-24), 8.04 (s, 1H, H-3), 7.83 (s, 1H, H-6), 7.82–7.74 (m, 2H, H-
26/28), 7.73 (d, JHH = 7.7 Hz, 2H, H-9/13), 7.68 (ddd, JHH = 8.0, 7.4, 0.5 Hz, (small 
JHH = 0.5 confirmed by 
1
HCosy), 1H, H-27), 7.52 – 7.51 (m, 1H, H-19), 7.51 – 7.38 
(br m, 10H, H-10/11/12/18/20/30/31/32/33/34), 2.37 (d, JHH = 0.7 Hz, 3H, H-1). 
13
C 
NMR (176 MHz, CD2Cl2) δ 159.74 (C-22), 149.85 (C-16), 145.74 (C-2), 141.32 
(C-8), 141.31 (C-23), 136.81 (C-4), 136.19 (C-7), 129.48 (C-26), 129.45 (C-25), 
129.39 (C-9/13), 129.34 (C-10/12), 129.27 (C-30), 129.16 (C-24), 129.04 (C-18/20), 
129.01 (C-27), 128.83 (C-11), 128.77 (C-34), 128.66 (C-32), 128.26 (C-15), 128.25 
(C-6), 127.94 (C-19), 127.92 (C-3), 127.64 (C-28), 127.60 (C-31/33), 127.58 (C-29), 
127.19 (C-17/21), 125.57, (C-5), 115.75 (C-14), 21.64 (C-1). IR (solid-state ATR, 
cm-
1
) 3054, 3029, 2958, 2921, 2853, 2008, 1931, 1553, 1477, 1446, 1378, 1313, 
1259, 1073, 1024, 898, 803, 757, 693. UV Vis. max. MS; HRMS (ESI+) 
m/z: [M + H]
+
 calcd for C34H26N 448.2065; Found448.2065. 
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Lab book reference number: NPY-5-315/316 F3F3 
η4-Tricarbonylmanganese complex (110) 
 
Following the general procedure E1; 105b, (0.25 mmol, 100 mg), in neat 
phenylacetylene 16 (1.5 mL., excess), column chromatography with petroleum 
ether:EtOAc (90:10, v/v), to afford the product as a pale orange solid (107 mg, 76 
%). MP 110.5–111.0 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 7.71 (dd, JHH = 7.9, 1.7 Hz, 2H, H-14/16), 7.46 (s, 
1H, H-9), 7.43 – 7.29 (m, 9H, H-13/15/17/19/20/21/22/23/26), 6.61 (d, JHH = 7.5 Hz, 
1H, H-27), 6.52 (d, JHH = 7.5 Hz, 1H, H-25), 6.49 (s, 1H, H-11), 5.93 (d, JHH = 1.1, 
1H, H-9), 5.47 (s, 1H, H-5), 3.71 (s, 3H, H-29), 2.03 (s, 3H, H-7). 
13
C NMR (176 
MHz, CD2Cl2) δ 168.59 (C-2), 163.79 (C-2), 162.64 (C-6), 149.52 (C-24), 139.52 
(C-9), [137.38, 136.06, 129.70, 129.40, 129.30, 128.69, 128.63 
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(C-12/13/15/18/19/20/21/22/23/26/28)], 126.89 (C-17/13), 111.81 (C-27), 109.64 
(C-25), 104.07 (C-5), 99.95 (C-3), 94.94 (C-11), 86.76 (C-8), 53.61 (C-10) 48.50 
(C-4), 44.12 (C-29), 19.50 (C-7). IR (solid-state ATR, cm-
1
) 3087, 3027, 2923, 
2853, 2073, 1993, 1946, 1634, 1599, 1261, 1260, 1093, 1049, 782, 629, 559, 455. 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C31H24MnNO6 560.0906; Found
 
560.0859. 
 
Lab book reference number: NPY-5-OMe C-H F2F3 
6-Methyl-4-(phenylethynyl)-2-pyrone (112a)
109
 
 
Following the general procedure F1; with 4-bromopyrone (250 mg, 1.32 mmol) and 
phenylacetylene (162 mg, 1.58 mmol), to afford the compound as a Cream solid (320 
mg, 91%). MP 107–110 °C.   
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1
H NMR (400 MHz, CDCl3) δ 7.52 (dd, JHH = 8.0, 1.6 Hz, 2H, H-11/15), 7.45 – 7.34 
(m, 3H, H-12/13/14), 6.29 (d, JHH = 0.6 Hz, 1H, H-3), 6.04 (d, JHH = 0.6 Hz, 1H, H-
5), 2.24 (s, 1H, H-7). 
13
C NMR (101 MHz, CDCl3) δ 162.35 (C-2), 162.06 (C-6), 
139.06 (C-4), 132.2435 (C-11/15), [130.07, 128.71 (C-12/13/14)], 121.34 (C-10), 
114.51 (C-3), 105.50 (C-5), 98.71 (C-9), 85.51 (C-8), 20.0235 (C-7). IR (solid-state 
ATR, cm-
1
) 2203, 1721, 1703, 1643, 1534, 1439, 1309, 1206, 1135, 955, 838, 760, 
692, 530, 1392, 1485. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C14H11O2 
211.0681; Found 211.0753. Elemental Analysis:  calcd C 79.98, H 4.79,; Found C 
79.48, H 4.79. 
Lab book reference number: NPY-4-287 
()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-phenyl-3a,4,5,6,7,7a-hexahydro-
1H-4,7-methanoinden-2-yl)- 2H-pyran-2-one (113a)109 
 
Synthesised following the general procedure G; with 112a (55 mg, 0.26 mmol), to 
afford to afford the desired product as a creamy solid (85 mg, 98 % yield). MP 115–
116. °C.  
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.31 (m, 3H, H-12/13/14), 7.20 (dd, JHH = 6.7, 
3.0 Hz, 2H, H-11/15), 6.22 (d, JHH = 0.6 Hz, 1H, H-3), 5.60 (s, 1H, H-5), 2.99 (d, 
JHH = 5.5 Hz, 1H, H-18), 2.61 (d, JHH = 3.3 Hz, 1H, H-17), 2.49 (d, JHH = 5.5 Hz, 
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1H, H-19), 2.22 (d, JHH = 3.3 Hz, 1H, H-22), 2.10 (s, 3H, H-7), 1.80 – 1.58 (m, 2H, 
H-21), 1.39 (d, JHH = 8.8 Hz, 2H, H-20/23), 1.10 (d, JHH = 8.8 Hz, 2H, H-20/23). 
13
C 
NMR (101 MHz, CDCl3) δ 207.81 (C-16), 163.55 (C-2), 162.72 (C-6), 162.25 (C-4), 
151.44 (C-8), 146.22 (C-9), [129.19, 128.66, 128.40 (C-12/13/14)], 111.59 (C-3), 
103.54 (C-5), 54.08 (C-20), 50.13 (C-19), 39.78 (C-18), 38.21 (C-22), 31.77 (C-17), 
29.02 (C-21), 28.67 (C-23), 20.17 (C-7). IR (solid-state ATR, cm
-1
) 1634, 1573, 
2954, 2871, 1695, 1717, 1444, 1306, 1196, 980, 854, 695, 750.  MS; HRMS (ESI
+
) 
m/z: [M + H]
+
 calcd for C22H21O3 333.1446; Found 333.1396. 
Lab book reference number: NPY-4-288F2 
()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-phenyl-3a,4,5,6,7,7a-hexahydro-
1H-4,7-methanoinden-2-yl)- 2H-pyran-2-one (113a)109 
 
 
Synthesised following the general procedure G; with 112a (55 mg, 0.26 mmol), to 
afford to afford the desired product as a creamy solid (46 % yield by 
1
H MNR with 
respect to - isomer). MP 116–118 °C.  
1
H NMR (400 MHz, CDCl3) δ 7.44 – 7.37 (m, 3H, H-12/13/14), 7.36 (d, J = 2.3 Hz, 
2H, H-11/15), 6.08 (s, 1H, H-3), 5.74 (s, 1H, H-5), 3.20 (d, J = 5.5 Hz, 1H, H-18), 
2.58 (d, J = 3.2 Hz, 1H, H-17), 2.49 (d, J = 5.4 Hz, 3H, H-19), 2.15 (s, 3H, H-7), 
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2.09 – 2.07 (m, 1H, H-22), 1.77 – 1.58 (m, 2H, H-21), 1.39 (d, J = 8.5 Hz, 2H, H-
20/23), 1.03 (d, J = 8.5 Hz, 2H, H-20/23). 
13
C NMR (101 MHz, CDCl3) δ 206.52 (C-
16), 174.37 (C-2), 162.98 (C-6), 162.72 (C-4), 161.98 (C-8), 148.51 (C-9), [130.87, 
130.37, 129.11, 129.07 (C-11/12/13/14/15)], 112.66 (C-3), 104.79 (C-5), 54.43 (C-
20), 51.49 (C-19), 39.78 (C-18), 38.57 (C-22), 31.77 (C-17), 29.07 (C-21), 28.76 (C-
23), 20.14 (C-7). IR (solid-state ATR, cm
-1
) 1634, 1573, 2954, 2871, 1695, 1717, 
1444, 1306, 1196, 980, 854, 695, 750. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for 
C22H21O3 333.1446; Found 333.1396. 
Lab book reference number: NPY-4-288F2 
(9aRS,10SR,13RS,13aSR)-2-Methyl-4,9,9a,10,11,12,13,13aoctahydro-10,13-
methanobenzo[h]indeno[1,2-f]isochromene-4,9-dione (113B) 
 
Synthesised following the general procedure H2; with irradiation of 113a (ca.15 
mg), in CD2Cl2 (0.6 mL) to afford to afford the desired product as a creamy solid. 
(100 % conversion by NMR).  MP 201–203 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 9.67 (dd, JHH = 7.9, 1.5 Hz, 1H, H-11), 9.28 (dd, JHH 
= 8.2, 1.4 Hz, 1H, H-14), 7.76 (ddd, JHH = 8.7, 6.9, 1.8 Hz, 1H, H-12), 7.74 – 7.69 
(m, 1H, H-13), 6.70 (s, 1H, H-5), 3.32 (d, JHH = 5.8 Hz, 1H, H-18), 2.69 (d, JHH = 
5.8 Hz, 1H, H-19), 2.66 (d, JHH = 4.0 Hz, 1H, H-17), 2.56 (d, JHH = 4.2 Hz, 1H, H-
22), 2.45 (d, JHH = 0.9 Hz, 3H, H-7), 1.85 – 1.65 (m, 4H, H-20/21), 1.00 (ddt, JHH = 
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10.8, 2.8, 1.5 Hz, 1H, H-23), 0.85 (ddt, JHH = 10.5, 3.4, 1.8 Hz, 1H, H-23). 
13
C NMR 
(101 MHz, CD2Cl2) δ 211.60 (C-16), 160.39 (C-2), 156.44 (C-6), 140.22 (C-4), 
139.99 (C-8), 133.62 (C-9), 131.49 (C-12), 131.17 (C-15), 130.85 (C-13), 130.69 
(C-10), 128.71 (C-11), 126.45 (C-3), 102.96 (C-5), 58.94 (C-19), 48.57 (C-18), 
42.86 (C-17), 42.29 (C-22), [34.29, 31.69 (C-20/21)], 30.70 (C-23), 22.15 (C-7). 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C21H18O3 331.1289; Found 331.1257. 
Elemental Analysis:  calcd C, 79.98; H, 5.49; Found C, 79.73; H, 5.47. 
Lab book reference number: NPY-3-161 
2-(2'-Tetramethylsilyl-ethynyl)pyridine (114a)
142
 
 
Following the general procedure F1; with 2-bromopyridine (1000 mg, 6.32 mmol) 
and TMS-acetylene (1367 mg, 13.94 mmol), to afford the compound as a colourless 
liquid (990 mg, 89%). 
1
H NMR (400 MHz, CDCl3) δ 8.51 (ddd, JHH = 4.9, 1.8, 1.0 Hz, 1H, H-1), 7.56 (td, 
JHH = 7.7, 1.8 Hz, 1H, H-3), 7.38 (dt, JHH = 7.8, 1.0 Hz, 1H, H-2), 7.15 (ddd, JHH = 
7.7, 4.9, 1.8 Hz, 1H, H-4), 0.22 – 0.21 (m, 9H, H-8/9/10). IR (solid-state ATR, cm-1) 
3126, 3298, 2962, 1584, 1259, 1094, 1013. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd 
for C10H14NSi 176.0851; Found 176.0821. 
Lab book reference number: NPY-3-168 
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2-Ethynylpyridine (114b)
142
 
 
Following the general procedure F1; with 114b (500 mg, 2.85 mmol), to afford the 
compound as a colourless liquid (230 mg, 81 %). 
1
H NMR (400 MHz, CDCl3) δ 8.55 (ddd, JHH = 4.8, 1.8, 1.0 Hz, 1H, H-1), 7.62 (td, 
JHH = 7.8, 1.8 Hz, 1H, H-3), 7.44 (ddt, JHH = 7.8, 1.8, 1.0 Hz, 1H, H-2), 7.23 (ddd, 
JHH = 7.7, 4.9, 1.0 Hz, 1H, H-4), 3.13 (s, 1H, H-7). 
13
C NMR (101 MHz, CDCl3) δ 
150.11 (C-1), 142.40 (C-5), 136.27 (C-3), 127.53 (C-2), 123.50 (C-4), 82.79 (C-6), 
77.21 (C-7). IR (solid-state ATR, cm
-1
) 3299, 3046, 2962, 2900, 2166, 2066, 1582, 
1562, 1461, 1427, 1250, 873. 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C7H6N 104.0456; Found 104.0425. 
Lab book reference number: NPY-3-169 
6-Methyl-4-(2-pyridilethynyl)-2-pyrone (114c)  
 
Following the general procedure F1; with 4-bromopyrone 103 (500 mg, 2.65 mmol) 
and 2-pyridilacetylene (327 mg, 3.17 mmol), to afford the compound as a Cream 
solid (490 mg, 88 % yield). MP 102–104 °C.  
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1
H NMR (400 MHz, CD2Cl2) δ 8.63 (ddd, J = 4.8, 1.7, 0.9 Hz, 1H, H-14), 7.74 (td, J 
= 7.8, 1.7 Hz, 1H, H-12), 7.56 (dt, JHH = 7.8, 1.7 Hz, 1H, H-11), 7.33 (ddd, JHH = 
7.8, 4.8, 1.7 Hz, 1H, H-13), 6.33 (d, JHH = 0.6 Hz, 1H, H-3), 6.10 (s, 1H, H-5), 2.25 
(d, JHH = 0.6 Hz, 3H, H-7).
 13
C NMR (101 MHz, CD2Cl2) δ 162.89 (C-2), 161.92 (C-
6), 150.83 (C-14), 142.07 (C-10), 138.25 (C-4), 136.71 (C-12), 128.36 (C-11), 
124.49 (C-13), 115.80 (C-3), 105.24 (C-5), 96.81 (C-9), 84.25 (C-8), 20.17 (C-7). IR 
(solid-state ATR, cm-
1
) 3068, 2214, 1704, 1632, 1579, 1537, 1461, 1430, 1312, 
1214, 1138, 1028, 961, 854, 812, 776, 739, 533. MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C13H10NO2 212.0633; Found 212.0706, Elemental Analysis:  calcd C 
73.92, H 4.29, N 6.63; Found C 72.62, H 4.17, N 6.69. 
 
Lab book reference number: NPY-3-119 
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4-(2'-Tetramethylsilyl-ethynyl)pyridine (115a)
142
 
 
Following the general procedure F1; with 4-bromopyridine (500 mg, 3.16 mmol) and 
TMS-acetylene (341 mg, 3.48 mmol), to afford the compound as a colourless liquid 
(500 mg, 90 %). 
1
H NMR (400 MHz, CDCl3) δ 7.37 (d, JHH = 4.2 Hz, 2H, H-1/5), 7.30 (d, JHH = 4.2 
Hz, 2H, H-2/4), 0.25 (s, 9H, H-8/9/10). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for 
C10H14NSi 176.0890; Found 176.0896.  Lab book reference number: NPY-5-325 
4-Ethynylpyridine (115b)
142
 
 
Following the general procedure F1; with 115a (500 mg, 2.85 mmol), to afford the 
compound as a dirty white solid (255 mg, 87 %). 
1
H NMR (400 MHz, CDCl3) δ 8.59 (dd, JHH = 4.4, 1.6 Hz, 2H, H-1/5), 7.34 (dd, JHH 
= 4.4, 1.6 Hz, 2H, H-2/4), 3.29 (s, 1H, H-7). 
13
C NMR (101 MHz, CDCl3) δ 149.96 
(C-1/5), 130.42 (C-3), 126.20 (C-2/4), 81.99 (C-6), 81.07 (C-7). IR (solid-state ATR, 
cm-1) 3044, 2097, 1590, 1539, 1402, 1217, 991, 813, 772, 745, 723, 543, 513, 469. 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C7H6N 104.0456; Found 104.0446. 
Lab book reference number: NPY-4-257 
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6-Methyl-4-(4'-pyridylethynyl)-2-pyrone (115c) 
 
Following the general procedure F1; with 4-bromopyridine 103 (500 mg, 2.65 
mmol) and 4-pyridilacetylene (327 mg, 3.17 mmol), to afford the compound as a 
Cream solid (510 mg, 91 % yield). MP 98–99 °C.  
1
H NMR (400 MHz, CDCl3) δ 8.66 (d, JHH = 5.2 Hz, 2H, H-13/14), 7.38 (dd, JHH = 
5.2, 1.5 Hz, 2H, H-11/14), 6.35 (d, JHH = 0.6 Hz, 1H, H-3), 6.05 (d, JHH = 0.6 Hz, 
1H, H-5), 2.27 (s, 3H, H-7). 
13
C NMR (101 MHz, CDCl3) δ 162.65 (C-2), 161.96 
(C-6), 149.99 (C-12/13), 125.85 (C-11/14), 115.87 (C-9), 105.20 (C-3), 94.71 (C-5), 
88.94 (C-9), 77.16 (C-8), 20.12 (C-7).IR (solid-state ATR, cm-
1
) 2213, 1707, 1632, 
1587, 1536, 1486, 1440, 1400, 1312, 1136, 1032, 959, 824, 536, 502, 555, 210. MS; 
HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C13H10NO2 212.0633; Found 212.0706, 
Elemental Analysis:  calcd C 73.92, H 4.29, N 6.63; Found C 73.87, H 4.28, N 6.63. 
 
Lab book reference number: NPY-3-182 
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2-(Tetramethylsilyl-2'-ethynyl)pyrazine (116a)
142
 
 
Following the general procedure F1; with 2-bromopyrazine (1000 mg, 6.30 mmol) 
and TMS-acetylene (1358 mg, 13.83 mmol), to afford the compound as a colourless 
liquid (1.07 g, 97 %). 
1
H NMR (400 MHz, CDCl3) δ 8.61 (d, JHH = 1.3 Hz, 1H, H-1), 8.49 (d, JHH = 2.5 
Hz, 1H, H-3), 8.38 (dd, JHH = 2.5, 1.4 Hz, 1H, H-2), 0.28 (s, 9H, H-7/8/9). IR (solid-
state ATR, cm-
1
) 3064, 2960, 2899, 1459, 1391, 1249, 1141, 1011, 839, 760 MS; 
HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C9H13N2Si 177.0803; Found 177.0779. 
Lab book reference number: NPY-4-213 
2-Ethynylpyrazine (116b)
142
 
 
Following the general procedure F1; with 116a (500 mg, 2.84 mmol), to afford the 
compound as a colourless liquid (260 mg, 88 %). 
1
H NMR (400 MHz, CDCl3) δ 8.71 (d, JHH = 1.4 Hz, 1H, H-1), 8.56 (dd, JHH = 2.5, 
1.4 Hz, 1H, H-2), 8.52 (d, JHH = 2.5 Hz, 1H, H-3), 3.35 (s, 1H, H-6). IR (solid-state 
ATR, cm-
1
) 3242, 3217, 2109, 1459, 1380, 1143, 1049, 1013, 850, 735, 695, 672, 
529.MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C6H5N2 105.0408; Found 105.0404. 
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6-Methyl-4-(2'-pyrazylethynyl)-2-pyrone (116c)  
 
Following the general procedure F1; with 2-bromopyrone 103 (1.0 g, 5.29 mmol) 
and 2-pyrazylacetylene (66 mg, 6.35 mmol), to afford the compound as a creamy 
solid (0.98 g, 87 %). MP 97–99 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.77 (d, JHH = 1.5 Hz, 1H, H-11), 8.62 (dd, JHH = 
2.4, 1.5 Hz, 1H, H-12), 8.58 (d, JHH = 2.5 Hz, 1H, H-13), 6.40 (d, JHH = 0.5 Hz, 1H, 
H-3), 6.09 (s, JHH = 1.1 Hz, 1H, H-5), 2.26 (s, 3H, H-7). 
13
C NMR (101 MHz, 
CD2Cl2) δ 162.77 (C-2), 161.72 (C-6), 148.25 (C-11), 144.95 (C-12), 144.37 (C-13), 
138.71 (C-10), 137.22 (C-10), 116.29 (C-3), 104.85 (C-5), 93.32 (C-9), 87.89 (C-8), 
20.14 (C-7). IR (solid-state ATR, cm-
1
) 3088, 1709, 1628, 1533, 1464, 1381, 1315, 
1315, 1139, 1012, 858, 536, 510, 409. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for 
C12H9N2O2 213.0586; Found 213.0596. 
Lab book reference number: NPY-4-215 
2-(Tetramethylsilyl-2'-ethynyl)thiophene (117a)
142
 
 
Following the general procedure F1; with 2-bromothiophene (1000 mg, 6.14 mmol) 
and TMS-acetylene (1.325 g, 13.49 mmol), to afford the compound as a colourless 
liquid (530 mg, 48 %). 
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1
H NMR (400 MHz, CD2Cl2) δ 7.25 (dd, JHH = 5.2, 1.1 Hz, 1H, H-1), 7.21 (dd, JHH = 
3.6, 1.1 Hz, 1H, H-3), 6.95 (dd, JHH = 5.2, 3.6 Hz, 1H, H-2), 0.22 (s, 9H, H-7/8/9). 
MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C9H13SSi 181.0463; Found 181.0459. 
Lab book reference number: NPY-4-232 
6-Methyl-4-(2-thienylethynyl)-2-pyrone (117c) 
 
Following the general procedure F1; with 4-bromopyrone 103 (500 mg, 2.65 mmol) 
and 2-ethynylthiophene (343 mg, 3.17 mmol), to afford the compound as a cream 
solid (360 mg, 63 % yield). MP 61–62 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 7.43 (dd, JHH = 5.2, 1.1 Hz, 1H, H-13), 7.38 (dd, JHH 
= 3.7, 1.1 Hz, 1H, H-11), 7.06 (dd, JHH = 5.1, 3.7 Hz, 1H, H-12), 6.26 (d, JHH = 0.6 
Hz, 1H, H-3), 6.03 (s, JHH = 0.6 Hz, 1H, H-5), 2.25 (s, 3H, H-7).
 13
C NMR (101 
MHz, CD2Cl2) δ 162.29 (C-2), 162.13 (C-6), 138.68 (C-4), 134.59 (C-11), 130.17 
(C-13), 127.72 (C-12), 121.22 (C-10), 113.92 (C-3), 105.08 (C-5), 92.26 (C-9), 
89.53 (C-8), 20.07 (C-7). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C12H9O2S 
217.0245; Found 217.0343, Elemental Analysis: calcd C 66.65, H 3.73, N 6.63; 
Found C 66.45, H 3.73. 
Lab book reference number: NPY-4-240F1F2F1 
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[4-(2'-Thienylethynyl)pyridine] (118) 
 
Following the general procedure F1; with 2-bromothiophene (500 mg, 3.07 mmol) 
and 4-pyridilacetylene (380 mg, 3.68 mmol), to afford the compound as a cream 
solid (330 mg, 58 % yield). MP 58–62 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.60 (dd, JHH = 4.6, 1.4 Hz, 1H, H-1/5), 7.39 – 7.34 
(m, 4H, H-2/4/9/11), 7.05 (dd, JHH = 5.1, 3.7 Hz, 2H, H-10). 
13
C NMR (101 MHz, 
CD2Cl2) δ 149.59 (C-1/5), 133.90 (C-11), 131.93 (C-5), 129.38 (C-2/4), 127.86 (C-
10), 125.68 (C-9), 122.20 (C-8), 90.61 (C-7), 87.88 (C-6). IR (solid-state ATR, cm-
1
) 3071, 2200, 1694, 1589, 1404, 1208, 1007, 818, 705, 540, 504. MS; HRMS (ESI
+
) 
m/z: [M + H]
+
 calcd for C11H8NS 186.0299; Found 186.0381. 
Lab book reference number: NPY-4-224 
[2-(2'-Thienylethynyl)pyridine] (119)
143
 
 
Following the general procedure F1; with 2-bromothiophene (700 mg, 4.30 mmol) 
and 2-ethenylpyridine (531 mg, 5.15 mmol), to afford the compound as a Cream 
solid (562 mg, 71 % yield). MP 56–59 °C.  
1
H NMR (400 MHz, CDCl3) δ 8.60 (ddt, JHH = 4.9, 1.8, 0.8 Hz, 1H, H-1), 7.66 (tdd, 
JHH = 7.8, 1.8, 0.8 Hz, 1H, H-3), 7.49 (dd, JHH = 7.8, 0.8 Hz, 1H, H-4), 7.39 – 7.36 
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(m, 1H, H-11), 7.33 (dt, JHH = 5.1, 1.0 Hz, 1H, H-9), 7.22 (dd, JHH = 7.8, 4.9 Hz, 1H, 
H-2), 7.01 (ddd, JHH = 5.1, 3.6, 1.0 Hz, 1H, H-10). 
13
C NMR (101 MHz, CDCl3) δ 
150.24 (C-1), 143.34 (C-3), 136.29 (C-5), 133.43 (C-11), 128.49 (C-9), 127.33 (C-
4), 127.02 (C-10), 122.90 (C-2), 122.33 (C-8), 92.41 (C-6), 82.79 (C-7). IR (solid-
state ATR, cm
-1
) 3077, 2202, 1666, 1642, 1631, 1577, 1558, 1458, 1414, 1275, 
1211, 1151, 1043, 986, 835, 775, 706, 568, 502. MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C11H8NS 186.0299; Found 186.0372. 
Lab book reference number: NPY-4-255 
 [2-(4'-Pyridylethynyl)pyridine] (120)
144
 
 
Following the general procedure F1; with 4-bromopyridine (200 mg, 1.27 mmol) and 
2-ethenylpyridine (157 mg, 1.52 mmol), to afford the compound as a cream solid 
(194 mg, 85 % yield). MP 83–86 °C. 
1
H NMR (400 MHz, CDCl3) δ 8.35 (ddd, JHH = 4.9, 2.0, 1.0 Hz, 2H, H-1/5), 7.53 
(ddd, JHH = 8.0, 7.2, 2.0 Hz, 2H, H-11/12), 7.46 (dt, JHH = 8.0, 1.0 Hz, 2H, H-10/13), 
7.24 (ddd, JHH = 7.2, 4.9, 1.0 Hz, 2H, H-2/4). 
13
C NMR (101 MHz, CDCl3) δ 150.34 
(C-1/5), 142.37 (C-6/9), 138.57 (C-11/12), 134.00 (C-8), 128.72 (C-7), 128.35 (C-
10/13), 122.71 (C-2/4). IR (solid-state ATR, cm
-1
) 3041, 1593, 1576, 1460, 1408, 
987, 825, 776, 736, 545, 508. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C12H9N2 
181.0687; Found 181.0768. 
Lab book reference number: NPY-4-282 
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()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-pyridyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (121)  
 
Synthesised following the general procedure G; with 114c (55 mg, 0.26 mmol), to 
afford to afford the desired product as a creamy solid (84 mg, 95 % yield). MP 107–
110 °C.   
1
H NMR (400 MHz, CDCl3) δ 8.71 (d, JHH = 4.2 Hz, 1H, H-14), 7.69 (td, JHH = 7.8, 
1.8 Hz, 1H, H-13), 7.35 – 7.28 (m, 2H, H-12/14), 6.02 (s, 1H, H-3), 5.77 (s, 1H, H-
5), 3.42 (d, JHH = 5.4 Hz, 1H, H-17), 2.58 (d, JHH = 2.1 Hz, 1H, H-16), 2.50 (d, JHH = 
5.3 Hz, 1H, H-18), 2.20 (d, JHH = 3.2 Hz, 1H, H-21), 2.17 (s, 3H, H-7), 1.73 – 1.58 
(m, 2H, H-19), 1.49 – 1.34 (m, 2H, H-20), 1.14 (d, JHH = 10.7 Hz, 1H, H-22), 1.04 
(d, JHH = 10.7 Hz, 1H, H-22). 
13
C NMR (101 MHz, CDCl3) δ 207.19 (C-15), 172.34 
(C-2), 162.85 (C-6), 162.06 (C-4), 152.75 (C-8), 150.45 (C-14), 148.58 (C-9), 
140.26, 136.56 (C-12), 124.64 (C-11/13), 112.50 (C-3), 104.84 (C-5), 54.42 (C-18), 
50.71 (C-17), 40.00 (C-16), 38.64 (C-19), 31.79 (C-22), 29.18, 28.64 (C-20), 20.16 
(C-7). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C21H20NO3 334.1365; Found 
334.1443, Elemental Analysis:  calcd C 75.66, H 5.74, N 4.20; Found C 74.96, H 
5.72, N 4.13. 
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Lab book reference number: NPY-3-160 
(9aRS,10SR,13RS,13aSR)-7-Pyridyl-2-methyl-4,9,9a,10,11,12,13,13a-octahydro-
10,13- methanobenzo[h]indeno[1,2-f]isochromene-4,9-dione (121B) 
 
Synthesised following the general procedure H2; with irradiation of 121A (ca.15 
mg), in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a 
creamy solid (100 % conversion by NMR).  MP 197–199 °C.  
1
H NMR (700 MHz, CD2Cl2) δ 10.00 (dd, JHH = 8.7, 1.6 Hz, 1H, H-14), 9.05 (dd, 
JHH = 4.1, 1.6 Hz, 1H, H-12), 7.90 (d, JHH = 0.9 Hz, 1H, H-5), 7.74 (dd, JHH = 8.7, 
4.1 Hz, 1H, H-13), 3.77 (d, JHH = 5.8 Hz, 1H, H-17), 2.90 (d, JHH = 3.3 Hz, 1H, H-
16), 2.67 (d, JHH = 5.7 Hz, 1H, H-18), 2.62 (d, JHH = 3.3 Hz, 1H, H-21), 2.41 (d, JHH 
= 0.6 Hz, 3H, H-7), 1.83 – 1.77 (m, 1H, H-19), 1.73 – 1.67 (m, 2H, H-19/20), 1.51 – 
1.46 (m, 1H, H-20), 0.99 (d, JHH = 10.7 Hz, 1H, H-22), 0.83 (d, JHH = 10.7 Hz, 1H, 
H-22).
 13
C NMR (101 MHz, CD2Cl2) δ 211.60 (C-16), 160.39 (C-2), 156.44 (C-6), 
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140.22 (C-4), 139.99 (C-8), 133.62 (C-9), 131.49 (C-12), 131.17 (C-15), 130.85 (C-
13), 130.69 (C-10), 128.71 (C-11), 126.45 (C-3), 102.96 (C-5), 58.94 (C-19), 48.57 
(C-18), 42.86 (C-17), 42.29 (C-22), [34.29, 31.69 (C-20/21)], 30.70 (C-23), 22.15 
(C-7). IR (solid-state ATR, cm-
1
) 2951, 2870, 1693, 1644, 1556, 1499, 1346, 1294, 
1186, 1134, 1049, 994, 855, 795, 759, 565, 730. MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C21H18NO3 332.1242; Found 332.1209. Elemental Analysis:  calcd C, 
76.12; H, 5.17; N; 4.23,; Found C, 76.01; H, 5.23; N; 4.26. 
Lab book reference number: NPY-3-160 
[2-6-Methyl-4-(2-(2-pyridylethynyl))-2H-pyran-2-one]-hexacarbonyl dicobalt 
(121I) 
 
Following the general procedure F3; dicobaltoctacarbonyl (324 mg, 0.95 mmol) and 
the alkyne (200 mg, 0.95 mmol) to afford the complex as brownish crystals (410 mg, 
86 % yield) MP 86–88 oC.  
 1
H NMR (400 MHz, CDCl3) δ 8.63 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H, H-14), 7.71 (td, 
JHH = 7.7, 1.8 Hz, 1H, H-12), 7.52 (dt, JHH = 7.8, 1.0 Hz, 1H, H-11), 7.25 – 7.22 (m, 
1H, H-2), 6.62 (d, JHH = 0.9 Hz, 1H, H-3), 6.28 (s, JHH = 0.9 Hz, 1H, H-5), 2.29 (s, 
3H, H-7). MS; LRMS (LIFDI) m/z: [M + H]
+
 calcd for C19H16Co2NO8 503.94; 
Found 503.93. 
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Lab book reference number: NPY-5-293 
(β)-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(4-pyridyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (122) 
 
Synthesised following the general procedure G; with 115c (200 mg, 0.95 mmol), to 
afford to afford the desired product as a creamy solid (313 mg, 99 % overall yield) 
(mixture of 50/50 regioisomers by 
1
H NMR). MP 114–120 °C.  
1
H NMR (400 CDCl3) δ 8.77 – 8.67 (br. s, 2H, H-12/13), 7.21 (d, JHH = 5.9 Hz, 2H, 
H-11/14), 6.17 (s, 1H, H-3), 6.01 (s, 1H, H-5), 3.14 (d, JHH = 5.4 Hz, 1H, H-17), 
2.64 – 2.57 (m, 1H, H-18), 2.22 (d, JHH = 3.5 Hz, 1H, H-16), 2.14 (s, 3H, H-7), 2.07 
(d, JHH = 3.5 Hz, 1H, H-21), 1.78 – 1.59 (m, 2H, H-20), 1.39 (d, JHH = 8.4 Hz, 1H, 
H-19/22), 1.09 (d, JHH = 9.0 Hz, 1H, H-19/22). 
13
C NMR (101 MHz, CD2Cl2) δ 
206.68 (C-15), 166.99 (C-2), 163.42 (C-6), 162.68 (C-4), 150.88 (C-12/13), 150.26 
(C-8), 143.27 (C-9), 138.63 (C-10), 123.94 (C-11/14), 104.39 (C-3), 103.18 (C-5), 
54.38 (C-18), 51.00 (C-17), 40.21 (C-18), 38.35 (C-21), 31.88 (C-19), 29.15 (C-20), 
28.78 (C-22), 20.29 (C-7). IR (solid-state ATR, cm-
1
) 2953, 2872, 1698, 1636, 1590, 
1542, 1406, 1307, 1196, 982, 836, 855, 539, 656. MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C21H20NO3 334.1365; Found 334.1434, Elemental Analysis:  calcd C 
75.59, H 5.73, N 4.21; Found C 75.96, H 5.72, N 4.13. 
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Lab book reference number: NPY-4-241 
(α)-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-2-(4-pyridyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-3-yl)-2H-pyran-2-one (122) 
 
Synthesised following the general procedure G; with 115c (200 mg, 0.95 mmol), to 
afford to afford the desired product as a creamy solid (313 mg, 99 % overall yield) 
(mixture of 50/50 regioisomers by 
1
H NMR).  
1
H NMR (400 MHz, CDCl3) δ 8.66 – 8.75 (br. s, 2H, H-12/13), 7.16 (d, JHH = 5.1 
Hz, 1H, H-11/14), 5.70 (s, 1H, H-3), 5.58 (s, 1H, H-5), 3.00 (d, JHH = 5.4 Hz, 1H, H-
17), 2.64 – 2.58 (m, 1H, H-16), 2.54 – 2.48 (m, 1H, H-18), 2.16 (s, 3H, H-7), 2.07 
(d, JHH = 3.7 Hz, 1H, H-21), 1.77 – 1.60 (m, 2H, H-20), 1.39 (d, JHH = 8.5 Hz, 2H, 
H-19/22), 1.09 (d, JHH = 8.5 Hz, 2H, H-19/22). 
13
C NMR (101 MHz, CD2Cl2) δ 
206.05 (C-15), 170.81 (C-2), 162.45 (C-4), 151.04 (C-12/13), 147.57 (C-8), 141.99 
(C-9), 22.47 (C-11/14), 112.87 (C-3), 111.72 (C-5), 54.38 (C-18), 51.47 (C-17), 
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40.21 (C-21), 38.57 (C-16), 31.88 (C-19), 29.15 (C-20), 28.78 (C-22), 20.20 (C-7). 
IR (solid-state ATR, cm
-1
) 2953, 2872, 1698, 1636, 1590, 1542, 1406, 1307, 1196, 
982, 836, 855, 539, 656. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C21H20NO3 
333.1365; Found 334.1434, Elemental Analysis: calcd C 75.59, H 5.73, N 4.21; 
Found C 75.96, H 5.72, N 4.13. 
Lab book reference number: NPY-4-241 
(9aRS,10SR,13RS,13aSR)-5-Pyridyl-2-methyl-4,9,9a,10,11,12,13,13a-octahydro-
10,13-methanobenzo[h]indeno[1,2-f ]isochromene-4,9-dione (-122B) 
 
Synthesised following the general procedure H2; with irradiation of -124A (15 
mg), in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a 
creamy solid (100 % conversion by NMR).  MP 211–213 °C.  
1
H NMR (700 MHz, CD2Cl2) δ 10.00 (dd, JHH = 8.8, 1.6 Hz, 1H, H-14), 9.05 (dd, 
JHH = 4.1, 1.6 Hz, 1H, H-12), 7.90 (d, JHH = 0.9 Hz, 1H, H-5), 7.74 (dd, JHH = 8.8, 
4.1 Hz, 1H, H-13), 3.77 (d, JHH = 5.8 Hz, 1H, H-16), 2.90 (d, JHH = 3.8 Hz, 1H, 
H-15), 2.67 (d, JHH = 5.8 Hz, 1H, H-17), 2.62 (d, JHH = 3.8 Hz, 1H, H-20), 2.41 (d, 
JHH = 0.6 Hz, 3H, H-7), 1.86 – 1.76 (m, 2H, H-19), 1.73 – 1.63 (m, 1H, H-20), 1.53 
– 1.44 (m, 1H, H-20), 0.99 (d, JHH = 10.7 Hz, 1H, H-22), 0.83 (d, JHH = 10.7 Hz, 1H, 
H-22). 
13
C NMR (101 MHz, CD2Cl2) δ 208.88 (C-15), 167.76 (C-9), 161.70 (C-2), 
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160.30 (C-6), 150.48 (C-12), 145.22 (C-8), 137.47 (C-10), 135.28 (C-14), 133.07 
(C-4), 131.39 (C-11), 125.93 (C-13), 113.21 (C-3), 100.16 (C-5), 56.78 (C-18), 
47.26 (C-17), 41.16 (C-21), 40.91 (C-16), 32.61 (C-22), 29.87 (C-19), 28.92 (C-20), 
20.25 (C-7). IR (solid-state ATR, cm-
1
) 2956, 2871, 1705, 1646, 1601, 1538, 1498, 
1414, 1349, 1296, 1184, 948, 853, 565, 508. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd 
for C21H18NO3 333.1320; Found 333.1297.  
Lab book reference number: NPY-4-241cyc. 
(9aRS,10SR,13RS,13aSR)-5-pyridyl-2-methyl-4,9,9a,10,11,12,13,13a-octahydro-
10,13- methanobenzo[h]indeno[1,2-f ]isochromene-4,9-dione ( -122B) 
 
Synthesised following the general procedure H2; with irradiation of -124A (ca.15 
mg), in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a 
creamy solid (100 % conversion by NMR).  MP 211–213 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 10.93 (s, 1H, H-12), 8.84 (d, JHH = 5.5 Hz, 1H, 
H-13), 8.03 (d, JHH = 5.5 Hz, 1H, H-14), 7.89 (s, 1H, H-5), 3.57 (d, JHH = 5.8 Hz, 
1H, H-17), 2.72 (d, JHH = 5.8 Hz, 3H, H-18), 2.65 (d, JHH = 3.6 Hz, 1H, H-16), 2.58 
(d, JHH = 3.6 Hz, 1H, H-21), 2.42 (s, 3H, H-7), 1.89 – 1.71 (m, 2H, H-19), 1.68 – 
1.45 (m, 2H, H-20), 1.03 (d, JHH = 10.8 Hz, 1H, H-22), 0.83 (d, JHH = 10.8 Hz, 1H, 
H-22). 
13
C NMR (101 MHz, CD2Cl2) δ 208.46 (C-15), 168.68 (C-8), 167.14 (C-9), 
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160.68 (C-2), 159.65 (C-6), 158.66 (C-11), 150.57 (C-12), 146.61 (C-14), 139.69 
(C-4), 138.85 (C-10), 131.20 (C-3), 116.75 (C-13), 100.82 (C-5), 56.925 (C-18), 
47.15 (C-17), 40.88 (C-21), 40.29 (C-16), 32.40 (C-19), 29.72 (C-20), 28.63 (C-22), 
20.25 (C-7). IR (solid-state ATR, cm
-1
) 2956, 2871, 1705, 1646, 1601, 1538, 1498, 
1414, 1349, 1296, 1184, 948, 853, 565, 508. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd 
for C21H18NO3 333.1320; Found 333.1297.  
Lab book reference number: NPY-4-241cyc. 
-6-methyl-4-(2-(4-pyridylethynyl))-2H-pyran-2-one]-hexacarbonyl dicobalt 
(122I)
 
Following the general procedure F1; dicobaltoctacarbonyl (324 mg, 0.95 mmol) and 
the alkyne (200 mg, 0.95 mmol) to afford the complex as brownish crystals (350 mg, 
70 % yield). M.P 87–88 oC.  
1
H NMR (400 MHz, CDCl3) δ 8.63 (s, 2H, H-12/13), 7.32 (s, 2H, H-11/14), 6.33 (s, 
1H, H-3), 5.89 (s, 1H, H-5), 2.28 (s, 3H, H-7). MS; LRMS (LIFDI) m/z: [M + H]
+
 
calcd for C19H16Co2NO8 503.95; Found 503.95. 
Lab book reference number: NPY-5-290 
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(β)-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-pyrazyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (123) 
 
Synthesised following the general procedure G; with 116c (200 mg, 0.94 mmol), to 
afford to afford the desired product as a creamy solid (250 mg, 79 % overall yield). 
MP 110–111 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.69 (dd, JHH = 2.3, 1.6 Hz, 1H, H-12), 8.63 (d, JHH 
= 1.6 Hz, 1H, H-11), 8.56 (d, JHH = 2.3 Hz, 1H, H-13), 5.99 (d, JHH = 0.6 Hz, 1H, H-
3), 5.71 (s, 1H, H-5), 3.40 (d, JHH = 5.5 Hz, 1H, H-16), 2.55 (d, JHH = 3.6 Hz, 1H, H-
15), 2.51 (d, JHH = 5.5 Hz, 1H, H-17), 2.25 (d, JHH = 3.6 Hz, 1H, H-20), 2.18 (s, 3H, 
H-7), 1.75 – 1.61 (m, 2H18), 1.49 – 1.37 (m, 2H, H-19), 1.14 (d, JHH = 10.8 Hz, 1H, 
H-21), 1.06 (d, JHH = 10.8 Hz, 1H, H-21). 
13
C NMR (101 CD2Cl2) δ 206.64 (C-14), 
194.12 (C-2), 168.15 (C-6), 162.86 (C-4), 162.49 (C-8), 148.42 (C-4), 145.58 (C-
11/13), 145.22 (C-12), 141.85 (C-10), 112.63 (C-3), 104.62 (C-5), 54.66 (C-17), 
50.42 (C-16), 40.36 (C-15), 39.14 (C-20), 31.95 (C-18), 29.39 (C-19), 28.78 (C-21), 
20.28 (C-7). IR (solid-state ATR, cm-
1
) 2954, 2873, 1698, 1716, 1639, 1612, 1540, 
1446, 1394, 866, 1014, 1138, 1198, 1206, 1314, 1335. MS; HRMS (ESI
+
) m/z: [M + 
H]
+
 calcd for C20H19N2O3 334.1317; Found 335.1374, Elemental Analysis:  calcd C 
71.84, H 5.43, N 8.38; Found C 70.11, H 5.12, N 8.39. 
Lab book reference number: NPY-4-219 
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-6-methyl-4-(2-(2-pyrazinethynyl))-2H-pyran-2-one]-hexacarbonyl dicobalt 
(123I)
  
Following the general procedure F3; dicobaltoctacarbonyl (324 mg, 0.95 mmol) and 
the alkyne (200 mg, 0.95 mmol) to afford the complex as brownish crystals (430 mg, 
91 % yield) M.P 86–88 oC.   
1
H NMR (400 MHz, CDCl3) δ 8.77 (d, JHH = 1.3 Hz, 1H, H-12), 8.60 (dd, JHH = 2.4, 
1.5 Hz, 1H, H-11), 8.52 (d, JHH = 2.4 Hz, 1H, H-10), 6.56 (s, 1H, H-3), 6.16 (s, 1H, 
H-5), 2.29 (s, 3H, H-7). MS; LRMS (LIFDI) m/z: [M + H]
+
 calcd for 
C18H15Co2N2O8 504.94; Found 504.94. 
Lab book reference number: NPY-5-291 
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()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-thienyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (124) 
 
Synthesised following the general procedure G; with 117c (100 mg, 0.46 mmol), to 
afford to afford the desired product as a creamy solid (85 mg, 54 % yield). MP 85 - 
87 °C.  
1H NMR (400 MHz, ) δ 7.41 (dd, JHH = 5.1, 1.1 Hz, 1H, H-13), 7.34 (dd, JHH = 3.7, 
1.1 Hz, 1H, H-11), 7.03 (dd, JHH = 5.1, 3.7 Hz, 1H, H-12), 6.18 (d, JHH = 0.6 Hz, 1H, 
H-3), 5.86 (s, 1H, H-5), 2.91 (d, JHH = 5.5 Hz, 1H, H-16), 2.53 (d, JHH = 3.7 Hz, 1H, 
H-15), 2.45 (d, JHH = 5.5 Hz, 1H, H-17), 2.23 (d, JHH = 0.6 Hz, 3H, H-7), 1.73 – 1.58 
(m, 3H, H-18/20), 1.41 – 1.30 (m, 2H, H-19), 1.09 (d, JHH = 10.8 Hz, 1H, H-20), 
1.05 (d, JHH = 10.7 Hz, 2H, H-20). 
13C NMR (101 MHz, ) δ 206.74 (C-14), 163.60 
(C-2), 162.38 (C-6), 162.37 (C-4), 153.16 (C-8), 137.46 (C-9), 130.86 (C-10), 
128.90 (C-13), 128.37 (C-12), 127.18 (C-11), 111.04 (C-3), 103.26 (C-5), 54.07 (C-
16), 51.67 (C-15), 40.08 (C-14), 38.19 (C-19), 31.83 (C-17), 29.00 (C-18), 28.74 (C-
20), 20.32 (C-7). IR (solid-state ATR, cm-
1
) 3099, 2954, 2871, 1724, 1698, 1637, 
1540, 1424, 1296, 1215, 980, 848, 706, 1137, 1046. MS; HRMS (ESI
+
) m/z: [M + 
H]+ calcd for C20H18O3S 338.0977; Found 339.1062, Elemental Analysis:  calcd C 
70.98, H 5.36,; Found C 69.56, H 5.23. 
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Lab book reference number: NPY-5-300 
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()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-thienyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (124) 
 
 
Synthesised following the general procedure G; with 117c (100 mg, 0.46 mmol), to 
afford to afford the desired product as a creamy solid (19 mg, 12 % yield). MP 90–
93 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 7.61 (dd, JHH = 5.1, 1.1 Hz, 1H, H-13), 7.49 (dd, JHH 
= 3.8, 1.1 Hz, 1H, H-11), 7.14 (dd, JHH = 5.1, 3.8 Hz, 1H, H-12), 6.08 (d, JHH = 0.6 
Hz, 1H, H-5), 5.83 (s, JHH = 1.1 Hz, 1H, H-3), 3.16 (d, JHH = 5.6 Hz, 1H, H-15), 2.51 
– 2.45 (m, 3H, H-14/16/19), 2.23 (s, 3H, H-7), 1.80 – 1.63 (m, 2H, H-17), 1.54 – 
1.35 (m, 2H, H-18), 1.16 (d, JHH = 7.1 Hz, 1H, H-20), 1.09 (d, JHH = 10.7 Hz, 1H, H-
20). 
13
C NMR (101 MHz, CD2Cl2) δ 205.70 (C-14), 163.26 (C-2), 163.08 (C-6), 
162.69 (C-4), 149.95 (C-8), 136.93 (C-9), 136.63 (C-10), 132.13 (C-13), 132.09 (C-
11), 128.39 (C-12), 113.35 (C-3), 105.00 (C-5), 54.83 (C-17), 51.43 (C-16), 40.91 
(C-15), 39.72 (C-19), 32.33 (C-17), 29.46 (C-18), 28.81 (C-20), 20.30 (C-20). IR 
(solid-state ATR, cm-
1
) beta; 3083, 2962, 2870, 1735, 1690, 1538, 1419, 1295, 1197, 
980, 861, 714. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C20H19O3S 338.0977; 
Found 339.1070, Elemental Analysis:  calcd C 70.98, H 5.36,; Found C 70.56, H 
5.37.  
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Lab book reference number: NPY-5-300 
(9aRS,10SR,13RS,13aSR)-6-thienyl-2-methyl-4,9,9a,10,11,12,13,13a-octahydro-
10,13- methanobenzo[h]indeno[1,2-f ]isochromene-4,9-dione (-124B) 
 
Synthesised following the general procedure H2; with irradiation of -124A (15 mg), 
in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a creamy 
solid (100 % conversion by NMR).  MP 138–141 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.58 (d, JHH = 5.5 Hz, 1H, H-13), 7.85 (d, JHH = 5.5 
Hz, 1H, H-12), 6.66 (s, 1H, H-5), 3.42 (d, JHH = 5.8 Hz, 1H, H-16), 2.73 (d, JHH = 
5.8 Hz, 1H, H-15), 2.67 (d, JHH = 3.7 Hz, 1H, H-17), 2.58 (d, JHH = 3.9 Hz, 1H, H-
20), 2.42 (d, JHH = 1.0 Hz, 3H, H-7), 1.81 (ddd, JHH = 15.4, 8.3, 4.1 Hz, 1H, H-18), 
1.71 (ddd, JHH = 11.7, 9.8, 3.9 Hz, 1H, H-18), 1.65 – 1.57 (m, 1H, H-19), 1.52 – 1.43 
(m, 1H, H-19), 1.01 (d, JHH = 10.8 Hz, 1H, H-21), 0.81 (d, JHH = 10.8 Hz, 1H H-21). 
13
C NMR (101 MHz, CD2Cl2) δ 207.40 (C-14), 156.57 (C-8), 150.25 (C-9), 139.60 
(C-4), 139.44 (C-10), 137.76 (C-2), 136.70 (C-6), 134.93 (C-11), 131.60 (C-12), 
124.57 (C-13), 117.85 (C-3), 100.59 (C-5), 56.86 (C-17), 47.88 (C-16), 40.71 (C-
20), 40.46 (C-15), 32.60 (C-21), 29.42 (C-18), 28.78 (C-19), 20.13 (C-7). MS; 
HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C20H17O3S 337.0854; Found 337.0823. 
Lab book reference number: NPY-5-300 Cyc. 
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(9aRS,10SR,13RS,13aSR)-6-thienyl-2-methyl-4,9,9a,10,11,12,13,13a-octahydro-
10,13- methanobenzo[h]indeno[1,2-f]isochromene-4,9-dione ( -124B) 
 
Synthesised following the general procedure H2; with irradiation of -124A (15 
mg), in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a 
creamy solid (100 % conversion by NMR). MP 147–148 °C.  
1
H NMR (400 MHz, CDCl3) δ 8.64 (d, JHH = 5.5 Hz, 1H, H-13), 7.84 (d, JHH = 5.5 
Hz, 1H, H-12), 6.63 (s, 1H, H-5), 3.41 (d, JHH = 5.7 Hz, 1H, H-15 ), 2.78 – 2.72 (m, 
2H, H-14/16), 2.59 (d, JHH = 3.9 Hz, 1H, H-19), 2.44 (s, 3H, H-7), 1.83 (tt, JHH = 
11.3, 4.1 Hz, 1H, H-17), 1.77 – 1.67 (m, 1H, H-17), 1.65 – 1.59 (m, 1H, H-18), 1.53 
– 1.44 (m, 1H, H-18), 1.03 (d, JHH = 10.9 Hz, 1H, H-20), 0.85 (d, JHH = 10.9 Hz, 1H, 
H-20). 
13C NMR (101 MHz, ) δ 207.04 (C-14), 156.21 (C-8), 149.82 (C-9), 139.05 
(C-2), 137.40 (C-6), 136.30 (C-10), 134.56 (C-4), 132.26 (C-11), 131.24 (C-12), 
124.21 (C-13), 117.48 (C-3), 100.23 (C-5), 56.51 (C-17), 47.52 (C-16), 40.34 (C-
15), 40.10 (C-20), 32.23 (C-21), 29.10 (C-18), 28.41 (C-19), 19.77 (C-7). HRMS 
(ESI
+
) m/z: [M + H]
+
 calcd for C20H17O3S 337.0854; Found 337.0842. 
Lab book reference number: NPY-5-300 Cyc. 
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()-(3aSR,4RS,7SR,7aRS)-2-thienyl-3-(2-pyridyne-4-yl)-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-one (125) 
 
Synthesised following the general procedure G; with 119 (30 mg, 0.16 mmol), to 
afford to afford the desired product as a creamy solid (29 mg, 58 % yield). MP 115–
117 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.75 (ddd, JHH = 4.8, 1.6, 1.1 Hz, 1H, H-1), 7.67 (td, 
JHH = 7.8, 2.3 Hz, 1H, H-3), 7.35 (dt, JHH = 7.8, 1.1 Hz, 1H, H-2), 7.32 (td, JHH = 
2.3, 1.1 Hz, 1H, H-4), 7.30 (dd, JHH = 5.1, 1.0 Hz, 1H, H-11), 7.14 (dd, JHH = 3.7, 
1.0 Hz, 1H, H-9), 6.96 (dd, JHH = 5.1, 3.7 Hz, 1H, H-10), 3.28 (d, JHH = 5.5 Hz, 1H, 
H-14), 2.54 (d, JHH = 3.2 Hz, 1H, H-13), 2.47 (d, JHH = 5.5 Hz, 1H, H-15), 2.17 (d, 
JHH = 3.2 Hz, 1H, H-18), 1.67 – 1.60 (m, 2H, H-16), 1.42 – 1.34 (m, 2H, H-17), 1.21 
(d, JHH = 10.6 Hz, 1H, H-19), 1.02 (d, JHH = 10.6 Hz, 1H, H-19). 
13
C NMR (101 
MHz, CD2Cl2) δ 208.12 (C-12), 168.17 (C-6), 155.34 (C-7), 150.57 (C-1), 136.76 
(C-5), 136.54 (C-3), 132.24 (C-8), 128.08 (C-9), 127.23 (C-4), 126.97 (C-10), 
124.38 (C-2), 123.99 (C-11), 54.20 (C-15), 51.57 (C-14), 40.21 (C-13), 38.56 (C-
18), 31.89 (C-16), 29.22 (C-17), 28.95 (C-19). IR (solid-state ATR, cm-
1
) 3085, 
2959, 2870, 1736, 1692, 1640, 1538, 1420, 1296, 1211, 980, 861, 713. MS; HRMS 
(ESI
+
) m/z: [M + H]
+
 calcd for C19H18NOS 307.1031; Found 308.1103, Elemental 
Analysis: calcd C 74.23, H 5.57, N 4.56; Found C 74.33, H 5.58, N 4.55. 
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Lab book reference number: NPY-5-301 
()-(3aSR,4RS,7SR,7aRS)-2-Thienyl-3-(2-pyridyne-4-yl)-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-one(125)  
 
Synthesised following the general procedure G; with 119 (30 mg, 0.16 mmol), to 
afford to afford the desired product as a creamy solid (15 mg, 30 % yield).  MP 123–
126 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.69 (ddd, JHH = 4.9, 1.8, 1.2 Hz, 1H, H-1), 7.79 (td, 
JHH = 7.7, 1.8 Hz, 1H, H-3), 7.43 (ddd, JHH = 4.9, 4.4, 1.1 Hz, 2H, H-9/11), 7.34 – 
7.31 (m, 1H, H-2, H-2/4), 7.30 (dt, JHH = 8.0, 0.9 Hz, 1H, H-10), 3.23 (d, JHH = 5.5 
Hz, 1H, H-14), 2.54 (d, JHH = 3.2 Hz, 1H, H-13), 2.51 (d, JHH = 5.5 Hz, 1H, H-15), 
2.50 (d, JHH = 3.2 Hz, 1H, H-18), 1.82 – 1.64 (m, 2H, H-16), 1.57 – 1.40 (m, 2H, H-
17), 1.31 (d, JHH = 10.7 Hz, 1H, H-19), 1.11 (d, JHH = 10.7 Hz, 1H, H-19). 
13
C NMR 
(101 MHz, CD2Cl2) δ 207.60 (C-12), 162.89 (C-6), 152.98 (C-7), 150.39 (C-1), 
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140.46 (C-5), 137.91 (C-8), 136.89 (C-3), 131.48 (C-9/11), 131.42 (C-10), 127.67 
(C-11), 125.61 (C-2), 123.53 (C-4), 54.77 (C-15), 51.12 (C-14), 40.96 (C-13), 39.62 
(C-18), 32.47 (C-16), 29.60 (C-17), 28.97 (C-19). MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C19H18NOS 307.1031; Found 308.1107. 
Lab book reference number: NPY-5-301 
()-(9aRS,10SR,13RS,13aSR)-2-Thienyl-3-(2-pyridyne-4-yl)- 
4,9,9a,10,11,12,13,13aoctahydro-10,13--methanoinden-one (-125B) 
 
Synthesised following the general procedure H2; with irradiation of -125A (15 mg), 
in CD2Cl2 (0.6 mL) at 400 nm, 20 mA for 40 min. to afford the product as a creamy 
solid (100 % conversion by NMR after 2 h irradiation).  MP 122–123 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 9.03 (dd, JHH = 4.3, 1.7 Hz, 1H, H-1), 8.66 (dd, JHH 
= 8.4, 1.7 Hz, 1H, H-3), 7.96 (d, JHH = 5.4 Hz, 1H, H-11), 7.76 (d, JHH = 5.4 Hz, 1H, 
H-10), 7.64 (dd, JHH = 8.4, 4.3 Hz, 1H, H-2), 3.76 (d, JHH = 5.5 Hz, 1H, H-14), 2.89 
(d, JHH = 3.9 Hz, 1H, H-13), 2.67 (d, JHH = 5.5 Hz, 1H, H-15), 2.62 (d, JHH = 3.9 Hz, 
1H, H-18), 1.84 – 1.67 (m, 2H, H-16), 1.67 – 1.61 (m, 1H, H-17), 1.51 – 1.45 (m, 
1H, H-17), 0.95 (d, JHH = 10.6 Hz, 1H, H-19), 0.81 (d, JHH = 10.6 Hz, 1H, H-19). 
13
C 
NMR (101 MHz, CD2Cl2) δ 207.79 (C-12), 156.46 (C-5), 149.73 (C-1), 144.93 (C-
6), 137.23 (C-8), 135.13 (C-7), 132.69 (C-3), 130.07 (C-9), 129.01 (C-12), 128.53 
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(C-4), 123.87 (C-2), 121.27 (C-11), 56.43 (C-15), 48.34 (C-14), 40.51 (C-13), 40.36 
(C-18), 32.50 (C-16), 29.65 (C-17), 29.08 (C-19). MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C19H16NOS 306.0908; Found 306.0875. Elemental Analysis:  calcd C, 
74.72; H, 4.95; N, 4.59; Found C, 75.23; H, 5.37; N, 4.57. 
Lab book reference number: NPY-5-PKR3cyc. 
()-(3aSR,4RS,7SR,7aRS)-2-Thienyl-3-(4-pyridyne-4-yl)-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-one (126) 
 
Synthesised following the general procedure G; with 118 (100 mg, 0.54 mmol), to 
afford to afford the desired product as a creamy solid (110 mg, 67 % yield). MP 
131–135 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.66 (dd, JHH = 4.4, 1.7 Hz, 2H, H-1/5), 7.31 (dd, JHH 
= 5.1, 1.1 Hz, 1H, H-11), 7.26 (dd, JHH = 4.4, 1.7 Hz, 2H, H-2/4), 7.15 (dd, JHH = 3.7, 
1.0 Hz, 1H, H-9), 6.93 (dd, JHH = 5.1, 3.7 Hz, 1H, H-10), 3.00 (d, JHH = 5.5 Hz, 1H, 
H-14), 2.55 (d, JHH = 3.7 Hz, 1H, H-13), 2.48 (d, JHH = 5.5 Hz, 1H, H-15), 2.09 (d, 
JHH = 3.7 Hz, 1H, H-18), 1.70 – 1.59 (m, 2H, H-16), 1.45 – 1.29 (m, 2H, H-17), 1.20 
(d, JHH = 10.6 Hz, 1H, H-19), 1.05 (d, JHH = 10.6 Hz, 1H, H-19). 
13
C NMR (101 
MHz, ) δ 207.19 (C-12), 165.75 (C-6), 150.84 (C-1/5), 144.94 (C-7), 137.05 (C-8), 
131.74 (C-5), 128.16 (C-11), 127.51 (C-9), 126.98 (C-10), 122.41 (C-2/4), 54.27 (C-
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15), 52.49 (C-14), 40.14 (C-13), 38.15 (C-18), 31.84 (C-16), 29.09 (C-17), 28.88 (C-
19). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C19H18NOS 307.1031; Found 
308.1114, 
Lab book reference number: NPY-4-230 
()-(3aSR,4RS,7SR,7aRS)-2-Thienyl-3-(4-pyridyne-4-yl)-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-one (126) 
 
Synthesised following the general procedure G; with 118 (100 mg, 0.54 mmol), to 
afford to afford the desired product as a creamy solid (17 mg, 10 % yield).  MP 115–
117 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.66 (dd, JHH = 4.4, 1.7 Hz, 2H, H-1/5), 7.31 (dd, JHH 
= 5.1, 1.1 Hz, 1H, H-11), 7.26 (dd, JHH = 4.4, 1.7 Hz, 2H, H-2/4), 7.15 (dd, JHH = 3.7, 
1.0 Hz, 1H, H-9), 6.93 (dd, JHH = 5.1, 3.7 Hz, 1H, H-10), 3.00 (d, JHH = 5.5 Hz, 1H, 
H-14), 2.55 (d, JHH = 3.7 Hz, 1H, H-13), 2.48 (d, JHH = 5.5 Hz, 1H, H-15), 2.09 (d, 
JHH = 3.7 Hz, 1H, H-18), 1.70 – 1.59 (m, 2H, H-16), 1.45 – 1.29 (m, 2H, H-17), 1.20 
(d, JHH = 10.6 Hz, 1H, H-19), 1.05 (d, JHH = 10.6 Hz, 1H, H-19). 
13
C NMR (101 
MHz, ) δ 207.19 (C-12), 165.75 (C-6), 150.84 (C-1/5), 144.94 (C-7), 137.05 (C-8), 
131.74 (C-5), 128.16 (C-11), 127.51 (C-9), 126.98 (C-10), 122.41 (C-2/4), 54.27 (C-
15), 52.49 (C-14), 40.14 (C-13), 38.15 (C-18), 31.84 (C-16), 29.09 (C-17), 28.88 (C-
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19). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C19H18NOS 308.1031; Found 
308.1081. 
 
Lab book reference number: NPY-4-230 
2-1-(2'-thienyl)-2-(4'-Pyridyl)-ethynylhexacarbonyl dicobalt(0) (126I) 
 
Following the general procedure F3; dicobaltoctacarbonyl (369 mg, 1. 08 mmol) and 
the alkyne (200 mg, 1.08 mmol) to afford the complex as brownish solid crystals 
(350 mg, 68 % yield). MP 67–70 oC.  
1
H NMR (400 MHz, CDCl3) δ 8.63 (s, 2H, H-1/5), 7.51 (s, 2H, H-2/4), 7.41 (d, JHH 
= 5.1 Hz, 1H, H-11), 7.33 (s, 1H, H-10), 7.05 (s, 1H, H-9). MS; LRMS (LIFDI) m/z: 
[M + H]
+
 calcd for C17H13Co2NO6S 477.91; Found 477.92. 
Lab book reference number: NPY-5-292 
Chapter 6: Experimental section 
256 
 
()-(3aSR,4RS,7SR,7aRS)-4-pyridyl-3-(2-pyridyne-4-yl)-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-one (127) 
 
 
Synthesised following the general procedure G; with 120 (100 mg, 0.56 mmol), to 
afford to afford the desired product as a creamy solid (130 mg, 77 % yield).  MP 
210– 214 °C. 
1
H NMR (400 MHz, CD2Cl2) δ 8.68 (ddd, JHH = 4.8, 1.8, 1.0 Hz, 1H, H-1), 8.52 (dd, 
JHH = 4.4, 1.6 Hz, 2H, H-10/11), 7.55 (td, JHH = 7.8, 1.8 Hz, 1H, H-3), 7.26 (ddd, JHH 
= 7.6, 4.8, 1.2 Hz, 1H, H-2), 7.13 – 7.07 (m, 3H, H-4/9/12), 3.47 (d, JHH = 5.5 Hz, 
1H, H-15), 2.55 (d, JHH = 3.5 Hz, 1H, H-14), 2.50 (d, JHH = 5.5 Hz, 1H, H-16), 2.22 
(d, JHH = 3.5 Hz, 1H, H-19), 1.74 – 1.59 (m, 2H, H-17), 1.50 – 1.37 (m, 2H, H-18), 
1.23 (d, JHH = 102 Hz, 1H, H-20), 1.05 (d, JHH = 10.2 Hz, 1H, H-20). 
13
C NMR (101 
MHz, CD2Cl2) δ 208.19 (C-13), 171.35 (C-6), 153.75 (C-7), 150.48 (C-1), 150.17 
(C-10/11), 141.98 (C-5), 140.68 (C-8), 136.42 (C-3), 125.07 (C-2), 124.41 (C-
4/9/12), 54.54 (C-16), 50.82 (C-15), 40.30 (C-14), 38.93 (C-17), 31.90 (C-19), 29.42 
(C-18), 28.97 (C-20). IR (solid-state ATR, cm-
1
) 2956, 2866, 1696, 1626, 1588, 
1455, 1351, 1168, 1195, 990, 737, 555, 524, 408. MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C20H19N2O 302.1419; Found 303.1492. 
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Lab book reference number: NPY-5-299 
()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-pyridyl-3a,4,5,6,7,7a-
tetrahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (128) 
 
Synthesised following the general procedure G; with 114c (55 mg, 0.26 mmol), 
norbornadiene (120 mg, 1.30 mmol) to afford to afford the desired product as a 
creamy solid (52 mg, 60 % yield). MP 85–88 °C.   
1
H NMR (400 MHz, CD2Cl2) δ 8.72 (dd, JHH = 5.8, 0.9 Hz, 1H, H-14), 7.71 (td, 
JHH= 7.7, 1.9 Hz, 1H, H-12), 7.39 (d, JHH = 7.7 Hz, 1H, H-11), 7.34 (dd, JHH = 7.7, 
5.8 Hz, 1H, H-123), 6.37 (dd, JHH = 5.6, 3.0 Hz, 1H, H-19), 6.30 (dd, JHH = 5.6, 3.0 
Hz, 1H, H-20), 6.02 (s, 1H, H-3), 5.70 (s, 1H, H-5), 3.55 (d, JHH = 5.4 Hz, 1H, H-
17), 3.05 (d, JHH = 0.9 Hz, 1H, H-16), 2.80 – 2.74 (m, 1H, H-21), 2.60 (dd, JHH = 5.4, 
1.5 Hz, 1H, H-18), 2.15 (s, 3H, H-7), 1.44 (dt, JHH = 9.5, 1.5 Hz, 1H, H-22), 1.37 (d, 
JHH = 9.5 Hz, 1H, H-22). 
13
C NMR (101 MHz, CD2Cl2) δ 205.58, 171.98, 162.75, 
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162.28, 152.80, 150.58, 148.62, 141.15, 139.16, 137.82, 136.73, 125.15, 124.95, 
112.50, 104.88, 53.53, 50.45, 44.94, 44.12, 42.00, 20.19. MS; HRMS (ESI
+
) m/z: [M 
+ H]
+
 calcd for C21H18NO3 332.1208; Found 332.1287, Elemental Analysis: calcd C 
76.12, H 5.17, N 4.23; Found C 74.98, H 5.18, N 4.23. 
Lab book reference number: NPY-5-370 Diene 1F3 
()-(3aSR,4RS,7SR,7aRS)-6-Methyl-4-(1-oxo-3-(2-pyridyl-3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-2-yl)-2H-pyran-2-one (128) 
 
Synthesised following the general procedure G; with 114c (55 mg, 0.26 mmol), 
norbornadiene (120 mg, 1.30 mmol) to afford to afford the desired product as a 
creamy solid (21 mg, 24 % yield). MP 87–88 °C.  
.
1H NMR (400 MHz, ) δ 8.59 (ddd, JHH = 4.8, 1.8, 0.9 Hz, 1H, H-14), 7.77 (td, JHH = 
7.8, 1.8 Hz, 1H, H-12), 7.61 – 7.55 (m, 2H, H-11/13), 6.37 – 6.32 (m, 2H, H-19/20), 
6.16 (s, 1H, H-3), 5.68 (s, 1H, H-5), 3.67 (d, JHH = 5.5 Hz, 1H, H-18), 3.18 (d, JHH = 
6.3 Hz, 2H, H-21), 2.89 (s, 1H, H-17), 2.56 (s, 1H, H-16), 2.18 (s, 3H, H-7), 1.55 (d, 
JHH = 9.5 Hz, 1H, H-22), 1.43 (d, JHH = 9.5 Hz, 2H, H-22). MS; HRMS (ESI
+
) m/z: 
[M + H]
+
 calcd for C21H18NO3 332.1208; Found 332.1285. 
Lab book reference number: NPY-5-370 Diene 1F5 
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(Z)-4-(2'-Pyridylethenyl)-6-methyl-2-pyrone (Z-130a) 
 
Synthesised following the general procedure G; with 114c (55 mg, 0.26 mmol), to 
afford to afford the desired product as a creamy solid (6 mg, 11 % yield). 
1
H NMR (400 MHz, CDCl3) δ 8.58 (ddd, JHH = 4.9, 1.8, 0.9 Hz, 1H, H-14), 7.62 (td, 
JHH = 7.7, 1.8 Hz, 1H, H-12), 7.27 – 7.23 (m, 1H, H-13), 7.19 (ddd, JHH = 7.6, 4.9, 
0.9 Hz, 1H, H-11), 6.86 (d, JHH = 12.5 Hz, 1H, H-19), 6.42 (dd, JHH = 12.5, 1.1 Hz, 
1H, H-8), 6.06 (s, 1H, H-3), 5.78 – 5.75 (m, 1H, H-5), 2.12 (s, 3H, H-7). 13C NMR 
(101 MHz, CDCl3) δ 163.41 (C-2), 161.11 (C-6), 154.40 (C-10), 152.55 (C-4), 
149.77 (C-14), 136.41 (C-9), 135.80 (C-8), 128.75 (C-13), 124.59 (C-12), 123.02 
(C-11), 111.64 (C-3), 104.77 (C-5), 20.02 (C-7). MS; HRMS (ESI
+
) m/z: [M + H]
+
 
calcd for C13H12NO2 214.0823; Found 214.0860. 
Lab book reference number: NPY-4-243F3 
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(E)-4-(4'-pyridylethenyl)-6-methyl-2-pyrone (E-130b) 
 
Synthesised following the general procedure G; with 6-methyl-4-(2'-pyridylethynyl)-
2-pyrone) (55 mg, 0.26 mmol), to afford the desired product as a creamy solid (7 mg, 
13 % yield). MP 82–85 °C.  
1
H NMR (400 MHz, CD2Cl2) δ 8.54 (d, J = 5.1 Hz, 2H), 7.16 (dd, J = 4.8, 1.6 Hz, 
2H), 6.77 (d, J = 12.4 Hz, 1H), 6.48 – 6.43 (m, 1H), 5.97 (s, 1H), 5.69 (s, 1H), 2.11 
(s, 3H). MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C12H12NO2 214.0790; Found 
214.0870. IR (solid-state ATR, cm-
1
) 3042, 2919, 2956, 2995, 1698, 1620, 1540, 
1456, 1328, 1140, 983, 983, 842, 776, 741, 651. 
 
Lab book reference number: NPY-4 
Chapter 6: Experimental section 
261 
 
(Z)-4-(2'-Thienylethenyl)-6-methyl-2-pyrone (E-130c) 
 
Synthesised following the general procedure G; with (6-methyl-4-(2-pyridilethynyl)-
2-thiophene) (100 mg, 0.46 mmol), to afford to afford the desired product as a 
brownish solid (21 mg, 21 % yield). MP 57–59 °C.  
1
H NMR (400 MHz, CDCl3) δ 7.34 (d, JHH = 5.1 Hz, 1H, H-13), 7.31 (d, JHH = 16.0 
Hz, 1H, H-9), 7.19 (d, JHH = 3.5 Hz, 1H, H-14, H-11), 7.05 (dd, JHH = 5.1, 3.6 Hz, 
1H, H-12), 6.59 (d, JHH = 16.0 Hz, 1H, H-8), 6.19 (s, 1H, H-3), 6.04 (s, 1H, H-2), 
2.26 (s, 3H, H-7). 
13
C NMR (101 MHz, CDCl3) δ 163.98 (C-2), 161.78 (C-6), 151.84 
(C-4), 141.24 (C-10), 129.87 (C-11), 129.78 (C-9), 128.54 (C-12), 128.00 (C-13), 
123.99 (C-8), 109.33 (C-5), 100.84 (C-3), 20.53 (C-7). IR (solid-state ATR, cm-
1
) 
3083, 2960, 1699, 1612, 1546, 1406, 1330, 987, 945, 823, 854, 715, 659, 533. MS; 
HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C12H11O2S 219.0402; Found 219.0473.  
Lab book reference number: NPY-4-240F1F2F2 
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4-(2'-Pyridylethyl)-6-methyl-2-pyrone (131a) 
 
Synthesised following the general procedure G; with 114c (55 mg, 0.26 mmol), to 
afford the product as a colourless liquid (9 mg, 16 % yield). 
1
H NMR (400 MHz, CDCl3) δ 8.53 (d, JHH = 4.4 Hz, 1H, H-14), 7.59 (td, JHH = 7.6, 
1.8 Hz, 1H, H-12), 7.13 (dd, JHH = 7.0, 4.7 Hz, 1H, H-13), 7.11 (d, JHH = 7.5 Hz, 1H, 
H-11), 5.91 (s, 1H, H-3), 5.88 (s, 1H, H-5), 3.02 (dd, JHH = 8.8, 6.7 Hz, 1H, H-9), 
2.83 (dd, JHH = 9.1, 6.4 Hz, 1H, H-8), 2.20 (s, 3H, H-7). 
13
C NMR (101 MHz, 
CDCl3) δ 163.40 (C-2), 161.63 (C-6), 159.54 (C-10), 159.41 (C-14), 149.61 (C-4), 
136.71 (C-13), 123.12 (C-12), 121.78 (C-11), 110.04 (C-3), 105.63 (C-5), 36.54 (C-
9), 34.81 (C-8), 20.00 (C-7). MS; HRMS (ESI
+
) m/z: [M + H]+ calcd for C13H13NO2 
216.0946; Found 216.1011. MS; HRMS (ESI
+
) m/z: [M + H]
+
 calcd for C13H14NO2 
216.0980; Found 216.0947. 
Lab book reference number: NPY-4-243F4 
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9 Appendices 
9.1 Appendix 1: X -Ray Diffraction Data 
Crystallographic data for complexes 70, 74a and 74b. 
 
Figure 50  Single crystal X-ray diffraction structure of complexes 60, 70, 74a and 74b. Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. 
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Table 12 Summary of X-ray data for complexes 60, 70, 74a and 74b 
Identification code  60 (ijsf1213) 70 (ijsf1225) 74a (ijsf1219) 74b (ijsf1226) 
Empirical formula  C29.5H24ClN2O2PPd  C22H16N4O4Pd2  C27H27ClNPPd  C22H16N4O4Pd2  
Formula weight  611.33  613.19  538.32  613.19  
Temperature/K  110  110.00(10)  110  110.00(10)  
Crystal system  monoclinic  triclinic  triclinic  triclinic  
Space group  P21/c  P-1  P-1  P-1  
a/Å  16.9489(8)  8.9266(7)  10.5100(6)  8.9039(5)  
b/Å  9.3636(3)  11.2223(8)  14.8251(5)  11.2328(8)  
c/Å  17.3554(6)  12.2242(5)  16.6444(6)  12.2055(8)  
α/°  90.00  68.542(5)  80.535(3)  68.568(6)  
β/°  109.856(4)  69.674(5)  72.777(4)  69.609(6)  
γ/°  90.00  67.921(7)  70.959(4)  67.907(6)  
Volume/Å
3
  2590.61(18)  1024.38(13)  2334.94(18)  1020.91(13)  
Z  4  2  4  2  
ρcalcmg/mm
3
  1.567  1.988  1.531  1.995  
m/mm
-1
  0.912  1.795  0.993  1.801  
F(000)  1236.0  600.0  1096.0  600.0  
Crystal size/mm
3
  0.2526 × 0.2205 × 0.0868  0.1637 × 0.1002 × 0.0466  0.2162 × 0.1351 × 0.0728  0.1454 × 0.1019 × 0.0675  
2Θ range for data collection  5.8 to 64.26°  6.2 to 60.06°  5.72 to 60.16°  6.2 to 60.06°  
Index ranges  
-20 ≤ h ≤ 23, -11 ≤ k ≤ 13, -21 ≤ 
l ≤ 24  
-12 ≤ h ≤ 11, -15 ≤ k ≤ 15, -17 ≤ 
l ≤ 17  
-10 ≤ h ≤ 14, -19 ≤ k ≤ 20, -
23 ≤ l ≤ 20  
-7 ≤ h ≤ 12, -13 ≤ k ≤ 15, -
17 ≤ l ≤ 17  
Reflections collected  15564  11052  20406  10464  
Independent reflections  8183[R(int) = 0.0224]  5986[R(int) = 0.0261]  13090[R(int) = 0.0231]  5917[R(int) = 0.0233]  
Data/restraints/parameters  8183/3/363  5986/0/289  13090/0/565  5917/0/289  
Goodness-of-fit on F
2
  1.026  1.162  1.039  1.047  
Final R indexes [I>=2σ (I)]  R1 = 0.0318, wR2 = 0.0731  R1 = 0.0393, wR2 = 0.0843  R1 = 0.0263, wR2 = 0.0637  R1 = 0.0305, wR2 = 0.0622  
Final R indexes [all data]  R1 = 0.0377, wR2 = 0.0772  R1 = 0.0470, wR2 = 0.0878  R1 = 0.0313, wR2 = 0.0672  R1 = 0.0388, wR2 = 0.0664  
Largest diff. peak/hole / e Å
-3
  1.06/-1.21  1.22/-0.99  0.51/-0.60  0.82/-0.54  
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Crystallographic data for complexes 85, 89, 91 and 93. 
 
Figure 51 Single crystal X-ray diffraction structure of chloromonomer complexes 85, 89, 91 and 93. Hydrogen 
atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. 
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Table 13 Summary of X-ray data for complexes 85, 89, and 91  
Identification code  91 (ijsf1216) 93 (ijsf1314) 85 (ijsf1313) 
Empirical formula  C28H29ClNPPd C25H20Cl4NO3PPd  C16H13ClN2O2Pd 
Formula weight  552.34 661.59  407.13 
Temperature/K  110.00(10) 110.05(10)  110.05(10) 
Crystal system  monoclinic monoclinic  orthorhombic 
Space group  P21/n P21/c  Pbca 
a/Å  8.43431(6) 18.6500(7)  12.9846(3) 
b/Å  18.79277(14) 8.38258(17)  10.9888(2) 
c/Å  15.43388(11) 18.3610(6)  20.1211(6) 
α/°  90.00 90.00  90.00 
β/°  101.4672(7) 116.269(4)  90.00 
γ/°  90.00 90.00  90.00 
Volume/Å
3
  2397.50(3) 2574.03(13)  2870.98(12) 
Z  4 4  8 
ρcalcmg/mm
3
  1.530 1.707  1.884 
m/mm
-1
  0.969 1.228  1.486 
F(000)  1128.0 1320.0  1616.0 
Crystal size/mm
3
  0.2201 × 0.166 × 0.1273 0.2991 × 0.151 × 0.0679  0.2152 × 0.1579 × 0.0984 
2Θ range for data collection  5.8 to 64.42° 6.4 to 59.9°  6.28 to 64.3° 
Index ranges  
-12 ≤ h ≤ 12, -28 ≤ k ≤ 27, -
22 ≤ l ≤ 23 
-18 ≤ h ≤ 24, -11 ≤ k ≤ 10, -25 ≤ 
l ≤ 19  
-16 ≤ h ≤ 19, -16 ≤ k ≤ 15, -29 ≤ 
l ≤ 28 
Reflections collected  41976 12973  18815 
Independent reflections  7983[R(int) = 0.0289] 6602[R(int) = 0.0275]  4729[R(int) = 0.0265] 
Data/restraints/parameters  7983/0/292 6602/12/329  4729/0/200 
Goodness-of-fit on F
2
  1.042 1.083  1.092 
Final R indexes [I>=2σ (I)]  R1 = 0.0226, wR2 = 0.0515 R1 = 0.0345, wR2 = 0.0672  R1 = 0.0259, wR2 = 0.0593 
Final R indexes [all data]  R1 = 0.0264, wR2 = 0.0534 R1 = 0.0491, wR2 = 0.0733  R1 = 0.0375, wR2 = 0.0671 
Largest diff. peak/hole / e Å
-3
  0.78/-0.67 0.70/-0.61  0.61/-1.11 
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Crystallographic data for complexes 88, 90 and 92. 
 
Figure 52 Single crystal X-ray diffraction structure of complexes 88, 90 and 92. Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown with probability of 50%. 
Appendices 
268 
 
Table 14 Summary of X-ray data for complexes 88, 90 and 92 
Identification code  88(ijsf1209) 90(ijsf1217)  92(ijsf1218) 
Empirical formula  C30H25N2O2PPd C31H33Cl2N2O2PPd C28H29Cl0.76198N1.23802O0.47604PPd  
Formula weight  582.89 673.86 554.86  
Temperature/K  110.00(10) 110.00(10) 110.00(10)  
Crystal system  monoclinic monoclinic monoclinic  
Space group  P21/n P21/n P21/n  
a/Å  8.5484(3) 8.40880(15) 8.42346(12)  
b/Å  19.0146(8) 18.9504(3) 18.7653(3)  
c/Å  15.6947(7) 18.6891(3) 15.4050(2)  
α/°  90.00 90.00 90.00  
β/°  99.449(5) 95.4843(17) 101.5786(15)  
γ/°  90.00 90.00 90.00  
Volume/Å
3
  2516.45(18) 2964.48(9) 2385.49(6)  
Z  4 4 4  
ρcalcmg/mm
3
  1.539 1.510 1.545  
m/mm
-1
  0.832 0.892 0.950  
F(000)  1184.0 1376.0 1133.2  
Crystal size/mm
3
  0.2146 × 0.119 × 0.0907 0.1595 × 0.1188 × 0.0468 0.1437 × 0.1234 × 0.0426  
2Θ range for data collection  5.68 to 64.16° 5.92 to 64.34° 5.56 to 60.16°  
Index ranges  -11 ≤ h ≤ 12, -27 ≤ k ≤ 13, -14 ≤ l ≤ 23 -12 ≤ h ≤ 12, -27 ≤ k ≤ 28, -27 ≤ l ≤ 27 -11 ≤ h ≤ 9, -22 ≤ k ≤ 26, -21 ≤ l ≤ 21  
Reflections collected  14773 36957 13606  
Independent reflections  7922[R(int) = 0.0233] 9644[R(int) = 0.0475] 6996[R(int) = 0.0294]  
Data/restraints/parameters  7922/0/338 9644/15/381 6996/1/314  
Goodness-of-fit on F
2
  1.114 1.064 1.048  
Final R indexes [I>=2σ (I)]  R1 = 0.0378, wR2 = 0.0797 R1 = 0.0363, wR2 = 0.0765 R1 = 0.0294, wR2 = 0.0605  
Final R indexes [all data]  R1 = 0.0432, wR2 = 0.0824 R1 = 0.0454, wR2 = 0.0817 R1 = 0.0372, wR2 = 0.0645  
Largest diff. peak/hole / e Å
-3
  1.69/-1.34 0.82/-1.05 0.61/-0.66  
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Crystallographic data for complexes 105a, 105b, 107 and 110. 
 
Figure 53 Single crystal X-ray diffraction structure of complexes 105a, 105b, 107 and 110. Hydrogen atoms 
removed for clarity. Thermal ellipsoids shown with probability of 50%. 
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Table 15 Summary of X-ray data for complexes 105b, 107 and 110 
Identification code  105b(ijsf1510)  107(ijsf1416)  110(ijsf1512)  
Empirical formula  C16H10MnNO7  C22H14MnNO5  C31H22MnNO6  
Formula weight  383.19  427.28  559.43  
Temperature/K  110.05(10)  110.05(10)  110.05(10)  
Crystal system  triclinic  monoclinic  monoclinic  
Space group  P-1  P21/c  P21/n  
a/Å  6.9469(5)  7.4809(3)  10.9613(2)  
b/Å  10.1635(6)  19.0446(15)  19.3911(3)  
c/Å  12.3849(9)  12.8808(4)  13.0063(3)  
α/°  67.194(6)  90  90  
β/°  83.812(6)  93.949(3)  110.468(3)  
γ/°  71.460(7)  90  90  
Volume/Å
3
  764.12(10)  1830.78(17)  2589.97(10)  
Z  2  4  4  
ρcalcg/cm
3
  1.665  1.550  1.435  
μ/mm-1  0.905  0.757  4.540  
F(000)  388.0  872.0  1152.0  
Crystal size/mm
3
  MoKα (λ = 0.7107) MoKα (λ = 0.71073) CuKα (λ = 1.54184) 
Radiation  0.3277 × 0.0793 × 0.0616 0.2039 × 0.0557 × 0.0213 0.1513 × 0.0527 × 0.0334 
2Θ range for data collection/°  6.764 to 64.15  5.856 to 60.688°  8.57 to 142.028  
Index ranges  -10 ≤ h ≤ 10, -15 ≤ k ≤ 14, -17 ≤ l ≤ 17  
-7 ≤ h ≤ 10, -24 ≤ k ≤ 26, -14 ≤ l 
≤ 18  
-12 ≤ h ≤ 13, -23 ≤ k ≤ 17, -15 ≤ l ≤ 
15  
Reflections collected  12875  8927  17168  
Independent reflections  4850 [Rint = 0.0350, Rsigma = 0.0420]  
4803 [Rint = 0.0258, Rsigma = 
0.0453]  
4964 [Rint = 0.0316, Rsigma = 0.0286]  
Data/restraints/parameters  4850/0/228  4803/0/263  4964/0/354  
Goodness-of-fit on F
2
  1.056  1.048  1.047  
Final R indexes [I>=2σ (I)]  R1 = 0.0349, wR2 = 0.0736  R1 = 0.0374, wR2 = 0.0808  R1 = 0.0294, wR2 = 0.0744  
Final R indexes [all data]  R1 = 0.0441, wR2 = 0.0779  R1 = 0.0507, wR2 = 0.0876  R1 = 0.0336, wR2 = 0.0770  
Largest diff. peak/hole / e Å
-3
  0.47/-0.42  0.41/-0.42  0.30/-0.34  
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Crystallographic data for compound 108 and 109 
 
Figure 54 Single crystal X-ray diffraction structure of compound 108 and 109. Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown with probability of 50%. 
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Table 16 Summary of X-ray data for compound 108 and 109 
Identification code  108(ijsf1489)  109(ijsf1516a)  
Empirical formula  C27H19NO2  C34H25N  
Formula weight  389.43  447.55  
Temperature/K  110.05(10)  110.05(10)  
Crystal system  monoclinic  tetragonal  
Space group  P21/c  P43  
a/Å  11.4500(3)  13.86719(18)  
b/Å  13.3633(3)  13.86719(18)  
c/Å  12.4539(3)  12.4237(3)  
α/°  90  90.00  
β/°  93.005(2)  90.00  
γ/°  90  90.00  
Volume/Å
3
  1902.96(8)  2389.07(7)  
Z  4  4  
ρcalcmg/mm
3
  1.359  1.244  
m/mm
-1
  0.677  0.543  
F(000)  816.0  944.0  
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) 
Crystal size/mm
3
  0.233 × 0.1307 × 0.0883 0.1414 × 0.1144 × 0.0722 
2Θ range for data collection  7.732 to 134.144  9.02 to 141.98  
Index ranges  -10 ≤ h ≤ 13, -14 ≤ k ≤ 15, -14 ≤ l ≤ 14  -16 ≤ h ≤ 16, -11 ≤ k ≤ 16, -9 ≤ l ≤ 14  
Reflections collected  6811  6885  
Independent reflections  3383 [Rint = 0.0207, Rsigma = 0.0273]  3277 [Rint = 0.0217, Rsigma = 0.0313]  
Data/restraints/parameters  3383/0/272  3277/1/317  
Goodness-of-fit on F
2
  1.038  1.016  
Final R indexes [I>=2σ (I)]  R1 = 0.0393, wR2 = 0.0970  R1 = 0.0307, wR2 = 0.0783  
Final R indexes [all data]  R1 = 0.0447, wR2 = 0.1024  R1 = 0.0327, wR2 = 0.0801  
Largest diff. peak/hole / e Å
-3
  0.47/-0.25  0.15/-0.12 
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Crystallographic data for compound 114c, 115c and 130a 
 
Figure 55 Single crystal X-ray diffraction structure of complexes 114c, 115c and 130a. Compound 114c bottom, 
showing the packing between the molecules. Hydrogen atoms removed for clarity. Thermal ellipsoids shown with 
probability of 50%. 
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Table 17 Summary of X-ray data for complexes 114c, 115c and 130b 
Identification code  114c(ijsf1410)  115c(ijsf1327)  130b(ijsf1329)  
Empirical formula  C13H9NO2  C13H9NO2  C13H11NO2  
Formula weight  211.21  211.21  213.23  
Temperature/K  110.05(10)  110.05(10)  110.05(10)  
Crystal system  monoclinic  monoclinic  monoclinic  
Space group  P21/c  P21/n  P21/c  
a/Å  12.2868(3)  7.7732(2)  7.0432(3)  
b/Å  23.6736(4)  9.9544(3)  12.8083(5)  
c/Å  7.24297(15)  13.2388(4)  11.6581(4)  
α/°  90  90.00  90.00  
β/°  101.605(2)  97.545(3)  97.187(3)  
γ/°  90  90.00  90.00  
Volume/Å
3
  2063.72(7)  1015.52(6)  1043.43(6)  
Z  8  4  4  
ρcalcmg/mm
3
  1.360  1.381  1.357  
m/mm
-1
  0.093  0.094  0.092  
F(000)  880.0  440.0  448.0  
Crystal size/mm
3
  0.2968 × 0.1839 × 0.1127  0.2855 × 0.1649 × 0.0866  0.1849 × 0.1003 × 0.0826  
Radiation  MoKα (λ = 0.7107)  Mo Kα (λ = 0.7107)  Mo Kα (λ = 0.7107)  
2Θ range for data collection  5.988 to 60.482°  5.76 to 55.62°  5.82 to 64.44°  
Index ranges  -8 ≤ h ≤ 17, -33 ≤ k ≤ 26, -9 ≤ l ≤ 7  -7 ≤ h ≤ 9, -12 ≤ k ≤ 11, -13 ≤ l ≤ 16  -4 ≤ h ≤ 10, -18 ≤ k ≤ 16, -17 ≤ l ≤ 16  
Reflections collected  9966  3918  6204  
Independent reflections  5432 [Rint = 0.0212, Rsigma = 0.0333]  2063[R(int) = 0.0194]  3352[R(int) = 0.0172]  
Data/restraints/parameters  5432/0/291  2063/0/146  3352/0/146  
Goodness-of-fit on F
2
  1.063  1.089  1.070  
Final R indexes [I>=2σ (I)]  R1 = 0.0482, wR2 = 0.1155  R1 = 0.0434, wR2 = 0.1048  R1 = 0.0470, wR2 = 0.1250  
Final R indexes [all data]  R1 = 0.0647, wR2 = 0.1243  R1 = 0.0567, wR2 = 0.1122  R1 = 0.0577, wR2 = 0.1331  
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Crystallographic data for compound 121, 122 and 124. 
 
Figure 56 Single crystal X-ray diffraction structure of PKR compound containing 2-pyrone for 121, 
122 and 124. Hydrogen atoms removed for clarity. Thermal ellipsoids shown with probability of 
50%. 
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Table 18 Summary of X-ray data for complexes 121, 122 and 124 
Identification code  121(ijsf1325) 122(ijsf1421) 124(ijsf1440) 
Empirical formula  C21H19NO3 C21H19NO3 C20H18O3S  
Formula weight  333.37 333.37 338.40  
Temperature/K  110.05(10) 110.05(10) 110.00(10)  
Crystal system  monoclinic monoclinic triclinic  
Space group  P21/n P21/c P-1  
a/Å  11.0079(3) 19.1782(5) 9.3885(5)  
b/Å  10.2293(3) 8.3438(3) 9.7319(4)  
c/Å  15.0673(4) 10.3712(3) 9.9642(5)  
α/°  90.00 90 102.963(4)  
β/°  100.220(3) 95.910(2) 93.132(4)  
γ/°  90.00 90 114.627(5)  
Volume/Å
3
  1669.71(8) 1650.76(8) 795.15(7)  
Z  4 4 2  
ρcalcmg/mm
3
  1.326 1.341 1.413  
m/mm
-1
  0.089 0.090 0.219  
F(000)  704.0 704.0 356.0  
Crystal size/mm
3
  0.1479 × 0.1252 × 0.0913 0.2384 × 0.1758 × 0.0449 0.2706 × 0.2322 × 0.1678  
2Θ range for data collection  6.42 to 56.08° 6.274 to 56.194° 5.882 to 64.45  
Index ranges  -12 ≤ h ≤ 13, -8 ≤ k ≤ 12, -13 ≤ l ≤ 19 -23 ≤ h ≤ 24, -10 ≤ k ≤ 4, -11 ≤ l ≤ 12 -13 ≤ h ≤ 13, -14 ≤ k ≤ 14, -14 ≤ l ≤ 14  
Reflections collected  6179 5958 17495  
Independent reflections  3346[R(int) = 0.0221] 3297 [Rint = 0.0236, Rsigma = 0.0388] 5216 [Rint = 0.0289, Rsigma = 0.0297]  
Data/restraints/parameters  3346/0/227 3297/0/227 5216/0/218  
Goodness-of-fit on F
2
  1.056 1.042 1.073  
Final R indexes [I>=2σ (I)]  R1 = 0.0543, wR2 = 0.1127 R1 = 0.0544, wR2 = 0.1273 R1 = 0.0417, wR2 = 0.1080  
Final R indexes [all data]  R1 = 0.0746, wR2 = 0.1237 R1 = 0.0708, wR2 = 0.1388 R1 = 0.0497, wR2 = 0.1148  
Largest diff. peak/hole / e Å
-3
  0.34/-0.23 0.26/-0.22 0.50/-0.39  
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Crystallographic data for compound 125, 126 and 127 
 
Figure 57 Single crystal X-ray diffraction structure of PKR compound of 125, 126 and 127. 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown with probability of 50%. 
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Table 19 Summary of X-ray data for complexes 125, 126 and 127 
Identification code  125(ijsf1460) 126(ijsf1406) 127(ijsf1463a)  
Empirical formula  C19H17NOS  C19H17NOS  C20H18N2O  
Formula weight  307.39  307.39  302.36  
Temperature/K  110.05(10)  110.05(10)  110.05(10)  
Crystal system  monoclinic  monoclinic  orthorhombic  
Space group  P21/n  P21/c  Pbca  
a/Å  8.8893(3)  5.88552(11)  8.7098(5)  
b/Å  19.7148(5)  18.4965(4)  10.0132(4)  
c/Å  9.2543(3)  13.9295(3)  35.1795(16)  
α/°  90  90  90  
β/°  111.117(4)  97.2089(19)  90  
γ/°  90  90  90  
Volume/Å
3
  1512.91(8)  1504.40(5)  3068.1(3)  
Z  4  4  8  
ρcalcmg/mm
3
  1.350  1.357  1.309  
m/mm
-1
  1.895  0.216  0.641  
F(000)  648.0  648.0  1280.0  
Crystal size/mm
3
  0.2525 × 0.1996 × 0.0803  0.3773 × 0.1124 × 0.0594  0.2622 × 0.1912 × 0.0305  
2Θ range for data collection  8.972 to 142.16  5.89 to 64.4°  10.058 to 142.332  
Index ranges  -10 ≤ h ≤ 10, -23 ≤ k ≤ 19, -11 ≤ l ≤ 10  -8 ≤ h ≤ 7, -19 ≤ k ≤ 26, -10 ≤ l ≤ 19  -5 ≤ h ≤ 10, -10 ≤ k ≤ 12, -40 ≤ l ≤ 42  
Reflections collected  5420  8811  6657  
Independent reflections  2814 [Rint = 0.0183, Rsigma = 0.0248]  4764 [Rint = 0.0243, Rsigma = 0.0418]  2887 [Rint = 0.0273, Rsigma = 0.0360]  
Data/restraints/parameters  2814/0/206  4764/5/212  2887/0/208  
Goodness-of-fit on F
2
  1.033  1.033  1.051  
Final R indexes [I>=2σ (I)]  R1 = 0.0362, wR2 = 0.0905  R1 = 0.0447, wR2 = 0.1057  R1 = 0.0490, wR2 = 0.1173  
Final R indexes [all data]  R1 = 0.0425, wR2 = 0.0957  R1 = 0.0599, wR2 = 0.1163  R1 = 0.0604, wR2 = 0.1259  
Largest diff. peak/hole / e Å
-3
  0.26/-0.20  0.40/-0.28  0.41/-0.23  
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9.2 Appendix 2: UV–Visible spectroscopic data for compound 108 
and 109 
UV–visible spectroscopic data for compound 108 
 
 
 
Figure 58 UV–visible spectroscopic data for compound 108 
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UV–visible spectroscopic data for compound 109 
 
 
 
Figure 59 UV–visible spectroscopic data for compound 109 
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9.3 Appendix 3: UV–Visible irradiation Spectroscopic Data 
9.3.1 General procedure for the UV light-controlled irradiation for cyclisation 
/ aromatisation 
An in house new UV-vis. irradiation system developed in York to provide controlled 
irradiation in which the wavelength and intensity of the light can be adjusted when 
required were used for PK adduct irradiation. The system (device) uses a small 5W 
LED’s that attach directly on to the top of a cuvette.  The LED’s circuit is 
mechanically in-built in a special cuvette cap to a flexible wire, to allow the cuvette 
to be placed in the UV spectrometer for UV. A heat absorbing system (device) was 
developed for irradiating the NMR sample in the NMR tube for NMR simulation. 
The current LEDs in the system irradiate at 400 nm (Figure 60) 
 
Figure 60 An irradiation system using the 400 nm 5W LED drawing a current of 20 mA 
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UV–visible irradiation spectroscopic data for compound 113Ato form 113B 
 
Figure 61 UV–visible irradiation spectroscopic data for compound 113A to form 113B 
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UV–visible irradiation spectroscopic data for compound 121A to form 121B 
 
Figure 62 UV–visible irradiation spectroscopic data for compound 121A to form 121B 
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UV–visible irradiation spectroscopic data for compound 124A to form 124B 
 
 
Figure 63 UV–visible irradiation spectroscopic data for compound 124A to form 124B 
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UV–visible irradiation spectroscopic data for compound 124Ato form 124B 
 
Figure 64 UV–visible irradiation spectroscopic data for compound 124Ato form 124B 
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UV–visible irradiation spectroscopic data for compound 125Ato form 125B 
 
 
Figure 65 UV–visible irradiation spectroscopic data for compound 125A to form 125B 
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UV–visible irradiation spectroscopic data for compound 126Ato form 126B 
 
Figure 66  UV–visible irradiation spectroscopic data for compound 126A to form 126B
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9.4 Appendix 4: NMR spectra of prepared compounds 
 
 
Appendix for (60) 
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Appendix for (62A and B) 
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Appendix for 66 
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Appendix for (67) 
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Appendix for (68) 
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Appendix for (69)
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Appendix for (70) 
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Appendix for (71) 
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Appendix for (72) 
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Appendix for (73) 
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Appendix for (76) 
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Appendix for (77) 
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Appendix for (78) 
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Appendix for (80) 
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Appendix for (81) 
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Appendix for (82) 
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Appendix for (83) 
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Appendix for (84) 
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Appendix for (87) 
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Appendix for (88) 
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Appendix for (89) 
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Appendix for (90) 
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Appendix for (91) 
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Appendix for (92) 
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Appendix for (93) 
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Appendix for (94) 
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Appendix for (95) 
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Appendix for (96) 
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Appendix for (99) 
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Appendix for (100) 
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Appendix for (104) 
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Appendix for (105a) 
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Appendix for (105b) 
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Appendix for (106) 
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Appendix for (107) 
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Appendix for (108) 
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Appendix for (109) 
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Appendix for (110) 
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Appendix for (112a) 
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Appendix for (113a ) 
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Appendix for (113a ) 
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Appendix for (113B ) 
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Appendix for (114a) 
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Appendix for (114b) 
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Appendix for (114c) 
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Appendix for (115a) 
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Appendix for (115b) 
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Appendix for (115c) 
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Appendix for (116a) 
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Appendix for (116b) 
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Appendix for (116c) 
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Appendix for (117a) 
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Appendix for (117c) 
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Appendix for (118) 
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Appendix for (119) 
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Appendix for (120) 
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Appendix for (121 ) 
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Appendix for (121B ) 
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Appendix for (121I) 
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Appendix for (122  +) 
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Appendix for (122B  +) 
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Appendix for (122I) 
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Appendix for (123 ) 
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Appendix for (123I) 
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Appendix for (124 ) 
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Appendix for (124B ) 
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Appendix for (124 ) 
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Appendix for (124B ) 
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Appendix for (125 ) 
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Appendix for (125 ) 
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Appendix for (125B ) 
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Appendix for (126 ) 
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Appendix for (126I) 
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Appendix for (128 )
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Appendix for (128 ) 
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Appendix for (130a) 
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Appendix for (130c) 
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Appendix for (131a) 
Abbreviations 
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Abbreviations 
2-phpy  2-Phenylpyridine 
2-Bnpy  2-Benzylpyridine 
Ac  acetyl 
APCI  atmospheric pressure chemical ionisation 
aq.  aqueous 
ATR  attenuated total reflectance 
Bn  benzyl 
Bu  butyl 
C, c.  concentration 
c.  concentrated 
calcd calculated 
cat.  catalyst, catalytic 
cod  1,5-cycloocadiene 
conv.  conversion 
COSY  correlation spectroscopy 
Cp  cyclopentadienyl 
Cy  cyclohexyl 
d  (NMR) Doublet 
dec.  decomposition 
DCE  Dichloroethane 
DCM  Dichloromethane 
DFT  Density functional theory 
DMF  dimethylformamide 
Abbreviations 
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DMSO  dimethylsulfoxide 
dppe  1,2-bis(diphenylphosphino)ethane 
dppf  1,1'-bis(diphenylphosphino)ferrocene 
EDG Electron donating group 
EI  electron ionisation 
eq.  equivalents 
ESI  electrospray ionisation 
Et  ethyl 
EWG Electron withdrawing group 
FG  Functional group 
FTIR  Fourier transform infrared spectroscopy 
FGI  functional group interconversion 
Fu  furyl 
G gram(s) 
H hour(s) 
HMBC heteronuclear multiple-bond correlation spectroscopy 
HRMS high-resolution mass spectrometry 
HSQC heteronuclear single quantum coherence spectroscopy 
i-  iso- 
IR  infrared 
isol.  isolated 
J  Spin-spin coupling 
L  Ligand 
LED Light emitting diode 
LIFDI  liquid introduced field desorption ionisation 
Abbreviations 
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lit.  literature 
m  Milli 
M  (concentration) mol dm-3 
m  (nmr) Multiplet 
[M]  metal 
m-  meta- 
m/z  Mass-to-charge ratio 
Me  Methyl 
min  Minute(s) 
mM   millimolar 
mm  millimetres 
mol  Mole(s) 
M.P.  melting point 
MS  molecular sieves 
MW Microwave 
Mw  molecular weight 
n-  normal 
NBD 
Norbornadiene (Bicyclo[2.2.1]hepta-2,5-diene) 
NBN Norbornene (Bicyclo[2.2.1]hept-2-ene) 
nm   nanometres 
NMR  nuclear magnetic resonance 
Nu  nucleophile 
nOe  nuclear Overhauser effect 
NOESY  nuclear Overhauser effect spectroscopy 
Abbreviations 
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OAc  Acetate 
p-  para- 
Ph  phenyl 
PK Pauson-Khand 
PKR Pauson-Khand reaction 
ppm  parts per million 
Pr  propyl 
py.  pyridine 
quant.  quantitative yield 
rel.  relative 
q  (NMR) Quartet 
R  Substituent 
Rf  retention factor 
RT  at ambient temperature 
SM  starting material 
r.t. Room temperature 
s  Second(s) 
t  Time 
t  (NMR) Triplet 
t-  tertiary 
temp.  Temperature 
t-Bu  tert-Butyl 
 TFP  tri(2-furyl)phosphine 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
Abbreviations 
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TMS  trimethylsilane 
tol  toluene 
TS Transition state 
UV  Ultra-violet 
Vis  Visible 
w.r.t.  with respect to 
X  leaving group 
δ  Chemical shift downfield from tetramethylsilane 
μ  Micro 
References 
371 
 
 
References 
1. J. Tsuji, Palladium Reagents and Catalysts: New Perspectives for the 21st 
Century, Wiley, 2006. 
2. J. Tsuji, Palladium in Organic Synthesis, Springer, 2005. 
3. J. Tsuji, in Transition Metal Reagents and Catalysts, John Wiley & Sons, 
Ltd, 2003, pp. i-xv. 
4. J. Tsuji, Perspectives in Organopalladium Chemistry for the XXI Century, 
Elsevier, 1999. 
5. K. A. Horn, Chemical Reviews, 1995, 95, 1317-1350. 
6. E. Negishi and A. de Meijere, Handbook of Organopalladium Chemistry for 
Organic Synthesis, 2 Volume Set, Wiley, 2003. 
7. E. I. Negishi, Organometallics in organic synthesis, John Wiley & Sons 
Australia, Limited, 1980. 
8. E.-i. Negishi, in Handbook of Organopalladium Chemistry for Organic 
Synthesis, John Wiley & Sons, Inc., 2003, pp. 229-247. 
9. A. Ehrentraut, A. Zapf and M. Beller, Synlett, 2000, 2000, 1589-1592. 
10. A. F. Littke and G. C. Fu, Journal of the American Chemical Society, 2001, 
123, 6989-7000. 
References 
372 
 
 
11. K. J. Stowers, A. Kubota and M. S. Sanford, Chemical Science, 2012, 3, 
3192-3195. 
12. W. Yu and Z. Jin, Journal of the American Chemical Society, 2000, 122, 
9840-9841. 
13. T. W. Lyons and M. S. Sanford, Chem Rev, 2010, 110, 1147-1169. 
14. S. L. Zultanski and S. S. Stahl, Journal of Organometallic Chemistry, 2015, 
793, 263-268. 
15. C. C. C. Johansson Seechurn, A. DeAngelis and T. J. Colacot, in New Trends 
in Cross-Coupling: Theory and Applications, The Royal Society of 
Chemistry, 2015, pp. 1-19. 
16. E.-i. Negishi, Angewandte Chemie International Edition, 2011, 50, 6738-
6764. 
17. X. Chen, K. M. Engle, D.-H. Wang and J.-Q. Yu, Angewandte Chemie 
International Edition, 2009, 48, 5094-5115. 
18. K. C. Nicolaou, P. G. Bulger and D. Sarlah, Angewandte Chemie 
International Edition, 2005, 44, 4442-4489. 
19. T. Mizoroki, K. Mori and A. Ozaki, Bulletin of the Chemical Society of 
Japan, 1971, 44, 581-581. 
References 
373 
 
 
20. R. F. Heck and J. P. Nolley, The Journal of Organic Chemistry, 1972, 37, 
2320-2322. 
21. D. Milstein and J. K. Stille, Journal of the American Chemical Society, 1978, 
100, 3636-3638. 
22. D. Milstein and J. K. Stille, Journal of the American Chemical Society, 1979, 
101, 4992-4998. 
23. V. Farina, S. Kapadia, B. Krishnan, C. Wang and L. S. Liebeskind, The 
Journal of Organic Chemistry, 1994, 59, 5905-5911. 
24. N. Miyaura, K. Yamada and A. Suzuki, Tetrahedron Letters, 1979, 20, 3437-
3440. 
25. K. Sonogashira, Y. Tohda and N. Hagihara, Tetrahedron Letters, 1975, 16, 
4467-4470. 
26. R. Chinchilla and C. Nájera, Chemical Reviews, 2007, 107, 874-922. 
27. C. Tsukano and M. Sasaki, Journal of the American Chemical Society, 2003, 
125, 14294-14295. 
28. C. Tsukano, M. Ebine and M. Sasaki, Journal of the American Chemical 
Society, 2005, 127, 4326-4335. 
29. M. Sasaki, C. Tsukano and K. Tachibana, Tetrahedron Letters, 2003, 44, 
4351-4354. 
References 
374 
 
 
30. M. Sasaki, C. Tsukano and K. Tachibana, Organic Letters, 2002, 4, 1747-
1750. 
31. M. Satake, M. Shoji, Y. Oshima, H. Naoki, T. Fujita and T. Yasumoto, 
Tetrahedron Letters, 2002, 43, 5829-5832. 
32. F. P. Marmsäter and F. G. West, Chemistry – A European Journal, 2002, 8, 
4346-4353. 
33. M. Murata and T. Yasumoto, Natural Product Reports, 2000, 17, 293-314. 
34. M. Sasaki and H. Fuwa, Synlett, 2004, 1851-1874. 
35. J. L. Wood, J. A. Porco, J. Taunton, A. Y. Lee, J. Clardy and S. L. Schreiber, 
Journal of the American Chemical Society, 1992, 114, 5898-5900. 
36. J. Taunton, J. L. Wood and S. L. Schreiber, Journal of the American 
Chemical Society, 1993, 115, 10378-10379. 
37. K. C. Nicolaou, A. L. Smith, S. V. Wendeborn and C. K. Hwang, Journal of 
the American Chemical Society, 1991, 113, 3106-3114. 
38. K. C. Nicolaou, C. K. Hwang, A. L. Smith and S. V. Wendeborn, Journal of 
the American Chemical Society, 1990, 112, 7416-7418. 
39. J. Inanaga, K. Hirata, H. Saeki, T. Katsuki and M. Yamaguchi, Bulletin of the 
Chemical Society of Japan, 1979, 52, 1989-1993. 
References 
375 
 
 
40. L. Ackermann, Synlett, 2007, 2007, 0507-0526. 
41. S. E. Bajwa, T. E. Storr, L. E. Hatcher, T. J. Williams, C. G. Baumann, A. C. 
Whitwood, D. R. Allan, S. J. Teat, P. R. Raithby and I. J. S. Fairlamb, 
Chemical Science, 2012, 3, 1656-1661. 
42. I. J. S. Fairlamb, Angewandte Chemie International Edition, 2015, 54, 
10415-10427. 
43. J. Cámpora, P. Palma, D. del Río, E. Carmona, C. Graiff and A. Tiripicchio, 
Organometallics, 2003, 22, 3345-3347. 
44. J. B. Gerken and S. S. Stahl, ACS Central Science, 2015. 
45. L. Wang, J. Li, H. Yang, Y. Lv and S. Gao, The Journal of Organic 
Chemistry, 2012, 77, 790-794. 
46. V. I. Bakhmutov, J. F. Berry, F. A. Cotton, S. Ibragimov and C. A. Murillo, 
Dalton Transactions, 2005, 1989-1992. 
47. T. A. Stephenson, S. M. Morehouse, A. R. Powell, J. P. Heffer and G. 
Wilkinson, Journal of the Chemical Society (Resumed), 1965, 3632-3640. 
48. R. B. Bedford, J. G. Bowen, R. B. Davidson, M. F. Haddow, A. E. Seymour-
Julen, H. A. Sparkes and R. L. Webster, Angewandte Chemie International 
Edition, 2015, 54, 6591-6594. 
References 
376 
 
 
49. G. Cahiez, D. Bernard and J. F. Normant, Journal of Organometallic 
Chemistry, 1976, 113, 99-106. 
50. G. Cahiez and O. Gager, in PATAI'S Chemistry of Functional Groups, John 
Wiley & Sons, Ltd, 2009. 
51. T. Truong, J. Alvarado, L. D. Tran and O. Daugulis, Organic Letters, 2010, 
12, 1200-1203. 
52. G. Cahiez, A. Moyeux, J. Buendia and C. Duplais, Journal of the American 
Chemical Society, 2007, 129, 13788-13789. 
53. Y. Yuan and Y. Bian, Applied Organometallic Chemistry, 2008, 22, 15-18. 
54. G. Cahiez, C. Duplais and J. Buendia, Angewandte Chemie International 
Edition, 2009, 48, 6731-6734. 
55. Z. Zhou and W. Xue, Journal of Organometallic Chemistry, 2009, 694, 599-
603. 
56. Y.-C. Teo, F.-F. Yong, I. K. Ithnin, S.-H. T. Yio and Z. Lin, European 
Journal of Organic Chemistry, 2013, 2013, 515-524. 
57. Y.-C. Teo, F.-F. Yong and G. S. Lim, Tetrahedron Letters, 2011, 52, 7171-
7174. 
58. Y.-C. Teo, F.-F. Yong, C.-Y. Poh, Y.-K. Yan and G.-L. Chua, Chemical 
Communications, 2009, 6258-6260. 
References 
377 
 
 
59. F.-F. Yong and Y.-C. Teo, Synlett, 2012, 23, 2106-2110. 
60. F.-F. Yong and Y.-C. Teo, Tetrahedron Letters, 2010, 51, 3910-3912. 
61. F. Calderazzo, Inorganic Chemistry, 1965, 4, 293-296. 
62. Y. Kuninobu, M. Nishi, A. Kawata, H. Takata, Y. Hanatani, Y. S. Salprima, 
A. Iwai and K. Takai, The Journal of Organic Chemistry, 2010, 75, 334-341. 
63. Y. Kuninobu, A. Kawata and K. Takai, Journal of the American Chemical 
Society, 2006, 128, 11368-11369. 
64. Y. Kuninobu, A. Kawata, M. Nishi, H. Takata and K. Takai, Chemical 
Communications, 2008, 6360-6362. 
65. D. A. Valyaev, G. Lavigne and N. Lugan, Coordination Chemistry Reviews. 
66. H. Chen and J. F. Hartwig, Angewandte Chemie International Edition, 1999, 
38, 3391-3393. 
67. Y. Kuninobu, Y. Nishina, T. Takeuchi and K. Takai, Angewandte Chemie 
International Edition, 2007, 46, 6518-6520. 
68. Y. Kuninobu, Y. Fujii, T. Matsuki, Y. Nishina and K. Takai, Organic Letters, 
2009, 11, 2711-2714. 
69. B. Zhou, H. Chen and C. Wang, Journal of the American Chemical Society, 
2013, 135, 1264-1267. 
References 
378 
 
 
70. H. Werner, Angewandte Chemie International Edition, 2014, 53, 3309-3309. 
71. I. U. Khand, G. R. Knox, P. L. Pauson and W. E. Watts, Journal of the 
Chemical Society, Perkin Transactions 1, 1973, 975-977. 
72. I. U. Khand, G. R. Knox, P. L. Pauson, W. E. Watts and M. I. Foreman, 
Journal of the Chemical Society, Perkin Transactions 1, 1973, 977-981. 
73. I. U. Khand, G. R. Knox, P. L. Pauson and W. E. Watts, Journal of the 
Chemical Society D: Chemical Communications, 1971, 36a-36a. 
74. S. M. Roberts, M. G. Santoro and E. S. Sickle, Journal of the Chemical 
Society, Perkin Transactions 1, 2002, 1735-1742. 
75. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin and M. G. 
Santoro, Nature, 2000, 403, 103-118. 
76. N. Jeong, S. Lee and B. K. Sung, Organometallics, 1998, 17, 3642-3644. 
77. T. Shibata and K. Takagi, Journal of the American Chemical Society, 2000, 
122, 9852-9853. 
78. A. J. Pearson and R. A. Dubbert, Organometallics, 1994, 13, 1656-1661. 
79. A. J. Pearson and R. A. Dubbert, Journal of the Chemical Society, Chemical 
Communications, 1991, 202-203. 
References 
379 
 
 
80. L. Jordi, A. Segundo, F. Camps, S. Ricart and J. M. Moreto, 
Organometallics, 1993, 12, 3795-3797. 
81. N. Jeong, S. J. Lee, B. Y. Lee and Y. K. Chung, Tetrahedron Letters, 1993, 
34, 4027-4030. 
82. C. Mukai, M. Uchiyama and M. Hanaoka, Journal of the Chemical Society, 
Chemical Communications, 1992, 1014-1015. 
83. T. R. Hoye and J. A. Suriano, Journal of the American Chemical Society, 
1993, 115, 1154-1156. 
84. T. R. Hoye and J. A. Suriano, Organometallics, 1992, 11, 2044-2050. 
85. N. Wu, L. Deng, L. Liu, Q. Liu, C. Li and Z. Yang, Chemistry – An Asian 
Journal, 2013, 8, 65-68. 
86. Y. Lan, L. Deng, J. Liu, C. Wang, O. Wiest, Z. Yang and Y.-D. Wu, The 
Journal of Organic Chemistry, 2009, 74, 5049-5058. 
87. M. E. Krafft, I. L. Scott, R. H. Romero, S. Feibelmann and C. E. Van Pelt, 
Journal of the American Chemical Society, 1993, 115, 7199-7207. 
88. X. Verdaguer, A. Moyano, M. A. Pericas, A. Riera, V. Bernardes, A. E. 
Greene, A. Alvarez-Larena and J. F. Piniella, Journal of the American 
Chemical Society, 1994, 116, 2153-2154. 
References 
380 
 
 
89. C. M. Gordon, M. Kiszka, I. R. Dunkin, W. J. Kerr, J. S. Scott and J. 
Gebicki, Journal of Organometallic Chemistry, 1998, 554, 147-154. 
90. S. M. Draper, C. Long and B. M. Myers, Journal of Organometallic 
Chemistry, 1999, 588, 195-199. 
91. M. K. Pallerla, G. P. A. Yap and J. M. Fox, The Journal of Organic 
Chemistry, 2008, 73, 6137-6141. 
92. E. V. Banide, H. Müller-Bunz, A. R. Manning, P. Evans and M. J. 
McGlinchey, Angewandte Chemie International Edition, 2007, 46, 2907-
2910. 
93. Y. Gimbert, D. Lesage, A. Milet, F. Fournier, A. E. Greene and J.-C. Tabet, 
Organic Letters, 2003, 5, 4073-4075. 
94. S. A. Brusey, E. V. Banide, S. Dörrich, P. O’Donohue, Y. Ortin, H. Müller-
Bunz, C. Long, P. Evans and M. J. McGlinchey, Organometallics, 2009, 28, 
6308-6319. 
95. T. Zheng, H. Sun, J. Ding, Y. Zhang and X. Li, Journal of Organometallic 
Chemistry, 695, 1873-1877. 
96. H.-F. Klein, S. Camadanli, R. Beck, D. Leukel and U. Flörke, Angewandte 
Chemie International Edition, 2005, 44, 975-977. 
References 
381 
 
 
97. M. Yamanaka and E. Nakamura, Journal of the American Chemical Society, 
2001, 123, 1703-1708. 
98. S. E. Gibson and N. Mainolfi, Angewandte Chemie International Edition, 
2005, 44, 3022-3037. 
99. T. J. M. de Bruin, A. Milet, A. E. Greene and Y. Gimbert, The Journal of 
Organic Chemistry, 2004, 69, 1075-1080. 
100. M. E. Krafft, R. H. Romero and I. L. Scott, The Journal of Organic 
Chemistry, 1992, 57, 5277-5278. 
101. T. R. Hoye and J. A. Suriano, The Journal of Organic Chemistry, 1993, 58, 
1659-1660. 
102. M. E. Krafft, R. H. Romero and I. L. Scott, Synlett, 1995, 1995, 577-578. 
103. F. Robert, A. Milet, Y. Gimbert, D. Konya and A. E. Greene, Journal of the 
American Chemical Society, 2001, 123, 5396-5400. 
104. B. E. Moulton, J. M. Lynam, A.-K. Duhme-Klair, W. Zheng, Z. Lin and I. J. 
S. Fairlamb, Organic & Biomolecular Chemistry, 2010, 8, 5398-5403. 
105. B. E. Moulton, A. C. Whitwood, A. K. Duhme-Klair, J. M. Lynam and I. J. 
S. Fairlamb, The Journal of Organic Chemistry, 2011, 76, 5320-5334. 
106. T. Konno, T. Kida, A. Tani and T. Ishihara, Journal of Fluorine Chemistry, 
2012, 144, 147-156. 
References 
382 
 
 
107. N. Aiguabella, C. del Pozo, X. Verdaguer, S. Fustero and A. Riera, 
Angewandte Chemie International Edition, 2013, 52, 5355-5359. 
108. J.-C. Kizirian, N. Aiguabella, A. Pesquer, S. Fustero, P. Bello, X. Verdaguer 
and A. Riera, Organic Letters, 2010, 12, 5620-5623. 
109. B. E. Moulton, H. Dong, C. T. O'Brien, S. B. Duckett, Z. Lin and I. J. S. 
Fairlamb, Organic & Biomolecular Chemistry, 2008, 6, 4523-4532. 
110. R. B. Woodward and R. Hoffmann, Angewandte Chemie International 
Edition in English, 1969, 8, 781-853. 
111. R. B. Woodward and R. Hoffmann, Journal of the American Chemical 
Society, 1965, 87, 395-397. 
112. E. J. Corey and A. G. Hortmann, Journal of the American Chemical Society, 
1963, 85, 4033-4034. 
113. K. Hiraki, Y. Fuchita and K. Takechi, Inorganic Chemistry, 1981, 20, 4316-
4320. 
114. S. B. Atla, A. A. Kelkar, V. G. Puranik, W. Bensch and R. V. Chaudhari, 
Journal of Organometallic Chemistry, 2009, 694, 683-690. 
115. B. V. S. Reddy, G. Revathi, A. S. Reddy and J. S. Yadav, Tetrahedron 
Letters, 2011, 52, 5926-5929. 
References 
383 
 
 
116. G.-W. Wang, T.-T. Yuan and X.-L. Wu, The Journal of Organic Chemistry, 
2008, 73, 4717-4720. 
117. M. R. Warren, S. K. Brayshaw, A. L. Johnson, S. Schiffers, P. R. Raithby, T. 
L. Easun, M. W. George, J. E. Warren and S. J. Teat, Angewandte Chemie 
International Edition, 2009, 48, 5711-5714. 
118. L. E. Hatcher, M. R. Warren, D. R. Allan, S. K. Brayshaw, A. L. Johnson, S. 
Fuertes, S. Schiffers, A. J. Stevenson, S. J. Teat, C. H. Woodall and P. R. 
Raithby, Angewandte Chemie International Edition, 2011, 50, 8371-8374. 
119. M. R. Warren, S. K. Brayshaw, L. E. Hatcher, A. L. Johnson, S. Schiffers, A. 
J. Warren, S. J. Teat, J. E. Warren, C. H. Woodall and P. R. Raithby, Dalton 
Transactions, 2012, 41, 13173-13179. 
120. T. W. Lyons and M. S. Sanford, Chemical reviews, 2010, 110, 1147-1169. 
121. J. A. Camargo and Á. Alonso, Environment International, 2006, 32, 831-849. 
122. F. B. Jensen, Comparative Biochemistry and Physiology Part A: Molecular 
& Integrative Physiology, 2003, 135, 9-24. 
123. X.-Y. Dong, Z.-W. Gao, K.-F. Yang, W.-Q. Zhang and L.-W. Xu, Catalysis 
Science & Technology, 2015, 5, 2554-2574. 
124. W. Zhang, S. Ren, J. Zhang and Y. Liu, The Journal of Organic Chemistry, 
2015, 80, 5973-5978. 
References 
384 
 
 
125. X. Chen, K. M. Engle, D.-H. Wang and J.-Q. Yu, Angewandte Chemie, 2009, 
121, 5196-5217. 
126. C. Zhou and R. C. Larock, Journal of the American Chemical Society, 2004, 
126, 2302-2303. 
127. S.-G. Lim, J.-A. Ahn and C.-H. Jun, Organic Letters, 2004, 6, 4687-4690. 
128. Y. Kuninobu, Y. Nishina, M. Shouho and K. Takai, Angewandte Chemie 
International Edition, 2006, 45, 2766-2768. 
129. J. S. Ward, J. M. Lynam, J. W. B. Moir, D. E. Sanin, A. P. Mountford and I. 
J. S. Fairlamb, Dalton Transactions, 2012, 41, 10514-10517. 
130. M. Bruce, B. Goodall and I. Matsuda, Australian Journal of Chemistry, 1975, 
28, 1259-1264. 
131. M. J. Burns, R. J. Thatcher, R. J. K. Taylor and I. J. S. Fairlamb, Dalton 
Transactions, 2010, 39, 10391-10400. 
132. K. Gao, P.-S. Lee, T. Fujita and N. Yoshikai, Journal of the American 
Chemical Society, 2010, 132, 12249-12251. 
133. R. D. Rogers, H. G. Alt and H. E. Maisel, Journal of Organometallic 
Chemistry, 1990, 381, 233-238. 
134. I. J. S. Fairlamb, F. J. Lu and J. P. Schmidt, Synthesis, 2003, 2003, 2564-
2570. 
References 
385 
 
 
135. E. Fager-Jokela, M. Muuronen, M. Patzschke and J. Helaja, The Journal of 
Organic Chemistry, 2012, 77, 9134-9147. 
136. M. P. Coogan, R. L. Jenkins and E. Nutz, Journal of Organometallic 
Chemistry, 2004, 689, 694-697. 
137. Y.-M. Legrand, A. van der Lee and M. Barboiu, Science, 2010, 329, 299-302. 
138. W. H. Pirkle and L. H. McKendry, Journal of the American Chemical 
Society, 1969, 91, 1179-1186. 
139. Y. Ji, X. Verdaguer and A. Riera, Chemistry – A European Journal, 2011, 
17, 3942-3948. 
140. M. Irie, Chemical Reviews, 2000, 100, 1685-1716. 
141. X. Rao, C. Liu, J. Qiu and Z. Jin, Organic & Biomolecular Chemistry, 2012, 
10, 7875-7883. 
142. M. R. R. Prabhath, J. Romanova, R. J. Curry, S. R. P. Silva and P. D. 
Jarowski, Angewandte Chemie International Edition, 2015, 54, 7949-7953. 
143. R. Ul Islam, S. K. Mahato, S. K. Shukla, M. J. Witcomb and K. Mallick, 
ChemCatChem, 2013, 5, 2453-2461. 
144. A. N. Kozhevnikova, M. S. Shvartsberg and I. L. Kotlyarevskii, Bulletin of 
the Academy of Sciences of the USSR, Division of chemical science, 1973, 22, 
1132-1134. 
